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ABSTRACT 
The study of neurotransmission allows for greater understanding the central nervous 
system and can also improve our ability to understand and treat neurological disorders. 
The use of optical sensors to study neurotransmission can give insights that cannot be 
obtained through other techniques, as optical sensors are capable of providing spatial 
and temporal information about neurotransmission on a sub-cellular scale. Of particular 
interest is glycine, as while it is known as a primary inhibitory neurotransmitter in the 
central nervous system, it has also been shown to be important for the synaptic plasticity 
of glutamatergic neurons in the hippocampus. While this suggests that glycine plays a 
role in long term memory formation and learning, the exact contribution and regulation 
of this neurotransmitter is currently debated. An optical sensor for this neurotransmitter 
can provide new insight into the usage, release and distribution of glycine, which would 
improve our understanding of how learning and memory is moderated in the central 
nervous system.  
The main obstacle facing the use of optical sensors in biological imaging is that 
a specific sensor must be developed for a specific ligand, which is often a non-trivial 
process. As there is currently no optical sensor for glycine, one must be developed in 
order to allow for the study of this neurotransmitter. In this work we describe the 
engineering of a genetically encodable glycine specific optical sensor, GRIP (Glycine 
Ratiometric Indicator Protein) as well as the development of the semi-synthetic sensors 
GRIPPED (Glycine Ratiometric Indicator Protein Potency Enhanced by a Dye) and 
GASP (GABA Sensing Protein), which are a more sensitive optical sensor for glycine 
and a GABA sensor, respectively. The methodology and sensor designs employed in the 
creation of these sensors (GRIP, GRIPPED and GASP) could be useful for the 
development of optical sensors for other ligands, making optical sensor development for 
other neurotransmitters of interest more accessible in general.  
The genetically encodable sensor GRIP was also applied in situ within acute 
hippocampal brain slices from rats, in order to both demonstrate its functionality as well 
as to study glycine neurotransmission in the context of neuronal synaptic plasticity. Of 
the insights gained from the application of this sensor, two particularly noteworthy 
findings include differences in glycine availability between different neuron 
substructures with micron scale resolution and the time-correlated release of glycine in 
response to long term potentiation inducing stimulus (high frequency stimulation). The 
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physiological results are a direct confirmation of differential glycine regulation as a 
component of neuronal synaptic plasticity and the results also demonstrate that the 
GRIP sensor is able to report spatial and temporal information, as initially desired. 
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1 A. THE CENTRAL NERVOUS SYSTEM (CNS) AND NEUROTRANSMISSION 
From a functional and mechanistic perspective, the central nervous system (CNS) is the 
primary mediator of other physiological systems and organs, acts as the processor for all 
forms of external stimulation, and is the biological unit responsible for decision making 
and information storage.
1,2
 This makes the study of the CNS valuable for medical and 
scientific purposes, as it inevitably leads to improvements in the capacity and ability to 
treat disorders and diseases that influence or originate within the CNS.
3
 Alternatively, 
the CNS can be seen as the origin of an individual’s consciousness and self, giving the 
study of the CNS additional value beyond improving fundamental scientific 
understanding, as it may also answer or give insight into persistent philosophical and 
metaphysical questions. 
Many interweaving processes underlie the overall function of the CNS and 
understanding the mechanisms of these processes is critical in order to fully understand 
the CNS itself. One process particularly important to CNS function is neurotransmission 
(also referred to as synaptic transmission), which encompasses the communication 
between individual neurons and also across multiple systems of neurons.
4,5
 This 
communication can take the form of either electrical or chemical signals and will vary 
depending on the nature of the synapse between connected neurons as well as the types 
of neurons involved.
1,6
 When a neuron is at rest, sodium is actively pumped out from 
the neuron and potassium is taken in, which results in an overall positive charge across 
the outside surface of the neuron membrane, while the membrane surface on the inside 
of the neuron carries an overall negative charge (-70 mV relative to the outside surface). 
In a simplistic model of a neurotransmission event (Figure 1), a given neuron (the 
presynaptic neuron) will receive some form of stimulus or signal, and the magnitude of 
this signal must result in a change in the membrane voltage that exceeds a certain 
threshold (-55 mV). If this voltage threshold is reached, the neuron will undergo an 
action potential; a large spike in the membrane potential that is generated by the rapid 
influx of cations, usually sodium ions, through voltage dependent ion channels. If this 
voltage threshold is not reached, an action potential will not occur, and any accumulated 
positive (less negative) voltage will be offset by the permeation of potassium ions 
across the membrane, returning the neuron to a resting state. An action potential will 
propagate across the axon of the neuron towards a synapse, which connects presynaptic 
neuron to another neuron (the postsynaptic neuron). Depending on the nature of the 
Chapter 1 
3 
 
synapse, it can either allow this electrical current to continue on to the postsynaptic 
neuron directly (via a gap junction), or through a chemical synapse, where it will 
activate calcium channels at the presynaptic neuron, resulting in the uptake of calcium 
ions. This influx of calcium ions causes the vesicular release of chemicals 
(neurotransmitters) from the presynaptic neuron, which then diffuses across the synaptic 
cleft and interacts with the postsynaptic neuron. Once the postsynaptic neuron has 
received the electrical pulse or the chemicals, it can initiate another neurotransmission 
event, if necessary, to another neuron thereby continuing the propagation of the signal. 
Neurotransmission can be viewed broadly as encompassing the initiation of an action 
potential to the release and reception of the signal by another neuron, but the discussion 
and study of neurotransmission is often concerned only with what occurs at the synapse, 
specifically, the release and propagation of neurotransmitters. 
 
 
Figure 1: Schematic of a neuron undergoing neurotransmission after stimulation A) the 
dendrites of the neuron are stimulated (red circle), either by an electrical pulse or 
through activation of receptors that allow ion influx. B) The resulting action potential 
travels down the axon of the neuron away from the soma (body) towards the axon 
terminals. C) This activates voltage sensitive calcium channels, where the intake of 
calcium ions triggers the release of vesicles containing neurotransmitters from the 
presynaptic neuron (grey), which diffuses across the synaptic cleft towards receptors 
on the postsynaptic neuron (pink). 
 
In the case of a chemical synapse, the specific neurotransmitters released depend on the 
neuron type, with different neurons utilizing and prioritizing different chemicals. In the 
A B 
C 
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past, it had been thought that a given neuron would only release one type of 
neurotransmitter; it is now known that neurons are not necessarily restricted in this way 
and may release more than one type of neurotransmitter for signaling.
1,7-9
 For example, 
GABAergic neurons are primarily involved in γ-aminobutyric acid (GABA) signaling 
and glutamatergic neurons in glutamate signaling, but both can potentially release 
neurotransmitter peptides along with their primary neurotransmitter upon stimulation.
10
 
Furthermore, it has been found that it is possible for two “classical” neurotransmitters, 
such as glycine and GABA, to be released simultaneously from the same vesicle.
11
 
Different types of neurons are associated with different regions and substructures of the 
brain,
9,12-16
 and may be an important component as to why or how different brain 
structures fulfill different roles.
17
 The molecules that are used as neurotransmitters 
encompass a wide range of subgroups, including inorganic molecules such as nitrous 
oxide,
18
 to organic molecules such as amino acids, peptides and steroids.
19-22
 
Despite much research, the precise roles, interactions and contributions of many 
of these different molecules towards specific neuronal behaviors are not fully 
understood, with varying levels of understanding for different neurotransmitters as well 
as varying levels of agreement as to their importance.
5,23-25
 This makes the development 
of neurological imaging techniques important, as tools that can facilitate the precise 
real-time observation and documentation of neurotransmission in vivo (or in situ) will 
provide greater insight into a wide range of physiological and neurological processes, 
and by extension the CNS. 
 
1 B. OVERCOMING LIMITATIONS IN STUDYING NEUROTRANSMISSION 
A substantial part of our understanding of CNS function has been derived from 
extrapolation of observed therapeutic effects of medications and psychotropics, genetic 
manipulations, or correlating signal output of bulk tissue imaging techniques such as 
magnetic resonance imaging (MRI) to behavioral phenotypes.
26-28
 These techniques 
provide only limited insight into the true mechanisms and processes behind 
neurotransmission and related diseases. Electrophysiological techniques, which can 
operate on a cellular scale, can offer greater insight by allowing precise time-dependent 
measurement of neurotransmission events in the form of changes in the voltage (or 
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current) across the cellular membrane. However, use of electrophysiology has the pitfall 
of being unable to provide meaningful spatial observations, such as neurotransmitter 
compartmentalization or signaling events in small neuronal structures. Furthermore, due 
to the invasive nature of electrophysiology, it is difficult to observe multiple signaling 
events or perform synchronized recordings from several neurons due to the 
impracticality of immobilizing multiple electrodes within the limited space available.
29
 
Other techniques such as microdialysis and HPLC have been used to quantitatively 
monitor neurotransmitter availability, however these techniques also have their 
limitations in that although the quantitative accuracy of neurotransmitter estimations 
may be high, the resolution of both temporal and spatial parameters are poor due to the 
limitations in probe size and sampling frequency.
30,31
   
These issues are typically overcome by optical techniques, where there is no 
need for direct physical contact between the signal receiver and tissue for 
measurements, and where the nature of the signal (photons) means there is negligible 
interference with neuronal behavior. Most importantly, unlike electrophysiological 
techniques, which are voltage or current dependent and can only observe 
neurotransmission events essentially as a uniform signal across large neuronal 
structures, optical techniques can provide detailed spatial information.
32
 This is because 
optical reporters (also called optical biosensors) rely upon changes in their immediate 
environment, such as an increase or decrease in local neurotransmitter concentrations, 
making that the signal output of such sensors spatially defined and also potentially 
quantitative.
33
 In other words, electrophysiological techniques require a detectable 
change in measured membrane potentials in order to extrapolate the presence of a 
neurotransmitter, while optical techniques will respond directly to the presence of a 
neurotransmitter, even if the neurotransmitter is not currently inducing a physiological 
effect. In principle, this would allow for an optical sensor to distinguish regional 
differences in neurotransmitter usage and concentrations within neuronal structures in 
ways that electrophysiology does not. A more exhaustive examination and comparison 
of the strengths and differences between electrophysiological techniques and optical 
techniques can be found in the literature,
29
 but despite such comparisons, optical 
techniques should not be seen as incompatible with electrophysiology. Rather, there is 
the potential for these techniques to be used in a complementary manner as electrical 
and luminous signals do not interfere with each other and as such these techniques can 
be employed simultaneously,
34
 which only makes clearer the merits in further 
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developing such optical sensors. However, unlike electrophysiological techniques, 
where multiple forms of neurotransmission can be interpreted as voltage/current 
changes, optical biosensors are usually designed specifically for one target. For 
neurological studies that seek to use optical sensors, the main restriction is that an 
optical sensor that possesses specificity with a target neurotransmitter may not be 
available. 
As such, unless a sensor can be developed, it would not be possible to observe 
the neurotransmitter and related processes optically. This makes the development of 
new sensors of interest, as increasing the number of different neurotransmitters that can 
be studied will result in a more complete understanding of numerous neurological 
processes. 
1 C. CONTEMPORARY OPTICAL SENSORS 
In the context of studying biological and neurological processes, optical sensors, or 
biosensors, can be broadly categorized as either dye based sensors, including small 
molecule indicators (SMIs),
35-37
 or as a genetically encodable sensor.
38
 However these 
sensors fundamentally share the same principles of function, in that they typically 
operate by producing a change in a given sensor’s fluorescent (or luminous) output as a 
result of interactions with its target neurotransmitter or ligand. In practice this could be 
an observable change in signal intensity or a correlated change in signal across a range 
or set of wavelengths. In general, genetically encodable sensors, and some dye based 
protein based sensors, are comprised of one or more proteins that are capable of 
recognizing a desired ligand. These proteins, which will be referred to as binding cores 
or recognition domains, usually undergo some kind of ligand induced change in the 
state of the protein, such as a change in conformation, location, or domain/protein 
associations, which is exploited to alter the spectral output of the sensor.
39
 For sensors 
that utilize a single fluorophore, this is usually a result of the functional fluorophore 
becoming perturbed or solvated/desolvated and thereby undergoing greater excitation or 
quenching.
40
 For sensors that use more than one fluorophore (binary fluorophore 
sensors) conformational changes or domain associations of the proteins are exploited 
such that it ultimately results in the movement of the attached fluorophores into greater 
or further proximity from each other, which can change the observed emission spectra 
of the fluorophores through the phenomenon of Förster resonance energy transfer 
Chapter 1 
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(FRET), making such sensors also known as FRET sensors.
41,42
 There are advantages to 
both single fluorophore and binary fluorophore systems, but comparison of the two in 
both principle and practice identifies that, for long term quantitative analysis, binary 
protein based sensors are more suitable. This is primarily owing to the independence of 
binary type sensors to variability in sensor concentration, but there are other 
contributing factors, as discussed in the following sections. 
 
1 D. SINGLE FLUOROPHORE SENSORS 
                    
 
 
Figure 2: Representations of various single fluorophore sensors. A) Calcium sensing 
dye Fluo-4, where the linked BAPTA is able to chelate calcium ions which results in a 
several fold increase in the fluorescent output of the dye. B) SnFR type sensors, where 
binding of the ligand results in conformational changes to the circularly permuted 
fluorescent protein, which effects fluorescent output. C) EOS type sensor, where the 
tethered dye will undergo a change in solvation or local environment upon the binding 
core interacting with the ligand, in turn affecting fluorescent output. 
 
A 
B 
C 
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Single fluorophore, or intensity dependent, sensors include both protein based sensors 
and chemical sensors, both of which typically rely on the binding or chelation of the 
target neurotransmitter to alter its spectral properties (Figure 2). An example of 
functional SMIs are the commercially available BAPTA based (1,2-bis(o-
aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid) “Fluo” series of dyes for sensing 
calcium ions (Ca
2+
),
43
 which have low initial fluorescence but have increases in 
fluorescence up to several orders of magnitude when calcium is bound. The major 
strength of such SMIs is that they possess high fluorescence intensity outputs, which in 
practice results in greater signal to noise compared to non SMI counterparts. In some 
cases the changes in intensity due to neurotransmitter presence is sufficiently large 
enough that it allows these sensors to be used for quantitative measurements. However, 
there are limitations in their applicability, since SMIs are typically poorly suited to long 
term experiments, are difficult to selectively apply to a desired region of interest and 
can have issues with specificity.
35,44-46
 Comparatively, protein based sensors are usually 
genetically encodable, allowing for greater location selectivity within tissue and 
typically possess a greater experimental lifetime.
47
 These sensors possess desirable 
properties and practical functionalities that most SMIs lack, but most importantly, have 
demonstrated the ability to selectively and/or specifically image organic ligands and 
neurotransmitters, such as glutamate or cyclic adenosine monophosphate (cAMP).
48,49
 
This is something that is currently not possible with SMIs which are mostly limited to 
monitoring various metal ions or small inorganic compounds (sodium, calcium, 
hydrogen peroxide etc).
35,37,49,50
 
The use of fluorescent proteins (FPs) has allowed for the introduction of 
fluorescent capabilities to protein constructs without the need for organic reagents. 
Often FPs are expressed as fusions to either the N-terminus or C-terminus of a protein 
construct, and when these locations are not appropriate for the creation of an optical 
sensor, application of techniques such as circular permutation means that it is 
sometimes possible to insert them within a protein, allowing for relocation or re-
orientation of the fluorophore.
51
 While this has proven useful for binary sensors for 
FRET, in single fluorophore sensors this has allowed for the creation of FP-fused 
sensors where conformational changes in the binding core can influence the spectral 
output of the inserted FP. A good example is the range of sensing fluorescent reporters 
(SnFRs) developed by Marvin et al., where they have used green fluorescent protein 
(GFP) insertions into glutamate, maltose and phosphonate binding proteins to generate 
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single emission sensors which indicate binding through changes in fluorescent output 
(ΔF).52 These sensors have demonstrated large maximal fluorescent signals, as high as a 
six fold increase in fluorescent output in response to exposure to their target ligand in 
vivo within complex tissue. The main design principle behind these SnFRs is that the 
insertion of circularly permuted fluorescent proteins (cpFP) into a loop or helix that has 
a large ligand mediated change in backbone orientation can result in distortions to the 
cpFP barrel structure, which itself can result in large increases or decrease fluorescent 
output. The resulting sensor was demonstrably functional in vivo and the methodology 
has a significant advantage in that it can be applied to proteins which lack correctly 
orientated N and C termini. 
An alternative to using FPs in protein based single fluorophore sensors is to use 
small organic fluorescent dyes as a component to a protein based sensor, which, 
although not as cost-effective or experimentally convenient as genetically incorporating 
FPs, possess much higher extinction coefficients and therefore offer much higher 
fluorescent intensities and signal to noise ratios. The use of organic dyes has the 
significant benefit of permitting residue specific labelling of proteins of interest, 
allowing precise control over the fluorophore location to an even greater extent than 
SnFR type sensors. The use of these organic dyes has allowed Namiki et al to develop 
the “glutamate optical sensor” EOS, capable of visualizing excitatory glutamate 
transmission in situ.
40
 The methodology employed involved screening a library of single 
cysteine mutants of the glutamate binding protein labelled with a thiol specific 
fluorescent dye, selecting for constructs that demonstrated increased fluorescence as a 
function of glutamate concentration. Such sensors rely on the protonation/solvation 
dependency of fluorescent emission, where the solvent exposure, and therefore the 
conformational displacement of the dye as determined by the state of the binding core, 
will determine the spectral emission. The EOS found to produce the highest fluorescent 
signal (37%) had a cysteine mutation within a loop positioned over the binding cleft, 
which led Namiki et al. to suggest that the fluorescent dye is initially buried within the 
cleft and upon ligand binding it is liberated allowing for greater solvent interactions, 
which is consistent with the principle of altering fluorescence through solvent exposure. 
As with the SnFR type sensors, the EOS sensors were shown to be functional in vivo. 
These techniques are not without disadvantages. For the SnFRs there may be 
issues with implementation. For example, Marvin et al. have put forward a rational 
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basis for the selection of cpFP insertions for the creation functional SnFR constructs. 
Specifically, locations where there are large changes in the pseudo-dihedral angle of the 
carbon backbone.
52,53
 However, the actual magnitude of change in the pseudo-dihedral 
angle does not appear to correlate to the magnitude of change (if any) in the observable 
fluorescent signal. Additionally, although insertion locations could be selected based on 
rational criteria, it was still necessary to generate and screen, via high-throughput 
methods, randomized linker libraries between the cpFP and binding core in order to 
improve the dynamic range. Furthermore, after doing these optimizations it was 
possible that the insertions decreased binding affinity to the extent that the sensor 
construct was no longer suitable for practical use.
53
 
For SMIs, there are issues with selectivity, where various SMIs can have 
particular sensitivities to other metals, such as magnesium or an array of heavy metals.
46
 
This can contribute towards the difficulty in using such indicators for quantitative 
analysis, as the presence or these metals can influence the effective affinity of the SMIs. 
There are also disadvantages that are intrinsic to single fluorophores in that they 
are generally qualitative.
39,41
 The major contributor towards this is due to the signal 
output is directly dependent on the availability or concentration of sensor, meaning that 
without rigorous calibration, or a method of determining the true concentration of 
sensor in vivo, it can be difficult to accurately correlate accurately observed signal with 
bound ligand, restricting many single emission sensors to qualitative rather than 
quantitative analysis.
39
 In order to obtain a greater level of sensitivity, it is necessary to 
have a sensor that functions independent of sensor concentration (assuming that there is 
100% sensor activity), which becomes possible with the use of ratiometric, binary 
fluorescent sensors, identified previously (section 1 C) as FRET sensors. 
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1 E. FÖRSTER RESONANCE ENERGY TRANSFER (FRET) 
    
Figure 3: Basic representation of FRET. When the two fluorophores are not in 
sufficient proximity to each other the donor fluorophore (green) will not undergo FRET, 
meaning that there is no transfer of energy to the acceptor (yellow) and as such the 
energy will be emitted at the donor emission wavelength. When the fluorophores are 
within sufficient proximity, the energy, instead of being re-emitted as a photon at the 
donor wavelength, will instead excite the acceptor fluorophore, which will then undergo 
fluorescence, emitting at the acceptor emission wavelength. 
 
FRET occurs when two fluorophores (a FRET pair) are in proximity to each other and 
the spectral emission of one fluorescent constituent (the donor) overlaps with the 
excitation range of another fluorescent constituent (the acceptor) resulting in non-
radiative energy transfer that allows for spectral emission from the acceptor 
(Figure 3).
54
 In practice, this usually results in an observable loss of emission intensity 
from the donor and a corresponding increase in emission from the acceptor, which can 
be expressed as a ratio (FA/FD). As this transfer is dependent on the interfluorophore 
distance (r) between donor and acceptor, changes in this distance will result in changes 
in the efficiency of this transfer (FRET efficiency, EFRET).
55
 
𝟏) 𝐸𝐹𝑅𝐸𝑇 =
𝑅0
6
𝑅0
6 + 𝑟6
 
The term R0 is the Förster distance, which refers to the distance where a given pair of 
fluorophores will have a FRET efficiency of 50%. When values of r become small or 
large, the FRET efficiency will approach the maximum and minimum possible values 
respectively (Figure 4). 
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Figure 4: The relationship between interfluorophore distance and FRET efficiency for 
an ECFP and Venus FRET pair, assuming the fluorophores are orientated randomly. 
The Förster distance for this FRET pair is 4.9 nm. Changes in interfluorophore distance 
approximate to the Förster distance will result in a larger change in FRET efficiency. 
For example, increasing the distance from 4 nm to 6 nm will have a larger change in 
FRET efficiency than from increasing the distance from 6 nm to 8 nm. 
 
A consequence of this relationship is that when the interfluorophore distance is within a 
range that is approximate to the R0 value, there will be a larger change in FRET 
efficiency per unit of distance (ΔEFRET/d). The Förster distance is be mathematically 
defined by equation 2. 
𝟐) 𝑅0
6 =  
9000 𝑙𝑛 10  𝐽 𝜅2𝑄𝐷
𝑁𝐴128 𝜋5𝑛4
 
As the Förster distance is dependent on fluorophore orientation, defined by the term κ, 
this also means that changes in orientation will affect the FRET efficiency. In simple 
terms, a higher the FRET efficiency means more energy is transferred from the donor to 
the acceptor, and a lower FRET efficiency means that less energy is transferred, 
allowing it to be lost through other energy pathways, such as emission from the donor 
fluorophore. 
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In the case of protein based FRET sensors that follow a typical one site/substrate 
binding system (i.e. not allosteric or modulated), the interfluorophore distance changes 
between one of two values depending on the binding state of the protein (bound or 
unbound). This essentially means that the sensor will have one of two possible FRET 
efficiency values depending on the presence of ligand. This appears to hold true even 
for sensors that rely on more than simple conformational dynamics, such as those that 
rely on multi domain or multi step association/dissociation to facilitate FRET. As the 
outgoing FRET signal is a composite spectrum of both bound and unbound sensor, it is 
possible to use the observed FRET ratio to quantify the population distribution of apo 
and holo sensor. For example, assuming the sensors behave ideally, if the open state of 
the sensor had an interfluorophore distance of x which corresponded to a ratio of xratio 
and the bound state had a distance of y which corresponded to a ratio of yratio, then at 0% 
occupancy (therefore 100% open/unbound state) the observed spectrum will be equal to 
xratio, while conversely, at 100% occupancy the observed spectrum would be yratio. 
Similarly, should there be 50% occupancy; in principle the observed ratio would be the 
midpoint value between xratio and yratio. As the population distribution of sensor is 
dependent on available ligand concentrations, quantifying the population distribution 
will by extension allow for quantification of ligand concentrations. 
The population distribution of bound/unbound protein at a given concentration 
of ligand is determined by the affinity (or dissociation constant, Kd) of the binding core 
and follows the same dynamics as any system of equilibrium, i.e. that when equilibrium 
has been reached and the free ligand concentration [L] is equal to the Kd, there will be a 
1:1 ratio of bound to unbound protein ([P] = [LP]). Furthermore, when equilibrium has 
not yet been reached but [L] is equal to the Kd and at the same time is also much greater 
than [P] (i.e. [L]>>[P]), then it can be assumed that once equilibrium has been reached 
the amount of ligand bound will not drastically affect the concentration of [L] and 
therefore [P] will still approximate to [LP] once equilibrium has been reached. 
𝟑) 𝐾𝑑 =
[𝐿][𝑃]
[𝐿𝑃]
 
This means that binary sensors are largely independent of the sensor concentration, as 
the observed signal does not rely on [Ptotal] (or fluorophore total) as with single 
fluorophore sensors, but is instead proportional to the ratio of [P]:[LP] (or [LP] to 
[Ptotal]). As [Ptotal] may change during the time course of an experiment, this can greatly 
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affect the detected signal for single fluorophore sensors, making in vivo quantitative 
analysis difficult without a means to monitor [Ptotal] accurately. Conversely, for binary 
sensors, the ratio of [P]:[LP] or [LP]:[Ptotal] is dependent on the concentration of ligand, 
hence the ratio of intensities should remain the same, even if the total intensity 
decreases along with [Ptotal], which is a clear advantage when compared to single 
fluorophore sensors. 
This relationship also means that, in many cases, the hill equation can be used to 
quantify neurotransmitter concentrations for binary sensors. Which, for non-allosteric or 
cooperative sensors with a single binding site or a 1:1 interaction with the 
neurotransmitter, the equation allows for the hill co-efficient n to be removed (treated 
as 1), thereby simplifying the equation. 
𝟒) 
[𝐿𝑃]
[𝑃𝑡𝑜𝑡𝑎𝑙]
=
[𝐿]
𝐾𝑑 + [𝐿]
 
Within the literature there are different mathematical interpretations and methods as to 
how an observed ratio can be converted into an exact concentration using the hill 
equation.
56-58
 It should be noted that there are varying levels of simplification and 
derivatization between publications, so while an equation may appear different on initial 
inspection, in reality they are functionally identical.
33
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1 F. CONTEMPORARY BINARY SENSORS 
 
 
 
Figure 5: Representations of various binary type sensors. A) Conformation dependent 
sensors, such as the Chameleon calcium sensor or the glutamate sensor FLIPE, where 
the presence of the target ligand induces a conformational change in the sensor, in the 
case of the Chameleon calcium sensor, this is the reconfiguration of a disordered 
peptide (M13) which results in the repositioning of the fluorophores. B)  Snifit sensors, 
like the EOS single fluorophore type sensor, rely on tethered dyes. In this case, the 
dyes are arranged such that without the presence of the target ligand there is no FRET, 
when the target ligand binds the tethered dyes are liberated and will be able to undergo 
FRET. C) Design of the cAMP sensor, which relies on protein-protein interactions. The 
catalytic and regulatory domains are able to associate allowing for the fluorophore pair 
to undergo FRET. In the presence of cAMP the domains can no longer associate, 
which also prevents the fluorophores from undergoing FRET. 
 
As a consequence of the sensor function being independent from intensity, improving 
and maximizing the ligand mediated changes in FRET ratio or efficiency (FA/FD) 
C 
 
A 
 
B 
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becomes the priority for binary sensors, rather than changing ΔF as with the single 
fluorophore sensors (assuming that the Kd is within an acceptable range). The FRET 
efficiency is influenced by a number of factors such as the maximum change in inter-
fluorophore distance, orientation and the flexibility of the fluorophore.
55
 Various 
methods to improve these parameters include methods such as circular permutation, 
which can re-orient the FP location on a protein,
59
 linker optimizations,
60
 where the 
linker region can be made rigid or otherwise can re-orient the FP to a more ideal 
position, and cycling through various fluorophore orientation or FRET pairs,
61,62
 where 
changes to the Förster distance or orientation can optimize signal output by maximizing 
the change in FRET efficiency between the bound and unbound state. A number of 
these methods have been used to construct functional binary sensors that have 
demonstrated the ability to report spatial and quantitative information (Figure 5). 
While SMIs and some protein based single fluorophore sensors do possess some 
advantages over binary sensors, in particular SMIs possess higher relative signal 
intensity and signal to noise, the aforementioned issues with distribution, specificity, 
quantification and lifetime can make them less experimentally robust compared to their 
binary counterparts. An example of a functional binary sensor is the Chameleon calcium 
sensors Tsien et al. have developed, which are sensitive across a range from high 
micromolar to nanomolar concentrations of calcium.
63,64
 The sensors rely on the 
calcium dependent intermolecular interactions of calmodulin and the calmodulin 
binding peptide M13, where calcium induces a large conformational change that alters 
the proximity of the attached FRET pairs. Unlike the corresponding calcium SMIs, the 
protein based FRET sensor is calcium specific, has a longer experimental lifetime and is 
demonstrably genetically encodable, which can potentially allow it to be expressed in 
specific cellular compartments. These attributes allow for a greater level of detail and 
accuracy to be obtained, which would otherwise not be possible with SMIs. 
Another example is the glutamate fluorescent sensor series (FLIPE600n) 
developed by Okumoto et al. who were able to monitor glutamate release and 
distribution in real time and also determine glutamate concentrations at a neuron surface 
using this sensor.
48
 This was accomplished by taking the wild type glutamate binding 
protein ybeJ and attaching an Enhanced cyan fluorescent protein (ECFP)/Venus FRET 
pair to the N and C termini respectively, which gave a measurable glutamate dependent 
FRET response. The construct was then expressed on the membrane surface of a 
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neuronal culture which allowed for the documentation of glutamate release due to 
electrical stimulation. In addition, a series of affinity mutants were generated, although 
it appeared that only FLIPE600n was necessary for practical usage. It must also be 
stated that although it is described as a glutamate sensor, there was appreciable affinity 
for aspartate (~1 µM) which is a potential source of concern. Existing research and 
understanding suggests that in this particular case, it is most likely glutamate 
responsible for the observed signal changes (as aspartate is not known to undergo 
vesicular release).
65,66
 While there is some disagreement as to the status of aspartate as 
an endogenous neurotransmitter, the role it would fulfill would be the same as 
glutamate as an excitatory neurotransmitter, meaning that a sensor that observes both 
glutamate and aspartate could still be used to visualize excitatory neurotransmission.
67
 
While in this instance sensor promiscuity was not a debilitating issue for the practical 
application of this sensor, it is generally not ideal and could render a sensor useless due 
to ligand ambiguity. 
In addition to these genetically encodable sensors, there are also sensors that use 
dyes or synthetic fluorophores to function. One example is the GABA sensor (GABA-
Snifit) developed by Masharina et al.
68
 which comprises a modification of the GABAB 
receptor with the SNAP-CLIP system developed by Keppler et al.
69
 and Gautier et al.
70
 
This design allows for orthogonal covalent incorporation of two different dyes, organic 
compounds or potentially even other proteins to the sensor system. The GABA-Snifit 
contains a fluorescent dye and binding antagonist pair tethered to the SNAP domain and 
another dye attached to the following CLIP domain. In a GABA free environment the 
antagonist is bound to the receptor, which creates a fixed distance between the two 
attached fluorophores. Upon the introduction of GABA, which competes with the 
antagonist, the antagonist is displaced and as such is liberated along with the dye, which 
also results in a change in proximity between the two fluorophores. As the persistent 
binding of an antagonist to a receptor could conceivably influence normal neuronal 
behavior a functional alternative version was also developed, which was modified as to 
deactivate the intracellular signaling domain. The GABA-Snifit system showed a FRET 
ratio change of over 80% for the detection of GABA, could express on the surface of 
human embryonic kidney cells (HEK 293) and it was also shown that the sensor 
responded to perfusion and wash out of GABA in vivo, demonstrating that the sensor 
was functional. This sensor design is not without its drawbacks, for example, the use of 
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a transmembrane binding core can restrict the different environments that this sensor 
can be applied (Discussed further in chapter 3). 
The cAMP sensor, developed by Zaccolo et al. also uses a transmembrane 
protein complex as the recognition component of the cAMP sensor, specifically a 
cAMP dependent protein kinase.
71
 Two versions of the sensor have been described, one 
using organic dyes and the other using FPs, with the FP version developed because it 
could be applied in a wider range of experiments and environments. The sensor 
functions through a domain dissociation mechanism, where binding of cAMP results in 
dissociation of the catalytic domain and the regulatory domain, each with an attached 
fluorophore. This was able to produce a ratio change of over 40% (for the dye modified 
sensor) and was able to monitor physiologically relevant events such as the 
norepinephrine mediated release of cAMP in COS-7 cells. In addition, it was found that 
over-expression of the modified kinase did not appreciably influence correct 
physiological behavior, on the basis of traits such as cell morphology and calcium 
(Ca
2+
) levels. 
These designs can be further diversified and customized through the use of 
different FP based FRET pairs, which can offer a range of different spectral properties if 
so desired.
72
 Of particular note are FRET pairs that utilize the dimerization properties of 
fluorescent proteins to enhance or improve FRET spectra, called dimerization-
dependent fluorescent proteins (ddFPs), which are only optically active upon contact of 
two defined fluorescent proteins and can potentially improve signal sensitivities and 
(depending on the FRET system it has been used in).
73
 
Overall, binary sensors are intrinsically able to provide ratiometric spectra 
which, in principle, allows for quantitative analysis. This is something that is not 
possible (or optimal) for most single fluorophore systems and as a consequence, 
assuming all other sensor qualities being equal, binary sensors are preferable. 
 
1 G. SENSOR DESIGN AND CONSTRUCTION 
Taking the previous points into consideration, developing a protein based FRET system, 
rather than a SMI or a single fluorophore reporter, is the most appropriate option for the 
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purposes of developing a sensor that is able to report quantitative and spatial data over a 
physiologically relevant range and across physiologically relevant time intervals. This is 
also the most flexible option, as this allows for genetic encoding as well as the option 
for small organic dyes to be used as a means of signal optimization. The key issue then 
becomes determining the most suitable starting template for the sensor development. 
Primarily, it is a choice between whether the native receptor (usually transmembrane) 
can be engineered into a suitable sensor, or if an alternative can be found that is more 
appropriate. 
Using the native receptor can often be a sensible option, as most of the time 
selectivity and physiologically relevant affinity is already present. However, as with all 
sensor precursors, this is usually contingent on the availability of structural information 
or information about conformational dynamics, as without this information, sensor 
development proceeds blindly which is both inefficient and prone to failure. One key 
consideration is that structural characterization is generally far more demanding for 
transmembrane proteins than for soluble analogues.
74
 Additionally, if by chance it does 
sample favorable conformations, or there is reason to believe that it can be modified to 
undergo desired conformations, attempts to modify or engineer the receptor to improve 
signaling or binding can be more time consuming compared to an equivalent soluble or 
globular protein due to the instability associated with transmembrane proteins.
75
 
The main obstacle for developing a sensor using a soluble (and usually 
transgenic) protein is finding or creating one with the desired binding profile, however 
if one is found or engineered it can potentially have some advantages (or fewer 
disadvantages) over a transmembrane analogue. Fortunately, many members of the 
periplasmic binding protein family (PBPs) are able to bind amino acids, many of which 
are neurotransmitters (glutamate, glycine, etc.) or serve as biosynthetic precursors 
(tyrosine, tryptophan, etc.). Some of the previously described protein based sensors, 
including the SnFRs and EOS sensors, have used the PBP family as the binding 
core/template, which serves as evidence using these proteins are a practical starting 
point for sensor development. 
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1 H. PERIPLASMIC BINDING PROTEINS OR SOLUTE BINDING PROTEINS 
The adenosine triphosphate (ATP) binding cassette superfamily of transporters (ABC 
transporters) are transmembrane, multi-domain proteins that are responsible for the 
transport of specific ligands or molecules from the periplasm, or external environment 
of the cell, across the membrane into the cytoplasm, and vice versa.
76,77
 These proteins 
require the hydrolysis of ATP in order to undergo the necessary conformational changes 
to move the ligand across the transmembrane protein structure, following an 
“alternating access” mechanism of motion.78 The ligand specificity for the various ABC 
subtypes range from simple targets such as heavy metals and amino acids, to larger 
more complex molecules such as vitamins, antibiotics and even small peptides.
79
 The 
roles of ABC transporters are also varied, where they can transport molecules that are 
used for cellular construction (lipids, amino acids),
76
 facilitate cellular signaling 
(pheromones),
80
 or contribute to antibiotic resistance, as some bacterial ABC systems 
have evolved to export antibiotics out of the cytoplasm.
81
 
Although ABC transporters can be found in both eukaryotic and prokaryotic 
organisms, the ABC importer subtype is found only in prokaryotic life.
82,83
 ABC 
importers usually have an additional subunit that is responsible for ligand or substrate 
acquisition. In gram-negative bacteria, ABC transporters include a soluble globular 
protein which is responsible for the binding of the target ligand, or ligands. This protein 
is then capable of docking to the transmembrane component of the ABC system, which 
can then move the bound ligand across the membrane to the cytoplasm.
84
 In cases where 
there is no periplasm, as in gram-positive bacteria, the binding domain is either 
expressed as a component of the transmembrane protein or adhered to the cell 
membrane through either a transmembrane leader peptide or post-translational 
modification into a lipoprotein. Despite these differences, the role and function of these 
proteins and/or domains remains essentially the same. These proteins have been referred 
to as periplasmic binding proteins (PBPs), although they have also been referred to by 
the broader description of substrate or solute binding proteins (SBPs),
83,85
 which is 
becoming a more accurate term, as the source organisms that these proteins come from 
may lack a periplasm. Furthermore, the term SBP can also be used to describe related 
proteins or domains that are functionally and structurally similar to PBPs, but may 
originate from a protein complex that is not an ABC transporter system.
83,86
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Figure 6: Crystal structures of the leucine binding SBP in the apo and holo form, 
showing the large conformational change that SBPs undergo upon ligand binding or 
release. 
 
PBPs (or SBPs) can be described as alpha beta proteins that have a “Venus flytrap” 
structure (Figure 6). The protein consists of two globular domains linked by one or 
more “bridging” loops/helices that are capable of ligand mediated conformational 
changes.
87
 PBPs have previously been classified as either type 1 or type 2 based 
exclusively on the topology of the central β-sheet, however further generalizations can 
be made regarding these subtypes. Most type 1 PBPs have three bridging loops and are 
more homogenous in size, whereas type 2 PBPs have either two or three bridging loops 
and display significant variability in topology and size.
88
 Increased study and 
characterization of PBPs has led to the identification of numerous proteins for which 
classification as either the type 1 or type 2 is not informative or accurate. On the basis of 
fold similarity and/or sequence, new SBPs or PBP/SPB-like proteins have been found 
and identified as a part of a wide range of protein complexes or systems including ABC 
transport systems, hybrid ABC/kinase-type systems, transcriptional regulators and more 
(Table 1). In light of this, the classifications of these proteins has been expanded and 
elaborated upon within the literature, both within the PBP family and as a part of a 
broader classification encompassing SBPs in general.
83
 It should be noted that while 
different subgroups of the SBP classifications may have limited sequence homology, 
they all possess the same general Venus flytrap protein fold and conformational 
behavior due to ligand binding, which is the main property of interest for the purposes 
of biosensor development. 
The majority of SBPs possess high binding affinities, with typical Kd values for 
at least one of their substrates ranging between the low micromolar to low nanomolar 
range. Different families have been documented with particular specificities, including 
amino acids, sugars and metal complexes (Table 1). Only SBPs that have been 
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structurally characterized with a related publication have been included for succinctness 
and accuracy. Additionally, families that are primarily catalytic in nature have been 
excluded, as they are arguably not SBPs. 
Pfam 
classification 
Name/Gene Endogenous 
ligand(s) 
PDB 
reference 
Role Reference(s) 
PF00532 
Periplasmic 
binding 
protein 
domain 
group 1 
furR fructose 1-
phosphate 
3O75 Transcriptional 
regulator 
89
 
araF L-arabinose 1ABE Transport 
protein 
90
 
PF01497 
Periplasmic 
binding 
protein 
group 2 
PiaA Ferrichrome 4HMQ Transport 
protein 
91
 
FhuD2 Ferrioxamine B 4FIL Transport 
protein 
92
 
FhuD Gallichrome 1EFD Transport 
protein 
93
 
HmuT Heme 3NU1 Transport 
protein 
94
 
BtuF Vitamin B12 1N4A Transport 
protein 
95
 
FeuA Ferri-Bacillibactin 2WHY Transport 
protein 
96
 
PF13377 
Periplasmic 
binding 
protein (like) 
domain 
group 3 
TreR trehalose-6-
phosphate 
4XXH 
 
Transcriptional 
regulator 
97
 
XylR Xylose 4FE7 Transcriptional 
regulator 
98
 
AraR Arabinose 3TB6 Transcriptional 
regulator 
99
 
LacI Lacotose 2P9H 
(bound 
to IPTG) 
Transcriptional 
regulator 
100
 
PF13407 
Periplasmic 
binding 
protein 
domain 
group 4 
ChvE Galactose, 
arabinose, glucose 
3URM Transcriptional 
regulator, 
transport 
protein 
101
 
xylT Xylose 3M9W Transport 
protein 
102
 
Fructose binding 
domain 
Fructose 2X7X Transcriptional 
regulator 
86
 
ytfQ Galactofuranose 2VK2 Transport 
protein 
103
 
mglB Glucose, galactose, 
(2R)-glyceryl-beta-
D-
galactopyranoside 
3GA5 Transport 
protein 
104
 
SmLsrB Autoinducer-2 3EJW Signaling 
105
 
Glucose binding 
protein 
Glucose 2QVC Transport 
protein 
106
 
Ribose binding 
protein 
Ribose 2FN8 Transport 
protein 
107
 
LuxP Autoinducer-2 2HJ9 Signaling 
108
 
alsB Allose 1RPJ Transport 
protein 
109
 
PF13433 
Periplasmic 
binding 
AmiC Various amides, 
Butyramide, 
acetamide 
1PEA Transcriptional 
regulator 
110
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protein 
domain 
group 5 
Number 
PF13458 
Periplasmic 
binding 
protein 
group 6 
livK Leucine 1USK Transport 
protein 
111
 
LivJ Leucine, isoleucine, 
valine 
1Z16 Transport 
protein 
112
 
Atu2422 GABA, serine, 
alanine, proline, 
glycine, valine, 
cysteine, threonine 
3IP9 Transport 
protein 
113
 
Aromatic compound 
transport protein, 
RPA1789 
Various aromatic 
compounds, p-
hydroxybenzoic 
acid, p-coumaric 
acid 
4F06, 
4F8J, 
4JB2 
Transport 
protein 
114,115
 
PF04069 
Substrate 
binding 
domain of 
ABC-type 
glycine 
betaine 
transport 
system 
TmoX Trimethylamine N-
oxide, glycine 
Betaine, carnitine, 
choline 
4XZ6 Transport 
protein 
116
 
OpuBC Choline 3R6U Transport 
protein 
117
 
OpuC Carnitine, glycine 
betaine, choline, 
ectoine 
3PPO Transport 
protein 
118
 
OpuAC glycine betaine, 
proline betaine 
3L6H, 
2B4M 
Transport 
protein 
119,120
 
ChoX Acetylcholine, 
choline 
2RIN Transport 
protein 
121
 
ProX glycine betaine, 
proline betaine, 
trimethyl 
ammonium 
1SW4 Transport 
protein 
122
 
PF12974 
ABC 
transporter, 
phosphonate, 
periplasmic 
substrate-
binding 
protein 
PhnD Phosphonates, 2-
aminoethyl 
phosphonate 
3P7I Transport 
protein 
123
 
PF12849 
Periplasmic 
binding 
protein 
superfamily 
like type 2 
pstS1 Phosphate ions 4Q8R Transport 
protein 
124
 
pstS3 Phosphate ions 4LVQ Transport 
protein 
125
 
Human phosphate 
binding protein 
Phosphate ions 2V3Q Transport 
protein 
126
 
PF01547 
Bacterial 
extracellular 
solute-
binding 
protein 
group 1 
algQ1 Alginate, 
triguluronate 
4TQV, 
3VLV, 
1Y3P 
Transport 
protein 
127-129
 
Xylo-oligosaccharide 
binding protein, 
XBP1 
Various sugars, 
Xylobiose to 
Xylohexaose, 
Arabinoxylobiose to 
Arabinoxylotetraose 
3ZKK, 
4G68 
Transport 
protein 
130,131
 
Thiaminase I Thiamin 4KYS, 
2THI 
Catalytic 
degradation 
132,133
 
AcbH Beta-D-
galactopyranose 
3OO6 Transport 
protein 
134
 
FbpA Iron (III) 3OD7 Transport 
135
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protein 
gltA lacto-N-biose, 
galacto-N-biose 
2Z8D Transport 
protein 
136
 
TogB Various polymeric 
forms of 
galacturonic acid 
2UVJ Transport 
protein 
137
 
Glucose/Galactose 
binding protein 
Glucose, galactose 2B3B Transport 
protein 
138
 
MalE Maltose, 
Maltodextrin, 
Trehalose 
1URD, 
1EU8 
Transport 
protein 
139,140
 
PF00497 
Bacterial 
extracellular 
solute-
binding 
proteins, 
group 3 
hybrid histidine 
kinase Hk1sensor 
domain 
Unknown 5BWJ Signaling 
141
 
nocT Opines, nopaline, 
pyronopaline 
4P0I Transport 
protein 
142
 
ArgBP Arginine 4PSH Transport 
protein 
143
 
GlnP domain 1 Asparagine, 
Glutamine 
4KPT Transport 
protein 
144
 
GshT Glutathione, 
glutathione 
disulfide 
4C0R Transport 
protein 
145
 
DalS D-alanine 4DZ1 Transport 
protein 
146
 
Cysteine binding 
protein 
Cysteine 2YJP, 
1XT8 
Transport 
protein 
147,148
 
Cystine binding 
protein 
Cystine 2YLN Transport 
protein 
147
 
Arginine binding 
protein 
Arginine, methyl-
arginine 
2Y7I Transport 
protein 
149
 
hisJ Histidine 1HSL Transport 
protein 
150
 
glnH Glutamine 1WDN Transport 
protein 
151
 
argT Lysine, arginine, 
ornithine 
1LAF Transport 
protein 
152
 
PEB1a Aspartate/glutamate 2V25 Transport 
protein 
153
 
EhuB 
 
Ectoine, 
hydroxyectoine 
2Q89 Transport 
protein 
154
 
ArtJ Arginine, lysine, 
histidine 
2PVU Transport 
protein 
155
 
AvGluR1 Glutamate, alanine, 
cysteine, 
methionine, 
phenylalanine, 
serine, aspartate, 
asparagine 
4IO2 Transport 
protein 
156
 
Table 1: The different subfamilies of SBPs, categorized by their pfam identifier. This is 
representative, as there are proteins which have been functionally characterized, but 
not structurally characterized, meaning that the range of possible ligands that can be 
bound is much larger than what is shown above. Additionally, many of the presented 
proteins are able to bind ligands besides their endogenous targets, with varying 
degrees of affinity. 
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It is clear that SBPs have the potential to generate a wide array of sensors for various 
biologically relevant molecules, including neurotransmitters. From inspection of the 
above table we can see that there are already proteins that have the capacity to bind 
some neurotransmitters of interest. As mentioned earlier, a glutamate sensor has already 
been constructed by Okumoto et al. using the native binding protein which fortuitously 
was able to produce an appreciable FRET signal without significant optimization or 
modification. Unfortunately for the specific neurotransmitters of interest (glycine and 
GABA) the proteins that possess binding properties for these ligands are either highly 
promiscuous, or do not produce a FRET response with simple N and C terminal fusions 
of FPs (elaborated upon in Chapters 2 and 3). 
It should also be noted that structural elements of the (now outdated) type 1 and 
type 2 PBP folds are mirrored in a number of neurologically relevant receptors, 
including mammalian ionotropic glutamate receptors (iGluRs).
157,158
 This is important 
from an engineering perspective, as this similarity may allow for structural information 
of the native receptor to act as an informative guideline for engineering purposes. 
 
1 I. STRUCTURAL SIMILARITY TO NEUROLOGICAL RECEPTORS 
Outside of the membrane, iGluRs possess an amino terminal domain (ATD), sometimes 
referred to as the regulatory domain, which is structurally similar to the 
leucine/isoleucine/valine binding PBP family (LivK, type 1).
159
 This ATD is followed 
by the ligand binding domain or region (LBD or LBR) which itself can be further 
divided into the segment 1 and segment 2 domains (S1 and S2).
157,160
 The LBD is 
responsible for glycine and glutamate recognition and, like the ATD, has structural and 
functional similarity to a particular PBP family, in this case the glutamate PBPs (ybeJ, 
type 2).
161
 As there are iGluR analogs found within plants, and due to the structural 
similarity of the LBD to bacterial PBPs, it has been proposed that these proteins may 
share a common ancestor that predated the evolutionary separation between eukaryotes 
and prokaryotes,
162,163
 or in the very least, predate the separation of plants and 
animals.
164,165
 Throughout this time, the protein family has retained their core structural 
elements throughout their evolution, despite the large divergence in sequence homology 
between the many plant, bacterial and animal glutamate receptors. 
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Similarly, metabotropic glutamate receptors (mGluRs) and γ-aminobutyric acid type B 
receptors (GABABRs) also possess an analogous ATD domain, referred as the N-
terminal extracellular domain (NTED) or Venus flytrap module (VFTM) which has fold 
similarity to the LivK protein PBP family.
166-168
 However, as the transmembrane 
domain of these receptors (G-coupled proteins) are of a completely different structural 
class to the iGluRs (ion channels), it is difficult to determine whether the LBDs/VFTMs 
are a structural feature that has been retained from the last common ancestor of the 
ionotropic and metabotropic receptors or if it is a result of fortuitous domain 
fusion/swapping or convergent evolution. Despite sharing this similar domain feature, 
iGluRs and mGluRs are sometimes stated as being structurally and evolutionarily 
separate,
169
 with the few studies looking towards investigating any potential 
evolutionary relationships being mostly inconclusive.
170
 
The binding targets and roles of the LBD/VFTMs domains vary and, counter-
intuitively, do not necessarily match the behavior of their bacterial analogues. For 
example, in the case of the LivK-like ATD, it appears to be able to interact with a wide 
range of ligands, including spermine, ifenprodil and zinc, the binding of which appears 
to have allosteric effects towards iGluR function.
171
 None of these aforementioned 
ligands interact with the bacterial LivK, despite the structural similarity. In addition, the 
ybeJ like LBD is capable of binding glycine, a property not observed in the bacterial 
homolog.
157
 
An evolutionary link, or at the very least, a structural link, between SBPs and 
these receptors does have promising implications in terms of designing sensors as 
establishing the relationships between particular PBP families to particular receptors 
may aid in the identification of SBPs (or PBPs) that are likely to possess the desired 
binding properties. This rationale has been used to aid the development of a D-serine 
sensor (Jason Whitfield, unpublished work) where the binding site of a promiscuous D-
alanine SBP has been engineered to mimic the binding site of the D-serine binding NR1 
subunit of NMDA receptors. This shows that knowledge of the structural features of the 
various receptors can potentially aid in the identification of SBPs with desired binding 
behaviors, or alternatively, provide a blueprint towards engineering and redesigning of 
SBPs to introduce or improve binding towards desired ligands.  
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1 J. NEUROTRANSMITTERS OF INTEREST 
As stated previously, there is still ongoing debate as to the roles of various 
neurotransmitters, as well as their importance. While it is possible to determine the 
prevalence of certain neurotransmitter and correlate their usage to particular regions of 
the brain or types of signaling, it is difficult to gauge the true extent of a given 
neurotransmitter’s role, without the information that could be gained from an optical 
sensor. Arguably, there is more to be gained from developing optical sensors for 
neurotransmitters that are known to be important for important CNS functions, but for 
which specific parameters and details still remain indistinct, than for neurotransmitters 
that are hypothesized to be utilized, but for which there is no well understood role. In 
this regard, two neurotransmitters are immediately attractive targets for study; the amino 
acids GABA and glycine (Figure 7). 
    
Figure 7: Glycine (left) one of the major inhibitory neurotransmitters in the CNS and co-
agonist of NMDARs. GABA (right) another major inhibitory neurotransmitter. 
 
Both glycine and GABA are important inhibitory neurotransmitters in the central 
nervous system and, as such, merit study.
1,172
 Both these molecules act as the primary 
inhibitory neurotransmitters in the CNS, and in the case of glycine, as a co-agonist of N-
methyl-D-aspartate receptors (NMDARs) that mediate processes such as synaptic 
plasticity and pain transmission. Moreover both GABA and glycine are further 
implicated in numerous neurological disease states, such as schizophrenia.
173,174
 
Since GABA and glycine are both small amino acid neurotransmitters that are 
utilized widely by bacteria it is likely there is already an SBP that is capable of binding 
them in some form. This thesis describes the identification and engineering of SBPs into 
optical sensors for the purposes of detecting and imaging glycine and GABA. The 
FRET sensors created in this work are shown to possess dynamic ranges appropriate for 
use, and to further demonstrate this, the genetically encodable glycine sensor, (GRIP 
sensor), was used to investigate glycine neurotransmission as a component for synaptic 
plasticity in vivo. The application of GRIP in hippocampal tissue not only established 
the functionality of the developed sensor, but resulted in numerous new revelations in 
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glycine utilization, as well as confirming previously suggested hypotheses. A more 
detailed discussion for the physiological role and relevance of each of these particular 
neurotransmitters can be found in their related chapters. The development of these 
FRET sensors also demonstrates new or alternative avenues by which FRET sensors 
can be created and will hopefully contribute to the improvement and creation of 
additional FRET sensors for other neurotransmitters of importance. 
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Foreword 
All work in this chapter was completed by the author, with the exception of the 
molecular dynamics analysis of the sensor construct, which was performed by Joshua 
Mitchell, a student under the author’s supervision. 
 
2 A. THE ROLE OF GLYCINE 
The neurotransmitter glycine is an important co-agonist of NMDARs within synaptic 
neurons and is also one of the primary inhibitory neurotransmitters in the CNS.
175
  In 
the hippocampus, the activation of NMDARs is required for the long term strengthening 
and weakening of signaling interactions between two neurons (synaptic plasticity), 
which is critical for memory formation and learning.
176
 Although the primary agonist of 
the NMDARs is the amino acid glutamate, these ion channels will usually remain 
closed without the presence of the co-agonists glycine or D-serine, making both glycine 
and D-serine essential for proper receptor function.
177
 It is believed that different 
subtypes of NMDARs primarily interact with one of the two co-agonists, with D-serine 
and glycine being endogenous to synaptic NMDARs and extrasynaptic NMDARs 
respectively.
178,179
 Further electrophysiological studies have suggested that D-serine is 
the primary mediator of long term potentiation (LTP), whereas both glycine and D-
serine are necessary for long term depression (LTD).
179,180
  The other role of glycine is 
within other regions of the CNS, where the vesicular release of glycine from glycinergic 
neurons results in the activation of glycine specific receptors (GlyRs), which then 
inhibits neuronal firing through chloride ion mediated hyperpolarization of the 
postsynaptic cell.
24
 This makes glycine responsible for moderating important functions 
within the respiratory and cardiovascular systems as well as controlling aspects of the 
motor and sensory systems.
181,182
 It also means that disruption to glycine signaling, 
glycine receptors and glycine transporters are causes and potential treatment targets of 
many conditions and diseases, including chronic pain and schizophrenia.
183-185
 
Given the numerous roles that glycine plays in the CNS, as well as the 
importance of these functions, characterization of poorly understood parameters such as 
maximal concentration, spatial distribution and reuptake of this neurotransmitter would 
prove invaluable towards understanding the usage and importance of this 
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neurotransmitter, and by extension, glycine mediated receptors and related processes. 
As with existing optical sensors, such as the glutamate sensor FLIPE600n, the 
development of a functional FRET sensor is contingent on the existence of a binding 
core that possesses the appropriate affinity and specificity for the desired ligand, i.e. 
glycine. The periplasmic binding protein Atu2422, a relative of the leucine binding SBP 
family, has been shown by Planamente et al. to bind to a number of small amino acids 
through uptake inhibition studies.
113
 Based on their results, it appears that it should also 
be capable of interacting with glycine. This protein is therefore a candidate binding core 
for the creation of a fluorescent glycine sensor. However, the promiscuity of the wild 
type protein for other ligands that have a significant presence in synapses (L-serine, 
GABA) prevents its immediate use. Described in this chapter is the computationally 
aided rational engineering of Atu2422 to remove promiscuous binding of unwanted 
synaptic ligands and the further conversion of this binding core into a functional glycine 
optical FRET sensor. This was done through the addition of a rigid helix, which acts as 
a lever, allowing angular changes from protein binding to increase the displacement of 
fluorophores and therefore the dynamic range. Modifying sensors on this basis may be 
more appropriate for improving the dynamic ranges of sensors compared to orientation-
based methods that have previously been proposed in the literature. 
 
2 B. MATERIALS AND METHODS 
 
DNA Cloning and mutagenesis. Genes were ordered either from the GeneArt service 
(ThermoFisher Scientific) with the desired sequence supplied in a non-expression 
plasmid, or as a gBlock fragment (Integrated DNA Technologies). The desired DNA 
sequence was PCR amplified, gel purified and cloned through restriction digest and 
ligation (NdeI, EcoRI) into the vector PETMCS3 (Appendix AC2.1), which allowed for 
the expression of the binding protein for the purposes of ITC analysis. The genes and 
relevant mutants were also cloned into the vector pDOTS10 (Appendix AC2.2) through 
restriction digestion (SapI), which arranged the protein such that there was a Biotin tag 
and ECFP linked at the N-terminus and a VenusFP linked to the C-terminus. The sensor 
construct was then cloned out of pDOTS10 and into PETMCS3 using the T7 promoter 
and terminator primers and Gibson assembly. The restriction digestion method was used 
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for cloning into the Pertz kit array (BspEI, NotI) and for replacement of the circularly 
permuted mTFP variants with ECFP in the same array (A1 – A5). 
Mutants/linker optimizations were generated through a Gibson assembly 
protocol where fragments containing the desired mutation were created via PCR using 
large primers with at least 40 base pair overlap.
186
 SnFR constructs were also cloned 
using Gibson assembly, with the circularly permuted FPs ordered as a gBlock 
(Integrated DNA Technologies). 
 
Expression and purification of proteins. All proteins were expressed through 
transformation into BL21(DE3) E.Coli cells and grown for 48-72 hours at room 
temperature (20-25 °C) in 1 L autoinducing TB media supplemented with 100 mg of 
ampicillin (Appendix AC2.3). In some cases, the full expression of the fluorescent 
protein constructs needed to be monitored by observing the Venus/ECFP spectra over 
time, which typically peaked at approximately 50 hours of expression at 20 °C. 
Cells were harvested through centrifugation and the pellet would be stored 
at -20 °C if it was not purified immediately after centrifugation. For purification, the 
pellet (frozen or otherwise) was suspended in buffer A (NaH2PO4 50 mM, NaCl 
200 mM, imidazole 20 mM, pH 7.5), lysed through sonication, re-centrifuged at high 
speed (13500 rpm, 60 min, 4 °C) and the clarified supernatant was collected. This was 
loaded onto a Ni-NTA (Qiagen) or a His-trap (GE Healthcare Life Sciences) column 
and washed with 10 column volumes of buffer A (5 ml/min) and eluted with 4 column 
volumes of 100% buffer B (NaH2PO4 50 mM, NaCl 200 mM, imidazole 300 mM, pH 
7.5) and the eluted protein was dialyzed against 2 exchanges of 4 L of buffer C 
(NaH2PO4 50 mM, NaCl 200 mM, pH 7.5). In the case of proteins with high affinity 
(determined by ITC, Kd < 2 µM), on column refolding was performed in order to 
remove bound ligand from the protein, this followed the previous protocol with the 
exception that prior to elution with buffer B, the column was washed with 10 column 
volumes of buffer D (Phosphate 50 mM, NaCl 200 mM, Guanidine 6 M, pH 7.5) and 
then returned from 100% buffer D slowly to 100% buffer A over a gradient of 3 hours 
at room temperature at a lower flow rate (1 ml/min). After returning to 100% buffer A, 
the column was washed an additional 10 column volumes of buffer A at a regular flow 
rate (5 ml/min) prior to elution with buffer B. 
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Further purification (when necessary) was performed by size exclusion chromatography 
(SEC) on a Hiload 26/600 superdex 200pg SEC column (GE Healthcare Life Sciences) 
using buffer C. For FRET protein constructs, size exclusion chromatography was 
performed in all cases and fractions tested for their maximum FRET range. Fractions 
that had a poor range compared to the maximal range were discarded and the remaining 
viable fractions were pooled. In practice this resulted in a batch of sensor that had a 
good dynamic range, but not at the peak possible dynamic range. For long term storage 
and long distance transfer, the protein samples would be concentrated to a total volume 
of approximately 2 ml and then lyophilized. 
 
Isothermal titration calorimetry (ITC). Binding studies were performed on a Nano-
ITC (TA instruments, 1 ml active cell volume) at 25 °C with a stir rate of 250 rpm and 
samples were degassed using a TA instruments degassing station (350 mmHg). Protein 
concentrations used were between 50-100 µM and ligand concentrations were between 
0.5 to 5 mM depending on the affinity of the binding, with low ligand concentrations for 
higher affinity proteins (Kd <2 µM) and higher ligand concentrations for lower affinity 
proteins (Kd >2 µM). 3 µL injections of the ligand solution were injected every 200 
seconds until a three-fold excess of ligand to protein was reached. The obtained data 
was processed with the Nanoanalyze software provided (TA instruments). 
Competition assays were performed by pre-incubating a known concentration of 
ligand B (the competitor) and then performing a titration on the same protein sample 
with ligand A of a higher and known affinity. The observed affinity of ligand A (KAobs) 
was then used to determine the affinity of ligand B (KB) using equation 5.
187
 
𝟓) 𝐾𝐵 = (
𝐾𝐴
𝐾𝐴𝑜𝑏𝑠
− 1) ×  
1
[𝐵]
 
 
Fluorescence assays. Fluorescence titrations were performed on a Varian Cary Eclipse 
using a quartz narrow volume fluorescence cuvette (10 mm, Hellma Analytics). 
Samples underwent excitation at 433 nm and were scanned over a range of 460 nm to 
560 nm for full spectra analysis. Venus/ECFP ratios were determined using peak 
wavelength values of 525 nm (Venus) and 476 nm (ECFP). 
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Computational assessment of mutations. Mutations were assessed by first creating the 
mutation in YASARA v14.5.21 with the FoldX v4.4.23 plugin enabled, using the 
crystal structure of the protein of interest in the closed/bound state that had undergone 
the FoldX repair process and with bound ligand (if any) removed.
188
 The conformation 
with the lowest energy was selected from the set(s) generated through this method and 
was then analyzed with Autodock v4.2.6 within the Autodock tools suite to assess the 
ability of desired and undesired ligands to fit/bind into the binding pocket of the 
protein.
189
 In scenarios where more than one residue could provide the desired 
conformation or pocket shape, the one that was the least destabilizing or most 
stabilizing were selected. If this was not possible due to the conformations/stabilizations 
being approximate, then the different residues were tested experimentally and then one 
that offered the better binding profile/properties was selected. 
 
Computational modelling of sensor linkers. The method has been previously 
described in full by Joshua Mitchell (Honors thesis). In brief, a model of a given sensor 
would be generated in PyMOL, where the binding-core and fluorophore domains would 
be fused with a linker of a specified residue composition. The models were then 
prepared for simulation in the MARTINI 2.1 coarse grained forcefield with a modified 
Martinize script that allowed specified residues to be excluded from any elastic network 
generated. All simulations were carried out using the GROMACS 5.04 package on an 
in-house system with an Intel Core i5-4690K processor and Nvidia GeForce GTX 780 
graphics card. 5x10
6
 step simulations (20 fs time step, 100 ns simulated time) were 
performed in triplicate with no elastic network using a “new-rf” parameter set with the 
Martini 2.1 force field. Periodic boundary conditions with a dodecahedron box were 
used, with a protein-to-box minimum distance of 0.5 nm. The non-polarizable Martini 
water model was used with 10% antifreeze water. Sodium or chloride counter-ions were 
used to neutralize the system, and additional ions were added to make the salt 
concentration up to the 200 mM concentration used in experiments.  After solvation and 
energy minimization, a 10 step unrestrained molecular dynamics (MD) was performed 
with velocity generation, followed by equilibration for 50 000 steps with a force 
constant of 1000 kJ mol
-1
 nm
-1
. Force constants were then relaxed over 5x50000 step 
equilibrations with force constants of 500, 100, 50, 10 and 0 kJ mol
-1
nm
-1
. 
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2 C. RESULTS AND DISCUSSION 
 
2 C I. COMPUTATIONALLY AIDED RATIONAL DESIGN OF THE BINDING CORE 
Initial engineering attempts were first made to reduce GABA binding affinity on the 
basis of the mutagenesis and uptake assays performed by Planamente et al., where 
residue Y275 was identified as a key mediator of GABA binding due to its role as a 
hydrogen bonding partner. However, our own studies using ITC showed that GABA 
was still able to bind at the same affinity (~2.5 µM) even with this mutation. A further 
mutation to remove a second potential hydrogen bonding residue (Y330) initially 
appeared to remove GABA binding, but a competition titration revealed that GABA still 
bound at the same affinity, but with a zero magnitude enthalpy. 
The removal of these hydrogen bonds would reduce the enthalpy of binding for 
GABA should therefore reduce the Gibbs free energy of binding (ΔG), making binding 
less favorable. Experimentally this was not found to be the case, meaning that there was 
entropic compensation as a result of these mutations. It is likely that the removal of the 
hydroxyl groups through changing the tyrosine residue to a phenylalanine created new 
cavities within the binding pocket, which could be occupied by water molecules. The 
displacement or re-arrangement of these waters upon ligand binding would then provide 
entropy to the system, which would increase the Gibbs free energy for binding and 
offset the loss due to a decreased enthalpy. Enthalpy/entropy compensation has been 
discussed extensively within the literature,
190-192
  with the general consensus that 
engineering on the basis of reducing or improving enthalpic parameters through 
modification of hydrogen bonds and dipole interactions is an unreliable means of 
modifying the overall binding properties of proteins. Hence, subsequent mutations 
focused on modifying the steric parameters and overall shape of the binding site. 
Furthermore, computational tools such as FoldX and Autodock were used to evaluate 
the mutations and their likely effects on ligand binding in silico (Figure 8).
188,189,193
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Figure 8: Basic workflow for determining appropriate mutations. The FoldX program 
can predict residue conformations and Autodock can then evaluate the capacity of 
ligands to bind into the modified active site. Experimental data can contribute to more 
accurate docking parameters, identifying important residues and residue behaviors, 
which can guide further mutations. 
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Known binding ligands, L-serine, GABA and glycine were docked into wild type 
Atu2422 structure in order to benchmark the various possible Autodock parameters. 
Depending on the parameters used, the docked ligand would not occupy the correct site, 
or did not conform to the correct binding motif. As such, Autodock parameters were 
varied until the binding profile determined through Autodock matched the experimental 
binding profile of the wild type protein, at which point the parameters were viewed as 
suitable for assessing ligand docking into mutant models. 
Mutations that resulted in small changes to the binding pocket shape, such as 
D226E, generally decreased the affinity for all ligands, but did not improve selectivity 
or specificity for glycine over other ligands, with the exception of GABA (indicated by 
Autodock and then confirmed experimentally). It became clear that GABA binding was 
extremely sensitive to steric changes in the active site and binding affinity could be 
reduced with relative ease, however L-serine and other competitive amino acids were 
still of concern. We sought to reduce L-serine binding in particular as this ligand is 
present in high concentrations within the synapse due to its uptake and active 
conversion to D-serine.
194
 Visual inspection of the binding site identified residue A100, 
which if mutated to an aromatic residue, could be used to block the binding of amino 
acid side chains (Figure 9). However, due to the presence of the side chain of F77 there 
was the potential for the A100 mutant to be forced into an orientation that faced away 
from the binding pocket. FoldX analysis indicated that this would be the case, meaning 
it would be necessary to mutate reside F77 in order for the A100 mutant to adopt the 
correct orientation. Planamente et al. previously showed that removal of the F77 opened 
up the binding pocket, which increased the promiscuity of the protein, with larger amino 
acids such as leucine, glutamate and aspartate able to bind as the active site was now 
better able to accommodate a wider variety of amino acid side chains. This was not 
viewed as necessarily a concern, as subsequent mutations were designed to again block 
the side chain pocket, meaning that the new ligands, in particular glutamate, should 
again no longer bind. 
The mutations that were computationally determined to be the least destabilizing 
while still providing the desired structural changes were F77A and A100Y 
(mutant AY). Autodock analysis of this mutant suggested that glycine would bind in the 
same manner as seen in the wild type protein, whereas L-serine would have to adopt 
strained and inverted conformation. Experimentally this set of mutations did not remove 
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L-serine binding and decreased the binding affinities for both L-serine and glycine to 
approximately 18-20 µM (Figure 10, Table 2). However, it did reduce GABA and 
glutamate binding affinity, indicating that although it did not block the side chain of L-
serine, the Y100 residue was orientated in such a way as to block or hinder the larger 
glutamate side chain. 
Further inspection identified another residue, L202, located on the opposite side 
of the binding pocket from residue A100, which could also potentially orient itself to 
block side chain binding (Figure 9). ITC analysis of the mutant F77A/L202W (mutant 
AW) showed that L-serine and GABA could no longer bind with any detectable affinity 
and that glycine could bind with a Kd of 2.3 µM. However, leucine and glutamate could 
still bind, with leucine binding with high affinity in the nanomolar range (Kd 700 nM) 
and glutamate binding at the same affinity as glycine (Figure 10, Table 2). Autodock 
analysis of glutamate showed that it was possible for the mutated tryptophan residue to 
flip towards an alternative conformation, opening up the binding pocket and allowing 
glutamate side chain to occupy the opened space in an unstrained manner. Docking 
analysis of a model combining the previous A100Y mutation with the F77A/L202W 
mutations showed that glutamate, L-serine and GABA would not bind, nor would 
binding pocket residues flip to accommodate them, while glycine would still be able to 
occupy the binding pocket with the correct binding motif. This suggested that the 
mutation set of AYW would make the protein selective for glycine. 
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Figure 9: Modeled active sites of the mutants leading up to the functional mutant AYW. 
The archetypal bound ligand conformation has been used to show the increasing 
inability of ligands to bind as the binding pocket becomes more restricted. Shown in the 
glutamate bound AW mutant is the flipping of residue 202 to accommodate glutamate, 
also shown is a possible alternative ligand conformation for the serine bound AY 
mutant, consistent with experimentally obtained results. 
 
Experimentally, the combined mutant of F77A/A100Y/L202W (mutant AYW) showed 
an affinity (Kd) of 20 µM for glycine and had no promiscuous binding for other 
potential synaptic competitors such as D and L-serine, GABA, and L-glutamate, which 
were the primary concerns (Figure 10, Table 2). The mutation set also showed that it 
prevented the binding of the other small amino acids such as proline and alanine, which 
in the AW mutant, could still bind at low micromolar concentrations (5 µM for alanine), 
however, the mutant did have some weak binding affinity for leucine, valine and 
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threonine (410 ± 19 µM, 3230 ± 490 µM and 6030 ± 1360 µM respectively). As these 
amino acids are most likely not significant in the extracellular matrix and are not 
directly linked to neurotransmission (synaptic release),  as well as the affinity for these 
ligands being significantly lower, this slight promiscuity was not thought to be likely to 
impact the practical usage of the glycine optical sensor.
195-199
 
 
Figure 10: Affinity of mutants for different ligands. If no binding was observed through 
a direct ITC titration as well as through a competition titration with glycine the affinity 
was given a value of zero. Error bars represent the 90% confidence interval. *Value for 
L-serine from the original publication by Planamente et al. 
 
 
 
 
 
 
 
 
 
* 
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 Ligand affinity between mutants (Kd, µM) 
Ligand Wild Type L202W F77A, 
A100Y 
F77A, 
L202W 
F77A, 
A100Y, 
L202W 
F18W, 
F77A, 
L202W 
Glycine 0.11 ± 0.06 32.7 ± 8.2 18.2 ± 4.0 2.25 ± 0.76 20.3 ± 3.7 5.7 ± 0.9 
GABA 2.10 ± 0.69 N.B N.B N.B N.B N.B 
L-Serine -* 34.5 ± 11.4 20.1 ± 6.3 N.B N.B N.B 
D-Serine N.B - - N.B N.B N.B 
Glutamate N.B - N.B 2.30 ± 1.02 N.B N.B 
Table 2:  Summary of the binding properties of the various mutants at 25 °C (unless 
otherwise noted). Affinities were determined either directly or through 
inhibition/competition of glycine. N.B is assigned to a ligand if there is both no binding 
observed through a direct titration ITC experiment and if it shows no inhibition to 
glycine binding in a competition titration. Values shown are the measurement ± 90% 
confidence interval. *For L-serine affinity refer to study done by Planamente et al.113 
 
Another mutant, F18W/F77A/L202W, (mutant WAW) also was selective for glycine in 
the presence of other neurotransmitters (glutamate, L and D-serine, GABA) and did 
bind with a higher affinity compared to the AYW mutant (6 µM). However, it retained 
high affinity (700 nM) for leucine which made it unsuitable for practical use as there 
would be significant uncertainty in the interacting ligands identity.
 
Finally, to confirm if the F77A mutation was truly necessary for the AYW 
mutant and the WAW mutant as suggested by the computed models, L202W was 
mutated without the F77A and A100Y mutations. The protein displayed a lower affinity 
for glycine (32 µM), but was still able to bind L-serine at approximately the same 
affinity as glycine, meaning it did not possess the selectivity of AYW and had poorer 
overall affinity. This is consistent with the L202W mutant being unable to block L-
serine binding due to being forced away from the binding site by F77 and likely causing 
some strain towards the overall pocket shape, which would lower binding affinity for 
the general amino acid structure. As physiological basal levels of glycine in various 
brain subregions have been estimated to lie between 1 to 10 µM,
23,200-202
 with peak 
glycine estimated to reach as high millimolar concentrations within synapses in some 
brain regions and at motoneuron synapses the spine during signaling,
23,203
 the AYW 
mutant appeared to be suitable for conversion into an optical sensor for in vivo 
application. 
 
Chapter 2 
42 
 
2 C II. ENTHALPY-ENTROPY COMPENSATION 
As the number of mutations increased from the wild type binding protein to the triple 
mutant AYW, the free energy of binding for glycine transitioned from relying on 
equally favorable enthalpic and entropic contributions to being heavily favored by 
entropy and hindered by enthalpy (Figure 11). In particular, we see that the transition 
from the AY mutant to AYW suffers no significant impact to the Gibbs free energy of 
binding (and therefore affinity), despite the large increase to the enthalpic cost of 
binding. This is somewhat surprising, as the parallel mutant AW showed a detrimental 
effect on entropy, without appearing to have a large impact on enthalpy. When these 
mutations are combined, the mutation L202W that was previously entropically 
unfavorable now appears to instead greatly decrease binding enthalpy while increasing 
the entropy. The physical origin of this change can be explained by the increasingly 
hydrophobic binding pocket increasing binding entropy through what has been termed 
the “hydrophobic effect” which is a result of water molecules that are displaced by 
ligand binding having a greater degree of rotational freedom upon liberation.
204
 
Specifically, for the binding profile observed for AYW, the hydrophobicity prevents 
side chains with charged or polar characteristics from binding. Steric constraints further 
exclude larger side chains from occupying the active site, which explains the poor 
affinities for leucine, valine and threonine, while glycine is able to bind at higher 
affinity. 
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Figure 11: Thermodynamic parameters across the mutation pathway. The transition 
from F77A/A100Y to F77A/A100Y/L202W shows a large increase in endothermic 
binding character while binding entropy shows a corresponding increase. This 
enthalpy-entropy compensation results in a comparable Gibbs free energy, and 
therefore affinity. Values shown are the measurement ± SD. 
 
As discussed previously with mutant Y275F/Y330F, changes that impact on the binding 
enthalpy of a system can lead to compensation by an inverse response in binding 
entropy. There is some debate as to the nature and magnitude of entropy-enthalpy 
compensation, with some studies suggesting that systematic errors may over-estimate 
relative enthalpies by up to 20% which leads to false positives.
190
 In this case, even 
taking into account the potential of an extra 20% margin of error, the change in enthalpy 
and entropy is statistically significant and, in some cases, by several fold, making it 
clear that enthalpy-entropy compensation has occurred along the engineered trajectory 
for this protein. This suggests that the effect of mutations on binding properties may not 
be as severe as predicted by either inspection or computational modelling, as there is the 
potential for enthalpy-entropy compensation which can, to an extent, provide limited 
preservation of the binding affinity for the target ligand, while removing the binding of 
competing ligands. 
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2 C III. DEVELOPMENT AND CHARACTERIZATION OF THE GENETICALLY ENCODABLE 
GLYCINE OPTICAL SENSOR (GRIP SENSOR) 
Conversion of the Atu-2422-AYW mutant into an optical sensor for in vivo use was not 
found to be possible using orientation-based methods of sensor construction and 
optimization, nor through using circular permuted FPs, with the best sensor construct 
made through these means giving only a -8% dynamic range (Appendix AC2.5). 
Ultimately, the binding core was converted into a glycine optical sensor called the GRIP 
sensor (Glycine Ratiometric Indicator Protein) through rigidifying the N-terminal 
ECFP through truncation of the flexible C-terminal chain and the insertion of a rigid 
triple EAAAK linker between the glycine binding core and a C-terminal VenusFP. The 
addition of this linker provided the structural elements necessary to increase the 
dynamic range of the sensor to a -25% maximal change upon glycine saturation 
(Figure 12), with no detriment to binding affinity of the sensor. 
 
Figure 12: Maximum dynamic range of the sensor GRIP. The spectra was obtained 
from the fraction with peak dynamic range after SEC. 
 
In general, non-rational approaches, such as orientation optimization, only offered small 
improvements to the dynamic range of the sensor (Figure 13, Table 3). The initial 
fusion of the ECFP-Venus pair towards the N and C termini respectively, with the 
original flexible GGVSKGE linker, did produce a glycine dependent ratiometric 
response, but the maximum ratio change was low (-4.5%), making it unsuitable for use. 
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Circular permutation was initially considered as an option, yet Okada et al. have 
demonstrated that circular permutation of the close relative LivK resulted in a 1000 fold 
decrease in affinity despite the increased dynamic range,
59
 most likely due to the 
presence of an additional inter-domain loop. As the conversion of the binding core into 
a sensor should have minimal or no impact upon the binding affinity, this meant that 
circular permutation was not considered. Deuschle et al have previously demonstrated 
that truncations to the linker regions to rigidify the attached fluorescent proteins can 
potentially improve observed FRET ratios.
205
 Following this principle, successive 
truncations to the flexible termini of the FPs initially raised the dynamic range to a -7% 
FRET ratio, but further truncations of the VenusFP and even small truncations of the 
binding core resulted in either inactive protein or no protein expression (data not 
shown). 
 
Figure 13, Table 3: Dynamic range for various FRET constructs. Non-rational 
approaches such as successive truncations or orientation cycling did not result in 
adequate improvements to the dynamic range. Introduction of the rigid helical linker 
EAAAK allowed for a several fold increase in the dynamic range without impacting 
binding affinity. Values shown are the mean ± S.E.M. 
 
Repositioning of the fluorophore through loop insertions of cpFPs (Appendix AC2.6), 
as used by the intensity based SnFR type sensors, resulted in a fluorescent protein that 
expressed solubly. However, both ITC and spectral analysis showed that these 
insertions could inactivate the protein (no detectable binding of glycine at 1 mM 
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AYW-GG-YFP -5.5 
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through ITC), with the most likely explanation being that the GFP insertion reduced 
loop mobility, thereby preventing the protein from transitioning between open and 
closed states. This was unfortunate, as this also meant that it was not possible to 
reposition the FP as a part of a FRET pair. 
The next strategy involved cycling through different orientations of N and C 
terminal fusions of cpFPs, enabled through the commercially available Pertz lab FRET 
kit,
62
 which tests different pairs of circularly permuted monomeric teal fluorescent 
protein (cpmTFP) and cpVenus. Use of the kit did not yield a construct with a ratio 
greater than the previously obtained -7%. This was not unexpected, as the change from 
the ECFP/Venus pair to the mTFP/Venus pair changed the Förster distance (R0) from 
4.9 nanometers to 6.1 nanometers,
206
 which would lower the binding mediated change 
in FRET efficiency for constructs that operate over a smaller and closer interfluorophore 
distance and also potentially offset any benefits gained from changing fluorophore 
orientation. In order to return to a more relevant Förster distance while still aiming to 
cycle through different orientations, ECFP was cloned in place of the mTFP to generate 
a smaller library of ECFP/cpVenus pairs. Overall the ratios observed were comparable 
to the initial ECFP/Venus pair, with one construct, AYW-ECFP-cp195Venus, showing 
a -8% overall ratio range. 
Seeking to clarify why there were only minimal improvements to the dynamic 
range, the sensor construct was re-examined through computational simulations. MD 
performed on a model of AYW using the original flexible linkers (GGVSKGE) showed 
that the linker (and FP) would tend to collapse towards the binding core, resulting in 
surface-surface association of the FP with the binding core (Figure 14). Although there 
was some preference as to the regions of association, made apparent through examining 
a population set of these collapsing simulations, it was clear that there was high 
variability with regard to the exact location (and orientation) of the FP. This would 
effectively lower the overall perceived FRET dynamic range for a given 
sample/population of this protein. As while there would be a sub population where the 
FP would be orientated correctly or in a way that can facilitate FRET, there would also 
be sub-populations that are orientated such that there would be poor or no FRET 
observed. Specifically, the flexible linkers would, in most cases, not allow for large 
displacement/movement of the FPs as the surface-surface arranged construct would 
result in minimal or sub-optimal movement upon ligand binding. Additionally, 
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depending on where the FP had collapsed towards, it was also possible that the FPs 
were no longer able to interact. This means that for a given protein to yield a 
distinguishable FRET signal it would require the FP to collapse at a surface location 
that allows it to interact with the other FP in either the apo or holo conformations, but 
must also be on a surface location that still allows for a large displacement upon 
binding. 
 
Figure 14: A sample of the fluorophore distribution after linker collapse, generated by 
coarse-grained simulations in GROMACS using the MARTINI forcefield. Each 
fluorophore of the FP is represented by a red sphere. Modelling done by Joshua 
Mitchell. 
 
It was then decided that the insertion of a rigid α-helix between the C termini of the 
binding core and the VenusFP of the ECFP/Venus FRET pair could potentially increase 
the dynamic range, with two lines of reasoning. Firstly, the use of a rigid linker would 
ensure (or at least, promote) that the FP will be able to undergo a large displacement 
from ligand mediated conformational changes by preventing the construct collapsing 
together and forming surface-surface interactions (Figure 15). The second line of 
reasoning stems from further examination of the protein structure, which showed that 
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although the change in physical placement of the two fluorophores upon binding was 
small in the original sensor design, there was a significant change in the angular 
orientations of the N and C terminus of the binding core. It was hypothesized that the 
use of a rigid linker could act as a “lever” for the Venus FP, which would translate any 
angular changes into a larger displacement of the Venus FP relative to the ECFP upon 
ligand binding. Both of these factors could increase the dynamic range high enough to 
allow for practical application of the sensor. 
 
Figure 15: A model showing the EAAAK sequence forming an alpha-helical linker. The 
model was generated in Foldit standalone and then relaxed by atomistic MD. Modelling 
done by Joshua Mitchell. 
 
2 C IV. APPLICATION OF RIGID LINKERS TO IMPROVE THE DYNAMIC RANGE 
Using the previously mentioned construct with truncations to the ECFP and Venus 
linkers, a triple repeat of the documented alpha-helical EAAAK linker was inserted in 
between the binding core and the VenusFP.
207
 This resulted in a large increase to the 
dynamic range, with a maximal -25% change in ratio observed. 
Although in principle a longer linker would increase the change in distance for a 
given change in angle, it would also change the initial and final interfluorophore 
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distances. If the shift in distance is sufficiently large that the fluorophores operate 
within a range far away from the Förster distance of the ECFP/Venus pair (4.9 nm) it 
would offset any benefits from the large changes in interfluorophore distance due to the 
decreased sensitivity of the FRET efficiency to changes in distance, ΔEFRET/d. Based on 
measurements made in pyMOL of the modelled structures, the FRET distance for the 
ECFP/Venus construct in the apo form was estimated to range from between 5-6.5 nm 
(depending on the fluorophore collapse location), it was important to use a linker that 
would be unlikely to drastically shift the operating distance outside the Förster distance 
of this FRET pair while still being long enough to sufficiently convert angular changes 
into changes in distance. Hence, a linker comprising three repeats of the EAAAK 
helical motif, with an approximate length of 2.2 nm (also confirmed through 
measurements made in pyMOL),
208
 was determined to be an appropriate choice and was 
found to improve the dynamic range to -25%. The addition of the linker is thought to 
shift the interfluorophore distance in the apo form to approximately 4.5 nm (distance 
range of 4-5 nm), which is very close to the Förster distance, meaning that any changes 
in distance would, in principle, result in larger changes to the FRET efficiency (and 
therefore the dynamic range) compared to before. This is supported by experimental 
data, where the apo Venus/ECFP ratio (a measure of the FRET efficiency) of the linker-
free sensor is approximately 0.73, whereas in the GRIP sensor the apo ratio is approximately 
0.94, which reflects a higher FRET efficiency. To confirm the contribution of the proposed 
lever effect (if any) to the increased dynamic range, as well as to explore other possible 
causes of the improved dynamic range, other parameters such as linker flexibility, 
orientation and length were altered (Table 4). 
FRET construct Dynamic 
range (% of 
apo) 
AYW-EAAAK3-YFP -25 
AYW-GS(EAAAK)3GS-YFP -18.5 
AYW-EAAAK3GP-YFP -21 
AYW-EAAAK6-YFP -11 
Table 4: Table showing the observed maximum dynamic range for a given linker 
modification. 
 
To vary the linker flexibility, a small two residue flexible region (GS) was inserted 
between the EAAAK linker and the binding core and another between the EAAAK 
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linker and the VenusFP. By making the linker less rigid, it should mean that the same 
angle change should not result in the same change in overall displacement, as there 
would now be more freedom for the linker (and therefore FP) to adopt more random 
conformations and positions rather than being locked into precise locations as dictated 
by the angular change in the C terminus. The resulting construct showed a lower 
dynamic range of -18.5% (Figure 16, Appendix AC2.7), which is consistent with this 
view. To test if the change in the interfluorophore distance range was also a contributing 
factor to the improved dynamic range a sensor construct that contained a longer linker 
of six repeats of the EAAAK sequence was also tested. The additional three repeats of 
the EAAAK linker effectively adds an further 2.2 nanometers of distance between the 
fluorophores,
208
 which may shift it beyond the optimal Förster distance range and lower 
the dynamic range. The expressed construct showed a lower initial FRET ratio 
indicating that initial distance between the two FPs in the apo form is larger compared 
to the three repeat construct and the addition of saturating glycine resulted in a lower 
dynamic range of -11% (Figure 16, Appendix AC2.7). This is consistent with the 
previous idea, that while the “lever” action of a rigid helix can improve the dynamic 
range, it is also important to optimize or retain the FPs within an operational distance 
with a higher ΔEFRET/d (i.e. approximate to the Förster distance of the FRET pair in 
use). There is also the possibility that there was a fortuitous optimization in orientation, 
so another linker mutant with the addition of a glycine-proline turn between the linker 
and the VenusFP was tested. The addition of the dipeptide would, in principle, result in 
a large change to the orientation of the VenusFP, while only altering the distance range 
only slightly.
209
 Although there was some decrease to the dynamic range (-21%, Figure 
16, Appendix AC2.7) the addition of the glycine-proline turn would also slightly vary 
the flexibility of this linker, which could also contribute some part of the lower dynamic 
range. As the effect of variations in orientation upon the dynamic range is smaller 
compared to the effect from changes in the length and flexibility of the linker, it 
suggests that fluorophore orientation may have a more limited influence towards 
determining the dynamic range for a sensor compared to the effect of modifications that 
aim to maximize changes in interfluorophore distance. 
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Figure 16: Dose-response of the sensor with variations to the linker. The rigid linker 
(EAAAK)3 has the largest dynamic range, with linkers that alter orientation, flexibility 
and length all showing decreasing the maximum range. Values shown are the mean ± 
S.E.M. 
 
In the available literature, both rigidifying the FP location and linker optimization has 
shown to yield large increases in obtainable FRET ratios, however these approaches are 
typically non-rational and the increase in dynamic range has generally been attributed to 
the locking of the FPs into a set of more sensitive orientations.
62,205,210
 This may be an 
oversimplification as although it is true that there are certain values of κ (orientation) 
which will allow for very small changes in displacement to yield large changes in FRET 
efficiency, most values of κ have comparable FRET efficiencies per unit distance 
(Figure 17). This also suggests that randomly altering fluorophore orientations may not 
necessarily have a significant impact upon the dynamic range, or FRET efficiencies. 
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Figure 17: A) The theoretical relationship between fluorophore orientation (κ), 
interfluorophore distance and FRET efficiency for the ECFP-Venus pair. This shows 
that for a given FRET pair and orientation, there is a corresponding optimum range of 
change in FRET efficiency per change in unit of distance, which is centered at the 
Förster distance. Optimizations typically focuses on changing where a given sensor 
operates on this efficiency topology by manipulating dependent parameters such as 
orientation, magnitude of change in interfluorophore distance and the initial and final 
interfluorophore distance, until an improved dynamic range is reached. B) The 
relationship between orientation and FRET efficiency at a set distance (3.5 nm). Both 
figures have been provided by Joshua Mitchell using Wolfram Mathematica. 
A 
 
B 
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This also means that some proteins with conformational changes that primarily affect κ, 
rather than interfluorophore distance, may have low or unobservable changes in FRET 
efficiency and, similarly, attempts to engineer an improved sensor by randomizing 
orientation could decrease the dynamic range rather than improve it. This notion is 
consistent with what was observed with the gly-pro dipeptide modified sensor, where 
the random reorientation of the VenusFP did not result in a meaningful change in the 
dynamic range. Hence, while it is possible that a sensor may be improved by altering 
fluorophore orientation, without the ability to engineer a given sensor such that the 
fluorophores adopt a specific set of orientations, it should not be considered a 
systematic means of doing so. In contrast, increasing the change in 
displacement/interfluorophore distance from binding will in the majority of cases 
improve the dynamic range of a sensor, regardless of most orientations. Furthermore, it 
is possible that in some previously described optimized FRET sensors,
205
 rather than the 
fortuitous locking of the FPs into a particular orientation which happens to improve the 
dynamic range, the linker may have instead allowed for or improved the conversion of 
angular changes into large changes in relative FP displacement providing the observed 
large improvements in the dynamic range.   
While rational/non-combinatorial application of rigid linkers in various FRET 
systems has been used previously, it has been done strictly to preserve interfluorophore 
distances of conformation independent systems,
211,212
  or as a structural component for a 
multi-domain protein association type system, such as that created by Sato et al.
213
 In 
the latter case, the “flip-flop” type sensor relies on the ligand recognition domain of the 
sensor being able to associate with the cell membrane in order to undergo FRET, 
meaning that the “flip-flop” sensor design is limited in applicability. Furthermore, the 
rationale behind the sensor function is not based on the conversion of conformation 
dependent angular changes to distance, making it distinct from what is proposed here. 
Ultimately, this means that there is an alternative avenue of reasoning by which FRET 
constructs can be improved and developed, where proteins that have significant angular 
changes, but not necessarily large conformational changes, can have rigid helices 
introduced in order to create functional constructs. 
Finally, to confirm that GRIP retained the same binding capacity as previously 
determined by ITC, dose-response relationships were determined for relevant amino 
acids. The results were consistent with that shown through ITC, with the affinity for 
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glycine again being determined as 20 µM and showing detectable changes over a range 
of 1-300 µM glycine (Figure 18), with changes in response to leucine, valine and 
threonine only possible at high ligand concentrations in a range outside what is 
physiologically relevant in the CNS.
195-199
 The construct was then evaluated in vivo as 
described in Chapter 4. 
 
 
Figure 18: Dose response curve of GRIP showing a Kd of 20 µM. The screening of 
potential competitors identified leucine, valine and threonine, however these two 
ligands bind with weak affinity and the detection range lies outside of physiologically 
relevant levels of leucine/valine/threonine (blue), meaning they are not of concern in 
vivo. Values shown are the mean ± S.E.M. 
 
2 D. CONCLUSIONS 
Use of computational aides such as FoldX and Autodock facilitated the engineering of a 
glycine specific binding domain. Conversion of this binding core into an optical sensor 
was enabled through the use of a rigid EAAAK linker, which converts angular changes 
into an increased interfluorophore displacement by behaving as a lever, increasing the 
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dynamic range of the sensor. This is in comparison to methods which aim to increase 
dynamic range on the basis of fluorophore orientation, which did not yield sufficiently 
positive results for this sensor for it to be applied practically. Based on the results and 
finding presented here, it does not appear that orientation optimizations are as 
systematically applicable as indicated by the literature. Furthermore, it is possible that 
some of these sensors that have been described in the literature have instead been 
optimized by maximizing changes in fluorophore displacement and that the improved 
dynamic range has been misattributed to the sensor fluorophores occupying a set of 
more sensitive orientations. As such, by focusing on maximizing changes in 
interfluorphore distance rather than orientation, sensors may be improved more reliably 
and quickly, which may be facilitated through the use of rigid linkers. 
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CHAPTER 3: DEVELOPMENT OF A GABA SENSOR 
AND AN IMPROVED GLYCINE SENSOR USING 
SYNTHETIC DYES 
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Foreword 
This research was done in conjunction with Joshua Mitchell (Honors student) who 
performed experimental work under the author’s supervision. Unless otherwise stated, 
all related molecular dynamics and computational work for the assessment of dye 
optimization was completed primarily by Joshua Mitchell under the supervision of Dr. 
Megan O’Mara. 
 
3 A. THE ROLE OF GABA 
In the mature CNS, GABA acts as one of the primary neurotransmitters mediating 
inhibitory postsynaptic potentials.
172
 GABA is typically released from GABAergic 
neurons in vesicles (although, as mentioned previously, GABA can be co-released with 
glycine in the same vesicle),
11
 and can activate both ionotropic GABA receptors 
(GABAARs) and metabotropic GABA receptors (GABABRs).
214 The hyperpolarization 
of neurons through GABAAR activation is a key aspect to the moderation and control of 
neuronal signaling through the termination of action potentials, making GABA one of 
the primary neurotransmitters involved in many physiological processes including 
sensory processing and motor control.
181,215
 As a consequence, dysfunction of GABA 
signaling contributes to numerous diseases and complications, with evidence 
implicating it in epilepsy, schizophrenia and anxiety.
216,217
 How dysfunction of GABA 
release or uptake contributes to these disorders is not clear, for example, the evidence 
for altered GABA signaling in schizophrenia has largely been obtained through post 
mortem analysis rather than direct observation.
218,219
 The involvement of GABA in the 
developing brain is also of interest, since it is known that in the immature CNS GABA 
acts as an excitatory neurotransmitter, where throughout the maturation of the CNS it 
transitions into an inhibitory neurotransmitter.
220
 
Many aspects of neuronal signaling remain unclear, such as why the 
development of the auditory pathway requires excitatory glutamate release despite 
GABA also being an excitatory neurotransmitter at early developmental stage,
221
 or 
why stimulation of the mossy fibers in the hippocampus results in transient GABA 
release.
222
 One immediate use of an optical GABA sensor would be to discern and 
quantify GABA concentrations on a cellular scale, which is something that has typically 
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been done through techniques that operate on a larger diagnostic scale, such as MRI.
223
 
Differential GABA concentrations in different brain regions has been linked 
neurological conditions such as depression and attention deficit disorder or 
schizophrenia,
224,225
 and as such, being able to study these differences on an even finer 
scale (cellular and sub-cellular) than currently possible with magnetic imaging 
techniques may prove invaluable. The development of a GABA optical sensor could 
potentially answer a number of these questions by allowing real time in situ analysis of 
GABA signaling propagation and distribution. It would allow refinement of our current 
understanding of the role of GABA, while also allowing us to confirm or refute many of 
the current theories surrounding the role of GABA and the GABA receptors in the 
developing and mature CNS and related diseases.  
 
3 B. USE OF SYNTHETIC DYES 
Many contemporary sensors have used synthetic fluorescent dyes, rather than FPs as the 
signaling component of the sensor. The effectiveness of these sensors has already been 
discussed previously (Chapter 1). However the examples discussed in Chapter 1 are 
either single fluorophore emitters, require more than one organic dye or were developed 
through extensive high through put screening.
40,68
 It is possible to improve on one or 
more of these design components when creating a synthetic dye based sensor; 
specifically, it should be possible to create FRET sensors that are a combination of one 
FP and one synthetic dye, which would be an immediate improvement over both single 
fluorophore and two dye sensors by making a sensor ratiometric and requiring one less 
site specific modification. Additionally, rather than using brute force high-throughput 
screening of all residue locations to identify a dye labeling site, it should also be 
possible to expedite sensor development through the use of computational aids to 
provide an initial screen, which would narrow down the number of possible dye 
labeling sites to a subset that has a higher likelihood of yielding a functional sensor. 
One example of a FP-dye FRET sensor has previously described in the scientific 
literature,
226
 however this system relied on a peptide cleavage mechanism to function, 
studied protease activity rather than analyte concentration, and was not quantitative or 
time sensitive as it was unable to return to an “apo” sensor state. As such, the 
application of dye-FP FRET pairs to develop optical sensors has been limited. 
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For conformational-change based sensors, the benefits of using synthetic dyes in a dye-
FP pair over a FP-FP pair are clear, as while there are the general benefits intrinsic to 
synthetic dyes, such as their higher fluorescence intensity, which improves the signal-
to-noise ratio, they also allow a much wider range of possible binding cores to be used 
as a part of the sensor construct as it is far easier to optimize the location of a small 
organic dye than it is for a large FP. Additionally, it is more likely that a given protein 
will maintain proper function after the modification or mutation of a single surface 
residue to attach a fluorescent dye, when compared to alternative methods of 
fluorophore relocation such as insertion of a cpFP within a loop. As there is much 
greater control over the precise location of synthetic fluorophores, synthetic dyes can 
theoretically allow for even small conformational changes to produce a measurable 
FRET signal. While a large conformational change for a given protein is always 
desirable for sensor construction, it is often a necessity when using FPs, meaning that 
synthetic dyes are potentially applicable across a much larger range of proteins, rather 
than being restricted to those with large distance based conformational changes. 
We sought to improve the previously described glycine sensor (Chapter 2) using 
a FP synthetic dye pair and to create a FP-dye based sensor using a protein with very 
limited conformational change, namely the GABA specific protein Atu4243.
227
 Despite 
being a SBP, Atu4243 is somewhat unique in that there is only a 1 Å change in distance 
between the N and C termini of the holo and apo forms of the protein and a maximum 
distance change of 6.7 Å for subregions within the protein, which is significantly 
smaller than the 32 Å maximum displacement of Atu2422 (Figure 19). The creation of 
an improved GABA sensor would be of interest due to the large role this 
neurotransmitter plays in the CNS. 
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Figure 19: Overlay of apo (red) and holo (green) forms of both Atu4243 (GABA 
binding, left) and Atu2422 (Glycine binding, right). The conformational change of 
Atu4243 is significantly smaller than that of Atu2422. Although the change in distance 
between the N and C terminus of each protein may be small, regional changes may be 
larger, such as the displacement between two loops (or helices) that are each located 
on a different lobe. 
 
A ratiometric GABA FRET sensor has previously been reported by Masharina et al. 
using a “Snifits” based design (discussed previously in Chapter 1, section 1 F),68 where 
they demonstrated concentration dependent imaging of GABA in real time. However 
the addition of the fluorescent tether lowered the effective GABA affinity (𝐾𝑑 = 100 ± 
10 μM) compared to the unmodified GABAB receptor. This impacts the sensitivity of 
the sensor, particularly for the quantification and observation of GABA in the low 
micromolar to high nanomolar range. In addition, its capacity to be applied to different 
environments is limited due to the use of two synthetic dyes and because the sensor 
must be membrane bound. Therefore, creating a membrane independent GABA sensor 
that utilizes one FP and one synthetic dye would be an improvement, assuming that it is 
capable of sensitively reporting changes over a physiologically relevant GABA 
concentration range. 
Outlined in this Chapter is the development of synthetic dye-FP based sensors 
using computational assessment of dye conjugation sites, cysteine mutagenesis and thiol 
specific dye labelling, which has enabled the creation of a more sensitive glycine sensor 
with a dynamic range of 670%. A specific GABA sensor with a dynamic range of 19% 
was also created through this method. The glycine construct shows clearly how 
synthetic dyes and computational design can be used to improve the dynamic range of 
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existing FRET constructs by over an order of magnitude, while the GABA sensor shows 
that even proteins with very limited conformational dynamics can be converted into 
functional sensors through the use of synthetic dyes. Although the GABA sensor 
described here is not as sensitive as that created by Masharina et al. over the 
physiologically relevant range of GABA concentrations (1-10 µM) it is not membrane 
restricted and requires only a single organic dye. Hence, it can be argued that it has 
some situational advantages over the GABA-Snifit. 
Comparison of computationally predicted dynamic ranges to the experimentally 
observed dynamic ranges showed that, for Atu2422, computational assessment 
correlated with experimental values and is able to provide qualitative predictions of 
sensor sensitivity, with constructs predicted to have a low or poor dynamic range 
showing low ranges experimentally, and likewise for constructs predicted to have 
appreciable or high dynamic ranges. The poor correlation between the computationally 
predicted and experimental values for the Atu4243 simulation indicates that there are 
some remaining issues with the underlying assumptions used in the computational 
evaluation of FRET constructs. Nevertheless, our results show that the computational 
methods described can allow for in silico screening, which could both expedite and 
simplify the development of optical sensors. 
 
3 C. MATERIALS AND METHODS 
 
Foreword: The following methods section has been prepared as a chapter for 
publication and invited book chapter: “Synthetic Protein Switches – Methods and 
Protocols” to be published as a part of the “Methods in Molecular Biology” laboratory 
protocol series. Additional methods that are not a component of this publication, but are 
a part of this specific project can be found at the end of this section.  
 
Summary 
FRET based sensors offer the ability to observe target analytes with excellent spatio-
temporal resolution. However, the creation of such sensors is often complicated, as 
Chapter 3 
62 
 
some proteins might not produce responsive sensors with the addition of fluorescent 
proteins, or may require multiple rounds of optimization which can be time consuming 
and prone to failure. The use of synthetic dyes provides an avenue by which sensitive 
FRET based sensors can be created, as it allows for precise control over fluorophore 
positioning which in turn can allow for the maximization of the dynamic range of a 
sensor. Described is a method by which a cysteine modified protein can be rationally 
modified with a synthetic dye paired with a fluorescent protein for the purposes of 
creating FRET sensors. 
 
Materials 
Whenever possible, prepare all stock solutions and buffers in ultrapure water (MilliQ). 
For reagents that have poor solubility in water, dissolve them with the smallest possible 
proportion of organic solvent (i.e. 5% DMSO would be preferable to 10% DMSO) as 
some proteins may have poor stability in organic solvent. All solutions and reagents 
should be prepared as fresh as possible as some reagents will have short lifetimes when 
in solution, even at -20 °C. 
 
 
Dye labeling components 
1. Buffer solution, Phosphate buffer: Weigh out 6.0 g of disodium hydrogen phosphate 
(anhydrous), 0.93 g of sodium dihydrogen phosphate and 11.7 g of sodium chloride into 
a measuring cylinder and add water to a volume of approximately 900 ml. Using either 
hydrochloric acid or sodium hydroxide, adjust the pH to what is appropriate for both the 
protein of interest and the chemistry that is needed to label the protein with the synthetic 
dye. In the case of thiol-maleimide conjugations, the desired pH is between 7.0 and 7.5. 
After the correct pH has been reached, add more water to the buffer solution until the 
total volume is 1 L and then filter the solution through a membrane filter (pore size 0.45 
µm or smaller). Note: Phosphate buffer may not be compatible with all proteins; 
substitute with an appropriate buffer if needed. 
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2. TCEP stock solution: dissolve 0.1437 g of Tris(2-carboxyethyl)phosphine 
hydrochloride (TCEP-HCl) in 1 ml of buffer solution (501 mM stock solution). Note: 
TCEP, or reducing agents in general, are typically only necessary for thiol based 
conjugation. TCEP is far preferable to other reducing agents such as DTT, as under 
normal reactions TCEP will not interfere with the maleimide-thiol reaction and also 
does not have issues with odor. 
3. Dye stock solution: Add a suitable solvent to the synthetic dye to achieve a stock 
solution with a final concentration of 10 mM. In the case of the Alexa Fluor 532 C5 
Maleimide, 1 mg was dissolved in 123 µL of buffer (10 mM stock solution). Note: 
Sometimes there may be trace precipitate or undissolved dye in the stock solution. This 
is not a cause for concern so long as the precipitate is suspended homogenously prior to 
use. 
4. Protein solutions: proteins should be concentrated as much as practical (ideally at 
least 500 µM) and exchanged or dialyzed into the same buffer solution as used to 
prepare the reagent stock solutions. Purification methods that are appropriate for the 
target protein should be used. Note: the protein should be made as pure as possible, as 
impurities may be labeled by the dye, which can affect the observed dynamic range of 
the protein sample. If additional purification is needed, size exclusion chromatography 
can be performed either before or after the labeling reaction. 
 
Methods 
All experimental work should be performed at 4 °C unless otherwise specified. Python 
and Bash interpreters are required to run the computational scripts (available at 
www.gnu.org/software/bash and www.python.org respectively). The modelling 
program GROMACS and the Martini force field parameters are also required.
228,229
 
 
Computational screening and residue selection 
1. First prepare a model of the target protein with the desired binding properties (for 
both the apo and holo form of the protein in question) with a fluorescent protein (i.e. 
ECFP) attached at either the N or C termini of the structure. This can be done in the 
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program PyMOL by first adding any missing residues (including the linker) then 
selecting the appropriate atoms and using the “fuse” line command. Residues can be 
added to an existing model in PyMOL in editing mode, accessed by clicking the mouse 
key shortcuts box in the lower right corner of the viewer window while in the default 
Viewing mode. Once in editing mode, select the N-terminal nitrogen or C-terminal 
carbonyl carbon and then add residues by holding Alt and typing the single-letter code 
associated with the desired residue. 
2. Once the correct residues have been added, the two proteins should be linked by 
selecting the correct residues and using the “fuse” command. For example if a model 
with an ECFP on the N terminus of the protein is desired, start by selecting both the 
amine of the N terminus of the protein and the oxygen of the C terminus of the ECFP. 
Then, while both atoms remain selected, enter “fuse” as a command input, which will 
generate an approximate model of the fusion protein. Note: the fuse command may 
sometimes orient the proteins poorly; make sure to rotate the proteins as such that they 
do not overlap in physical space. 
3. Place the .pdb file containing the model sensor within a folder that also contains the 
model processing script “Martini_setup_multirun-rewrite.sh” (Appendix AC3.4). The 
apo and holo models should have their own respective directory separate from each 
other. Modify the appropriate script variables as indicated in the script file, including 
the PDB filename, length of the simulation, etc. 
4. Allow the “Martini_setup_multirun-rewrite.sh” script to run. In brief the script 
performs the following operations (in no particular order); preparation of a MARTINI 
coarse-grained force field, .PDB file conversion, vacuum energy minimization, 
solvation and addition of salts, solvated energy minimization, unrestrained MD, 
backbone-restrained MD for equilibration, unrestrained equilibration MD and a 
specified number of production runs. At one point, the script will pause and ask you to 
check its output; ensure the number of NA+, CL-, W and WA atoms match between the 
.GRO file and the topology. Refer to the MARTINI protein tutorial for details 
(http://md.chem.rug.nl/index.php/tutorials-general-introduction/proteins). 
5. Run the second script “pickleize-all.bash” (Appendix AC3.4). In brief the script 
performs the following operations (in no particular order); Water removal, model 
simplification and sampling and conversion of model to a .PDB format. 
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6. Run the final script “Pickleprocessall.py” (Appendix AC3.4). This script takes the 
relevant information from the .PDB model and generates a binary file. Calculations are 
then run using the information provided and the results are generated in an output file. 
This file assigns the predicted dynamic range for a given residue location. An example 
of this output is shown in section 3 D V (Figure 31). 
7. Using the computational data, select residues that are appropriate for cysteine 
mutagenesis. A residue that yields the largest predicted dynamic range may not 
necessarily yield the best sensor, as the residue may have some structural importance, 
which may be disrupted with mutagenesis. Residues with side chains oriented towards 
the solvent, or are not a part of structural motifs such as β-sheets should be selected. 
Notes: As a matter of course, any undesired solvent exposed cysteines should be 
removed to prevent unwanted labeling. Residues such as serine are typically more 
amenable to cysteine mutagenesis over more structurally distinct residues such as 
tryptophan. 
 
Dye labeling and purification. 
1. To a volume of 849 µL buffer add 100 µL of the concentrated protein solution 
(assuming 500 µM) and 1 µL of the TCEP solution. Wait approximately 5 minutes to 
allow this solution to equilibrate to room temperature and for any disulfides to be 
reduced. This reaction can be performed in an Eppendorf tube or an equivalent. Note: 
the reaction volume and reagents should be scaled appropriately relative to the 
concentration of the protein stock solution. 
2. To the reaction mixture add 50 µL of the dye stock. The final composition of the 
reaction mixture should contain approximately 50 µM of protein, 500 µM TCEP and 
500 µM dye. The reaction should be allowed to proceed overnight (16 h) at 4 °C in the 
dark with constant agitation. Note: when agitating the solution, care should be made 
that the solution does not begin to form froth or foam as this can lead to precipitation of 
protein. 
3. After the reaction period, centrifuge the reaction mixture at high speed (13500 rpm, 5 
mins) to separate out any precipitated dye or protein. Note: filtration can be used 
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instead of centrifugation; however there is typically some volume/yield loss when 
filtering small volumes. 
4. The mixture should then be purified through gel filtration, with a desalting column 
usually being sufficient. Note: PD-10 columns (GE healthcare) are usually sufficient to 
separate free dye from the protein. If the purity of the protein is a concern, the protein 
should be first buffer exchanged to remove excess TCEP and then purified with SEC 
(GE healthcare, Hiload 26/600 superdex 200pg, adequate for most proteins). This 
should separate labeled protein from free dye and any contaminant proteins. 
5. After one round of purification with the desalting columns, the protein mixture 
should be re-concentrated and buffer exchanged using centrifugal protein concentrators, 
which will remove trace TCEP and further remove unreacted and free dye. 
6. The protein should then undergo a final desalting step to ensure that no free dye or 
TCEP remains. 
 
Additional methods 
 
DNA cloning and mutagenesis. Genes were purchased through either the GeneArt 
gene synthesis service (ThermoFisher Scientific) or as a gBlock (Integrated DNA 
technologies), as described in Chapter 2. Vector cloning and mutagenesis was done 
using the Gibson assembly method described in Chapter 2. 
 
Expression and purification of proteins. All proteins were expressed and purified as 
described in Chapter 2, with the exception that they were grown at 18 °C and that 
constructs based on the GABA specific binding core Atu4243 were grown in LB media, 
rather than autoinducing TB. 
 
Fluorescence. Fluorescence assays were performed as described in Chapter 2. All 
sensor constructs were excited at 433 nm. The emission of sensors labeled with OG488 
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was monitored at 476 nm and 512 nm, while constructs labeled with AF532 were 
monitored at 476 nm and 553 nm. 
 
3 D. RESULTS AND DISCUSSION 
 
3 D I. DEVELOPMENT OF A GABA SENSOR 
Planamente et al. have reported the GABA specific SBP from Agrobacterium 
tumefaciens Atu4243,
227
 with a binding affinity of 10 µM. This immediately presented 
itself as a suitable binding core for the development of a GABA sensor. As mentioned 
previously, Atu4243 has only limited conformational movement of this protein due to 
ligand binding, meaning that it is unlikely that the traditional method of an N and C 
terminal fusion of fluorescent proteins would result in a sensitive FRET sensor. 
Furthermore, comparison of the ligand bound structure to the apo form identified that 
the N and C termini are orientated away from each other across a distance exceeding 4.5 
nm, meaning that the additional distance from the barrel structure of the fluorescent 
proteins would necessarily make the minimum interfluorophore distance large and 
outside the sensitive distance range (Förster distance). As expected, the fusion of an 
ECFP-Venus pair to the N and C termini of Atu4243 as well as use of the Pertz kit array 
did not produce a functioning FRET sensor. Closer structural examination showed that 
although there was only very limited overall conformational changes, there were some 
regions of comparatively large displacement. 
In an attempt to relocate a fluorophore to these regions of large displacement, a 
circular permuted FP (cpVenus-145) was inserted into a loop after residue N72. This 
location was chosen as it underwent the largest binding mediated displacement and was 
unlikely to play a critical structural role as the loop was flexible and disorganized, as 
shown by the B-factors in the crystal structure (Figure 20). 
Chapter 3 
68 
 
 
Figure 20: Crystal structure of Atu4243 with the B-factors represented by backbone 
size and coloration. A larger B-factor, and therefore a greater degree of disorder, 
corresponds to a larger the backbone and a red hue. Conversely, an ordered loop or 
structure of the protein would be thinner and tend towards a blue hue. The fluorescent 
protein was inserted after residue Asn72 (red circle), where there is the largest relative 
change in distance to the C-terminus (purple circle) due to ligand binding. The specific 
residue was selected due to having the largest B-factor (flexibility and disorganization) 
of the loop. 
 
The further addition of an N terminal ECFP did produce an inverse ligand response with 
a maximal change in the FRET ratio of 4% (Figure 21). However this was not adequate 
in terms of a dynamic range, which ideally we would require to be at least above 10%. 
Notably, this result showed that, unlike the results for loop insertions of cpFPs into 
Atu2422 (the glycine binding protein), insertions of a cpFPs into surface loops of 
Atu4243 did not appear to compromise GABA binding affinity, which may be due to 
the modified loop having a non-essential role for binding-mediated conformational 
change. 
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Figure 21: Spectra of the FRET construct consisting of a C-terminal ECFP attached to 
a cpVenus-Atu4243 binding core. Although a ratiometric change can be observed, the 
overall dynamic range is too small for practical application. 
 
It was clear that with the limited conformational changes observed in Atu4243 upon 
GABA binding, as well as the unfavorable locations of the N and C termini for 
maximizing fluorophore motion, that the fluorophores would have to be optimized by 
relocating at least one fluorophore within the protein structure. As the size of the FPs 
imposes some steric limitations as to how they can be repositioned within the binding 
core, the use a synthetic dye was viewed as a more viable option. By visual inspection 
and computational assessment, six residues were identified as candidates for cysteine 
mutation (for the covalent attachment of fluorescent dyes); four residues for an N-
terminal ECFP construct G51, G93, D104 and T114, and two residues for a cpFP 
construct, S196 and S213 (Figure 22).  
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Figure 22: Residues selected for cysteine mutagenesis shown (blue) on the structure 
of Atu4243. 
 
For the circularly permuted construct, the cpVenus-145 was replaced with a cpECFP-
145 in order for the FP to have the correct spectral overlap with the dyes used, Oregon 
green 488 (OG488) and Alexa Fluor 532 (AF532). Furthermore, the cysteine residues of 
the FPs (both the ECFP and cpECFP) used were mutated (C49S and C71V) to prevent 
unwanted labeling, the mutant residues were selected on the basis of the combination 
that gave the best expression as shown in the literature.
226
 The two residues for the Atu-
cpECFP construct were selected through visual inspection, as the accuracy of the 
Atu4242-cpECFP model was not sufficiently high enough, meaning it was not possible 
to use computational assessment. This visual selection used residue N72 (the cpFP 
insertion site) as an approximate location of the cpFP fluorophore and selected residues 
that had the largest binding-mediated change in distance relative to this residue location 
based on the holo and apo crystal structures of Atu4243. The selection process aimed to 
produce a functional GABA sensor and to also assess the accuracy of the computational 
screening method, hence some residues were selected with the expectation that the 
dynamic range would be low. For example, labeling residue D104 was predicted to 
result in a sensor with a low dynamic range (7.5%) and the labeling of residues G93 and 
T114 was predicted to result in sensors with large (56%) and intermediate (19%) 
dynamic ranges respectively (discussed further in section 3 D V). The computational 
screening used for developing the GABA and glycine dye based sensors was 
G51 
D104 
T114 
G93 
S213 
S196 
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accomplished by doing coarse grain molecular dynamics on the holo and apo forms of a 
given construct and then taking the interfluorophore distances to work out the FRET 
efficiency for a given conformational state. These FRET efficiencies could then be used 
to work out a theoretical dynamic range using the following equation: 
𝟔) 𝐷𝑦𝑛𝑎𝑚𝑖𝑐 𝑟𝑎𝑛𝑔𝑒 =  
𝐸ℎ𝑜𝑙𝑜 − 𝐸𝑎𝑝𝑜 
(1 − 𝐸ℎ𝑜𝑙𝑜)(1 + 𝑆(𝐸𝑎𝑝𝑜 − 1))
 
The “S” term in the above equation accounts for the effects of non-FRET based spectral 
excitation and emission overlap, such as direct excitation of the acceptor at the 
excitation wavelength of the donor as opposed to excitation from the emission of the 
donor fluorophore (full derivation in Appendix AC3.3). 
 
3 D II. EVALUATION OF THE GABA SENSORS 
Two dyes with spectral overlap to the ECFP, Oregon green 488 (OG488) and Alexa 
Fluor 532 (AF532) were used to label the potential sensor constructs. Although they 
could both be excited by ECFP, the exact excitation and emission wavelengths of these 
two dyes differed. Of particular note, AF532 had significantly less overlap with ECFP 
at 433 nm compared to OG488, meaning that OG488 would likely have an overall 
lower range due to non-FRET dependent excitation of the dye (also known as donor 
bleed-through, for both labelled dye and free/contaminating dye), while AF532 would 
have much less background signal and could therefore have a much better range 
(Figure 23). Although the use of cysteine reactive dyes would make in vivo labeling of 
the sensor unviable due to non-specific labelling, this limitation can be overcome by 
using bio-orthogonal reactive chemistries, such as the tetrazine and strained alkene 
“click” reaction.230 While the modified sensor could be produced through cell-free 
methods to introduce such functionalities, the sensor would also be able to to be 
genetically encoded, as the necessary chemical moieties for such reactions can be 
introduced through unnatural amino acid incorporation.
231
 However, such methods are 
necessarily costly and time consuming and as such, the use of cysteine reactive dyes can 
be used to first confirm the functionality of a given sensor design, before pursuing more 
selective methods of dye introduction. 
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Figure 23: The excitation wavelengths of ECFP (teal), OG488 (green) and AF532 
(yellow). The excitation overlap of OG488 with ECFP is larger than that of AF532, 
meaning that OG488 will have much more background excitation. Chemical structures 
of OG488 (green box) and AF532 (yellow box) are shown on the right. 
 
The stoichiometry of dye to protein after purification was determined using the 
equation: 
𝟕) 𝑀𝑜𝑙𝑒𝑠 𝑜𝑓 𝑑𝑦𝑒 𝑝𝑒𝑟 𝑚𝑜𝑙𝑒 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 =
𝐴
𝜀 × 𝐶
 
Where for a given sample “A” is the absorbance at the peak excitation wavelength of 
the dye in use, “ε” is the extinction coefficient of the dye and “C” is the concentration of 
protein. 
In general, the average ratio was found to be slightly higher than 1:1 (1.15 ± 
0.23 moles of dye per mole of protein), indicating firstly that there was efficient 
labeling of the protein with the dye, but also secondly that there was likely some 
residual free dye after the purification process. Additional purification typically did not 
have a significant effect on lowering this ratio and the sensors were used as-is under the 
assumption that the free dye did not have a significant impact on any obtained results.  
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Figure 24: Initial screen of the FRET ranges for different labeled residues, with ATU-
svCFP and ATU-cpCFP being cysteine-free (unmutated binding core) control samples. 
As there were two forms of the binding domain (with and without cpFP insertion) they 
were initially screened with the more accessible OG488 and the best of the two binding 
domain forms was then further screened with AF532, with residue 296 having the best 
dynamic range. Values shown are the mean ± S.E.M. 
 
The trend observed for the initial screening of the labelled proteins was that the proteins 
without the cpECFP had overall much lower dynamic ranges compared to that of the 
circularly permuted sensors (Figure 24). This was not unexpected; as the N-terminally 
fused ECFP was unlikely to interact with the dye as favorably as the repositioned 
cpECFP based on the results initially obtained using fluorescent protein pairs, where 
only the cpFP-FP sensor gave a detectable signal. The cpECFP constructs were then 
tested with AF532, which showed a comparable if not improved range dynamic over the 
OG488-modified proteins. A full dose response curve for the best construct, cpECFP-
AtuSer196, called GASP (GABA Sensing Protein) showed an overall 19 ± 0.8% 
dynamic range (AF532/ECFP ratio, Figure 25), confirming that repositioning of the 
Chapter 3 
74 
 
FPs can result in large improvements in the dynamic range even in proteins  that 
undergo only limited conformational changes. Unfortunately, the binding affinity of the 
construct was impacted by these changes, shifting the Kd from 10 µM to 221 ± 35 µM 
(Figure 26). This sensor is still useful, being able to detect binding in the concentration 
range between 7 µM and 10 mM. This suggests that either the insertion of the cpFP or 
the attachment of the dye (or both) may have caused a decrease in affinity, although the 
modification of the loop residue to a cysteine may also have decreased the affinity by 
impacting the overall mobility of the protein, or by influencing accessibility of the 
ligand to the active site. 
 
Figure 25: Spectra of GASP showing approximately an 18% change at 4.5 mM (sub-
saturating) of GABA. 
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Figure 26: Dose response of GASP to GABA showing detectable changes from 
approximately 7 µM to 10 mM. Values shown are the mean ± S.E.M. 
 
The existing GABA sensor developed by Marashina et al. possesses an overall dynamic 
range of +80%, which corresponds to an effective range of over 21% for concentrations 
in of the lower micromolar range (from 1-10 µM). For our best GABA sensor, GASP, 
the effective dynamic range over the same concentrations of interest is approximately 
+3%. Thus, in terms of sensitivity, the sensor developed by Marashina et al. is seven 
fold better. However, the GASP sensor does have the advantage in that it requires only 
one dye, making it easier to prepare, and it is potentially compatible with techniques 
such as the incorporation of unnatural fluorescent amino acids (for bio-orthogonal 
labelling or introduction of fluorescence). Furthermore, the sensor is not required to be 
membrane bound and does not necessarily need to be genetically expressed by the target 
system, making it potentially more applicable over a wider range of environments and 
cellular contexts; including examining GABA transmission between bacteria and their 
host plants as well as observing GABA within microstructures and intercellular 
compartments of neurons (or other cell types).
227,232-234
 Additionally, as physiological 
GABA concentrations has been observed to reach millimolar concentrations (depending 
on the studied system),
235
 GASP would be able to report changes at these concentrations 
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within the sensitive range of the sensor. This means the sensor may be preferable to the 
GABA-Snifits sensor in some situations. 
 
3 D III. DEVELOPMENT OF AN IMPROVED GLYCINE SENSOR 
Compared to Atu4243, the GABA binding protein, Atu2422 had a much larger domain 
to domain conformational change; this gave it the potential for an extremely high 
dynamic range if modified into a synthetic dye-FP pair construct, as the use of a dye 
would allow for precise positioning of a fluorophore onto areas of large displacement, 
which would maximize the changes in interfluorophore distance and therefore the 
changes in FRET efficiency. 
As discussed previously (Chapter 2), initial attempts to reposition the 
fluorophores of the FP pair was done through the insertion of cpECFP in order to create 
SnFR or SnFR-like type sensors (Appendix AC2.6). However, unlike Atu4243, the 
glycine binding protein was deactivated as a result of this insertion. As the N and C 
termini of the glycine binding protein were in a more preferable location compared to 
Atu4243 for allowing a FP-FP FRET pair to interact, this meant that the insertion of a 
cpFP in order to reposition one of the fluorophores was ultimately not necessary in 
order to create a functional FRET sensor (GRIP). However, based on visual inspection, 
it was still likely that many of the locations previously specified and modified with the 
SnFR insertions (Appendix AC2.6), in particular residue 178 (SnFR 180), could result 
in a extremely large FRET response if an appropriate fluorophore could be positioned 
there. The use of synthetic dyes was pursued, given that the structural modifications 
required were less likely to deactivate the protein than with the use of cpFPs. Along 
with residue G178, visual inspection and computational evaluation identified residues 
T168, L218, K219 and D340, which were mutated to cysteines to undergo labelling 
(Figure 27).  
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Figure 27: Residues selected for cysteine mutagenesis shown (blue) on the structure 
of Atu2422. 
 
As with the GABA sensor, cysteine residues on the FP were mutated to prevent 
unwanted labeling. Similarly, following the selection process for the GABA sensor 
development, the residues were selected on the basis of producing a highly sensitive 
sensor as well as evaluating the computationally predicted dynamic ranges, including 
residues predicted to give poor dynamic ranges. For example, residue G178 was 
predicted to yield a sensor with a large dynamic range (70%) while other selected 
residues such as D340 and L218 were expected to give intermediate (16%) and small 
(9%) dynamic ranges respectively (discussed further in section 3 D V). 
 
3 D IV. EVALUATION OF THE GLYCINE SENSORS 
As with what was observed with Atu4243, testing of the sensors showed that for all 
sensors that yielded a detectable FRET response, AF532 always performed equal to if 
not better than OG488 (Figure 28). 
G178 
K219 
D340 
T168 
L218 
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Figure 28: Initial screen for the AYW dye modified sensors, with AYW-svCFP being the 
cysteine-free (unmutated binding core) control sample. Of note is the fluorescently 
labeled residue 178, which shows an extremely large increase in the dynamic range in 
response to glycine, Values shown are the mean ± S.E.M. 
 
As expected, labeling residue 178 located on the loop previously identified for cpFP 
insertion (SnFR180) resulted in a sensor with a ratio change of over 200% at 100 µM 
glycine (Figure 29) and an overall dynamic range of over 670% at saturating 
concentrations of glycine (Figure 30). As with the GABA sensor, the resulting sensor 
has a lower Kd of 138 ± 7 µM (from 20 µM). This is not entirely surprising, as when a 
cpFP (SnFR) was inserted previously at this loop, the protein was deactivated, which 
indicates that the loop is important for protein function and may be sensitive to 
modifications. 
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Figure 29: Spectra of GRIPPED with approximately 100 µM glycine (sub saturating) 
showing a ratio change of over 200% 
 
Figure 30: Dose response curve of GRIPPED showing an overall maximum range of 
670% with over a 50% range between 1 to 10 µM of glycine. Values shown are the 
mean ± S.E.M. 
 
This reduced Kd is offset by the large increase to the dynamic range, such that the 
effective dynamic range at physiologically relevant glycine concentrations it has been 
increased by close to an order of magnitude (from 8% to over 50%), rather than 
decreased. This sensor, GRIPPED (Glycine Ratiometric Indicator Protein Potency 
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Enhanced by a Dye), can produce a change in FRET ratio of over 50% from 1 to 10 
µM, and over a 10% range from 10 nM to 1 µM, meaning that nanomolar changes can 
be detected. As mentioned previously, attempts to reposition genetically encodable 
fluorophores in the form of cpFP insertions resulted in the loss of binding affinity in 
Atu2422. This restricted the ability to implement sensor designs that required region-
specific placement of the fluorophore, meaning that although local regions of large 
displacement could be identified, it was not possible to translate that into a functional 
sensor in reality owing to the perturbation of binding through loop insertions. However, 
as demonstrated by the 670% dynamic range of the GRIPPED sensor, it is possible to 
realize some of these designs by using synthetic dyes. As the dyes have a comparatively 
smaller impact upon the binding core structure and function (compared to insertion of 
cpFPs into loops) it is possible to position fluorophores at locations that offer the largest 
binding-mediated displacement and therefore the largest dynamic range (in theory) with 
much lower risk of abolishing proper binding protein function. This gives dye-FP FRET 
pairs value as a means of developing optical sensors, as a dye-FP sensors might be 
functional in cases where cpFP-FP, or even FP-FP based sensors might not. 
 
3 D V. EVALUATION OF THE USE OF COMPUTATIONAL ANALYSIS FOR THE DESIGN OF 
DYE BASED FRET CONSTRUCTS 
Through comparing computationally predicted FRET dynamic ranges and those 
determined experimentally, it is possible to evaluate the capacity of computational 
modelling as a means to screen potential FRET constructs. As the high-throughput 
screening of multiple residues (fluorophore positions) in the development of a FRET 
sensor can consume both time and resources, there is value in streamlining the process 
by doing a screen in silico.  
For both the Atu2422 and Atu4243 sensors, it is immediately apparent upon 
comparison between the predicted dynamic ranges and experimental observations that 
the values do not always numerically agree (Figure 31, Figure 32). This is not 
unexpected, as a number of assumptions have been made in order to simplify the 
screening process. Specifically, the assumption that when there is a 100% bound or 0% 
bound protein sample, the entire population adopts the holo or apo form respectively. In 
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reality, proteins are always subject to “breathing” motions,236 meaning that a given 
protein sample will be highly heterogeneous in the conformational states between 
individual molecules, which would affect FRET ratios in reality. Another assumption 
used is that the orientation of each fluorophore is random and approximated to κ2 = 2/3, 
as calculating orientation trajectories for individual residues is not practical. Because 
fluorophore orientation has the capacity to significantly affect FRET efficiencies, this 
can also contribute to discrepancies between predicted and experimental values. 
Comparison between the predicted and estimated values (Figure 31) shows that, 
despite not being quantitative, the specific hierarchy of residue positions from the worst 
to best dynamic range is mirrored between the computational and experimental values. 
It appears that, overall, the computational assessment was able to separate poorly 
performing residues from high-output residues. This was confirmed with a Pearson 
correlation test, which found the experimental and predicted values to be correlated 
(p<0.05), indicating that the computational screen can give qualitative indications as to 
which residues are likely to produce a functional FRET sensor. 
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Figure 31: Predicted dynamic ranges and experimentally determined dynamic ranges 
for Atu2422. A) Output for the computationally predicted dynamic ranges for all residue 
positions of Atu2422. B) The predicted residues (red) compared to experimental values 
(blue), these values do not always match numerically, but qualitatively, residues 
predicted to give a low range are found to do so experimentally and likewise, predicted 
high-range residues result in a sensors with a large dynamic range when tested. Of 
note is residue 178, which was predicted to be the best performing residue of those 
tested, but was underestimated in magnitude by computational prediction C) The 
correlation between predicted and experimental dynamic ranges. They are found to be 
significantly correlated through a Pearson correlation test (p<0.05). 
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Although the results for the glycine binding core were encouraging, there was some 
issue in the computational predictions for the GABA sensor, as it was found that the 
experimental results did not correlate with the predictions (p>0.05, Figure 32). 
 
 
Figure 32: Predicted dynamic ranges and experimentally determined dynamic ranges 
for Atu4243. A) Output for the computationally predicted dynamic ranges for all residue 
positions of Atu4243. B) The predicted residues (red) compared to experimental values 
(blue), where it can be seen that despite the prediction indicating a spread of dynamic 
ranges, experimentally the ranges were found to be poor universally. No correlation 
could be found between predicted and experimental dynamic ranges through a 
Pearson correlation test (p>0.05). 
 
As mentioned earlier, this disagreement between predicted and experimental dynamic 
ranges may be a product of fluorophore orientation, where the fluorophores occupy a set 
of orientations with approximate FRET efficiencies in both the apo and holo forms, 
which would result in a lower than expected dynamic range. Another source of error 
could come from the aforementioned “breathing” motions of proteins, where Atu4243 
may have a significant subpopulation of proteins in states that favor a lower overall 
range of motion (compared to Atu2422). Overall, the contribution of fluorophore 
orientation combined with the conformational dynamics of Atu4243 could possibly 
explain the inconsistencies between experimental and predicted dynamic ranges. It 
should therefore be kept in mind that the predicted dynamic range for a given protein 
tends to be exaggerated when using the x-ray crystal structures, as the assumption that 
the crystal structure reflects the average population state of a protein may not 
necessarily hold true in reality. 
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The qualitative correlation between predicted and experimental dynamic ranges 
obtained for the development of the improved glycine sensor GRIPPED does support 
the use of computational methods to screen residues as a component of designing 
sensors, where the use of computational screens can qualitatively separate residues that 
are likely to result in a more sensitive sensor from those that will not, and thereby 
expedite the process of sensor creation. However the results for Atu4243 reflect the 
possibility that exceptions will arise due to factors such as orientation or skewed 
population states, which can in principle be addressed with additional computational 
modelling, but such modelling will necessarily increase the time and resources needed 
for the process of computationally screening residues for the creation of sensors. 
 
3 E. CONCLUSIONS 
The methodology of labelling a protein at a computationally predicted location with a 
synthetic dye paired with a fluorescent protein can provide an alternative to non-rational 
high-throughput screening and can allow for proteins to be converted into FRET sensors 
where alternatives such as using fluorescent protein FRET pairs cannot. It can also 
allow for existing sensors to be improved greatly, as shown by the development of the 
GRIPPED sensor, a glycine sensor with a dynamic range of 670%, over an order of 
magnitude larger than the genetically encodable GRIP sensor. Application of the 
GRIPPED sensor in situ in the future should allow for sensitive observation of glycine 
neurotransmission, and should allow for further investigation into some of the findings 
obtained through the in situ application of the GRIP sensor (Chapter 4). The 
computational screen used in the designs of GRIPPED was found to correlate to the 
experimental dynamic ranges and as such supports the viability of computational 
screening, even if only qualitative in nature, as a means to develop sensors more 
efficiently. The disagreement between the experimental and predicted values for 
Atu4243 highlights the need for caution, as some proteins may not have ideal 
conformational dynamics, which could introduce errors when computational analysis 
uses the corresponding crystal structures. Although the use of computational screening 
did not ultimately lead to the creation of the GABA sensor GASP, the use of a dye and 
fluorescent protein did. Hence, in the very least, the GASP sensor demonstrates the 
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utility in using synthetic dyes for the development of optical sensors, where the 
application FP-FP pairs may not be successful. 
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CHAPTER 4. APPLICATION OF GRIP WITHIN THE 
HIPPOCAMPUS FOR THE STUDY OF GLYCINE 
REGULATION IN A RAT MODEL 
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Foreword: This work was completed by the author under the supervision of Dr. Michel 
Herde, within the research group of Professor Christian Henneberger at the University 
of Bonn, Germany during the month of October. Some replicates of the experiments and 
data analysis shown were completed solely by Dr. Herde and the work studying the 
relationship between glycine and age in a rat model was completed solely by Dr. Herde 
but has been included for completeness.  
 
4 A. SYNAPTIC PLASTICITY IN THE HIPPOCAMPUS 
 
Figure 33: Representation of a glutamatergic synapse and factors mediating synaptic 
plasticity. During LTP, glutamate (red stars) and D-serine (blue squares) are released 
via vesicles from the presynaptic neuron and surrounding astrocytes (grey) 
respectively. These neurotransmitters cross the synapse and interact with NMDARs 
(blue receptor) on the post synaptic neuron, which results in various changes to the 
synapse, including the calcium mediated upregulation of AMPARs (not shown in 
figure). Transporters actively remove any D-serine diffusing away from the synapse as 
well as glycine diffusing into the synapse (red and light-blue transporters respectively). 
The action of glycine (green triangle) and glutamate on extrasynaptic NMDARs (green 
receptor) in conjunction with activation of synaptic NMDARs mediates LTD. 
 
The hippocampus is widely studied as a model system for understanding synaptic 
plasticity, as there are defined and identifiable subregions and structures,
237
 allowing for 
Glycine 
Glutamate 
D-serine 
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greater ease in functional characterization. Another reason is that the hippocampus is 
viewed as the primary mediator of memory formation,
238
 meaning that synaptic 
plasticity of the neurons is of particular importance in this brain region. Synaptic 
plasticity is essentially a property that refers to the capacity of a neuron to change the 
strength of signaling at a given synapse, distinct from synapse formation 
(synaptogenesis).
6,239
 While synaptic strength can change in the short term,
240
 it is 
thought that long term changes are necessary for memory formation and learning.
241
 
The long term strengthening of synapses, referred to as long term potentiation (LTP), 
involves multiple processes including increases in the number of receptors (primarily α-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, AMPARs) available to 
a synapse,
242
 morphological changes to the neurons and proximal glial cells,
243-245
 and 
an increase to the overall quantities of neurotransmitters released by the presynaptic 
neuron through vesicles.
241,246
 Overall this means that, for a strengthened synapse, the 
presynaptic neuron has a greater capacity to induce an action potential in the post 
synaptic neuron. The long term weakening of a synapse, called long term depression 
(LTD), is the inverse of this process, characterized by a reduction in receptor 
availability, reduced neurotransmitter release and also morphological changes.
241,245,247-
249
 While LTP and LTD are not restricted to hippocampal neurons, there has been 
limited study, leading to limited understanding, of synaptic plasticity in other brain 
regions and how LTP and LTD are mediated in non-glutamatergic systems. Hence it 
should be stressed that models describing the mechanisms and functions of LTP and 
LTD based on the study of synaptic plasticity in the hippocampus may not necessarily 
be applicable or hold true for all neuron subtypes and should only be viewed as accurate 
within the context of glutamatergic neurons in the hippocampus. 
As stated previously, based on a hippocampal model of synaptic plasticity, it is 
believed that D-serine mediates the process of LTP, while both D-serine and glycine are 
required for LTD (Figure 33).
179
 This model, proposed by Papouin et al., also states 
that during the induction of LTP, D-serine and glutamate are released from astrocytes 
and the presynaptic neuron respectively, where they bind to NMDARs and AMPARs. 
The astrocytes also act to contain D-serine within the synaptic cleft through D-serine 
transporters, which uptake and deplete any D-serine that diffuses away from the 
synapse. Activation of synaptic NMDARs by D-serine and glutamate is also required 
for LTD, but it also requires the activation of extrasynaptic NMDARs by glutamate and 
glycine.  It is known that astrocytes contribute to the regulation of basal glycine 
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concentrations as they express glycine transporters (both GlyT1 and GlyT2, although 
historically GlyT1 are associated with glia while GlyT2 are predominantly neuronal),
250-
252
 which are proposed to deplete glycine from the synaptic space and release glycine 
into the extrasynaptic space. However, due to the apparent lack of glycine accumulation 
within vesicles (sometimes referred to as small synaptic-like microvesicles, SLMVs) of 
astrocytes,
253
 it is not clear if the astrocytes are capable of releasing glycine in response 
to stimulation or as a component of LTD beyond what is possible through the glycine 
transporters. It is also unclear whether the glycine released into the extrasynaptic space 
is solely from the glycine removed and recycled from the synaptic space, or if astrocytes 
are able to introduce glycine from other sources. Moreover, how the regulation of 
glycine is effected by stimulation or other signaling events (if it is affected at all) 
remains an open question. 
 
4 B. REGULATION AND CONTROL OF GLYCINE BY NEURONS 
Unlike astrocytes (or glial cells), neurons within the CNS and spinal cord can 
accumulate and release glycine through vesicles, including at glutamatergic neurons. 
However it is unclear if this occurs for LTP and LTD related processes in the 
hippocampus.
254
 As glycine has been shown to be unnecessary for LTP by Papouin et 
al. it is possible that this neurotransmitter would not be released from the presynaptic 
neuron during LTP inducing stimulation, or have any regulatory link to LTD. Contrary 
to this, the discovery that the Asc-1 neuronal transporter can release both D-serine and 
glycine from neurons,
255
 suggests that the primary source of extrasynaptic glycine in the 
hippocampus is from neurons, not glial cells. Furthermore, because the release of 
D-serine and glycine is linked to a single transporter, glycine may contribute to the 
regulation of LTP, or conversely, LTP inducing stimulus may have some regulatory role 
on glycine levels. Glycine regulation by the Asc-1 transporters is made more definitive 
with genetic knockouts of these transporters in rats resulting in a decrease to 
extracellular glycine and L-serine (the precursor to glycine and D-serine) concentrations 
in various brain regions including the hippocampus, without affecting levels of D-serine 
or other neurotransmitters.
256
 These transporters, as well as glycine vesicles in 
hippocampal glutamatergic neurons, identify possible mechanisms and pathways that 
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can moderate glycine availability and release as a part of LTP and LTD and the 
investigation of these possible mechanisms is of interest. 
 
4 C. SPECIFIC MODELS TO CLARIFY WITH THE GLYCINE OPTICAL SENSOR 
The development of the GRIP sensor allows for in vivo or in situ visualization of the 
neurotransmitter glycine, which will allow for investigation into the mechanisms and 
parameters controlling the regulation and distribution of glycine and glycine receptors 
within hippocampal synapses during neurotransmission and its relation to synaptic 
plasticity. As overall glycine concentrations and expression of glycine receptors 
(GlyRs) are higher in other regions of the adult brain, as well as the spine, it is likely 
that these regions will utilize glycine more extensively than the hippocampus and 
therefore it may be easier to observe glycine neurotransmission in these regions.
257-260
 
However the importance of understanding synaptic plasticity gives studying glycine in 
the context of its usage within the hippocampus a degree of priority over examining its 
usage within these other brain regions. Furthermore, studying the hippocampus would 
serve as a proof of concept for the viability and functionality of the sensor, specifically 
as the hippocampus has an overall lower population of glycinergic neurons available 
and lacks some of the GlyR subtypes compared to other brain regions,
257,259,260
 it should 
be relatively more difficult to observe glycine neurotransmission and signaling (due to 
lower abundance). This means that if the sensor is able to observe and document 
meaningful information regarding glycine usage from the hippocampus, by extension it 
would mean that the sensor should be able to obtain information of a comparable or 
better standard from other brain regions where the use of glycine and glycine receptors 
is more pronounced (i.e. the majority of the CNS and brain stem). With the use of the 
optical sensor, it is also possible that it will allow for the observation of glycine release 
in response to various stimuli and inhibitors in a manner that electrophysiology cannot. 
While there may be the release and modulation of glycine, this may not necessarily have 
a detectable effect on membrane potentials, which is necessary for electrophysiological 
techniques.  
One point of investigation is the model proposed by Papouin et al., where 
glycine in the synaptic space of glutamatergic synapses in the hippocampus is taken up 
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by astrocytes and this has been demonstrated through indirect techniques utilizing 
various inhibitors and neurotransmitter oxidases.
179
 However, with the optical sensor, it 
should be possible to clarify and document this directly. It may also be possible to 
visualize changes (or the lack thereof) in glycine concentrations that occur as a result of 
LTP or LTD inducing stimuli. It has also been shown using indirect techniques, such as 
glycine depletion and High Performance Liquid Chromatography (HPLC) analysis, that 
there are developmental changes in glycine usage and glycine receptor populations.
261
 
Examining glycine levels in respect to its relation to age through direct observation 
should also be possible with an optical sensor. 
Shown in this chapter is the application of the GRIP sensor in situ and the 
documentation of glycine usage and concentration in relation to neuronal substructures, 
stimulation, age and pharmacological exposure. We demonstrate that the sensor is 
capable of ratiometric micron scale spatial resolution and can resolve changes in respect 
to time. We have used its properties to further contribute towards the understanding of 
glycine utilization within the hippocampus, with particular consideration as to the role 
of glycine in the synaptic plasticity of neurons. 
 
4 D. MATERIALS AND METHODS 
 
Hippocampus slice preparation. All experiments were done in full compliance with 
national and institutional guidelines on animal experimentation (University of Bonn, 
Germany). A Wistar rat (22-29 days old) was decapitated while under isofluorane 
induced anesthesia and the brain was quickly removed and kept in carbogen infused 
(5% CO2) ice-cold sucrose slicing solution (NaCl 80 mM, sucrose 65 mM, KCl 2.5 
mM, MgCl2 7 mM, NaH2PO4 1.25 mM, CaCl2 0.5 mM, NaHCO3 26 mM and glucose 
10 mM, 300–310 mOsm/L). The cerebellum, forebrain and sides of the brain were 
removed leaving the central brain region containing the hippocampus. This was then 
sliced using a vibrating microtome 7000smz (Campden instruments) and each slice 
acute horizontal hippocampal slice (300 µm) was allowed to recover in sucrose slicing 
solution at 34 °C for 15 minutes. After this time the slices were then transferred into 
artificial cerebrospinal fluid (ACSF, NaCl 131 mM, KCl 2.5 mM, MgSO4 1.3 mM, 
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NaH2PO4 1.25 mM, NaHCO
3
 21 mM, CaCl2 2 mM and glucose 10 mM, pH 7.35–7.45, 
295–305 mOsm/L) and was labeled with biotin through the addition of 50 µM Sulfo-
NHS EZ Link Biotin (Thermo Fisher). The slices were incubated for 45 minutes at 
room temperature, after which they were washed once with ACSF and transferred into a 
reservoir of ACSF with constant carbogen perfusion at room temperature, where they 
would stay until needed for use. 
 
Reconstitution of the GRIP sensor. A lyophilized sample of GRIP was dissolved in 
phosphate buffered saline (PBS, NaCl 137 mM, KCl 2.7 mM, Na2HPO4 8 mM and 
KH2PO4 2 mM), allowed to equilibrate at room temperature with gentle agitation for 
15-20 minutes. The solution was then filtered (0.45 µm) and purified with a PD-10 
desalting column (GE life sciences) into PBS and then concentrated to approximately 
60-90 µM protein. The solution was stored at 4 °C until needed. 
 
Two photon imaging. All imaging was performed on a FV10MP imaging system 
(Olympus) optically linked to a femtosecond pulse laser Vision S (Coherent, λ = 800 
nm) integrated with patch-clamp electrophysiology (Multiclamp 700B, Molecular 
Devices) and equipped with a 25× (NA 1.05) objective (Olympus). Fluorescence signals 
were collected with photomultiplier tubes connected to a single photon counting board 
(Picoharp, Picoquant). Their arrival times were recorded using Symphotime software 
(Picoquant). Emission is detected at 460-500 nm (ECFP) and at 520-560 nm (Venus). 
 
Two photon imaging of hippocampal slices. A hippocampal brain slice would be 
placed within a submersion-type recording chamber with a constant circulation of 
ACSF at 34 °C, where 50 µM D-2-Amino-5-phosphonovaleric acid (D-APV) and 1 µM 
strychnine was added to the circulating reservoir of ACSF to inhibit the action of 
various receptors (i.e. NMDARs). Labelling of the brain slice was done by loading a 
patch clamp pipette (2-4 MΩ Resistance) with a solution containing GRIP (60-90 µM) 
that has been pre-incubated with streptavidin (7.5-12 µM) in PBS. The pipette would 
then be penetrated into the desired region to a depth of approximately 70-100 µm, and 
then the solution would be puffed into the slice. The slice would be allowed to 
Chapter 4 
93 
 
equilibrate for 15 minutes to allow for any unlabeled GRIP to disperse. The end of each 
experiment usually includes a step where the glycine sensor is saturated (with 5 mM 
glycine) in order to obtain a baseline reference point (Rmax) that is consistent between 
experiments and brain slices (Figure 34). This baseline is used to normalize samples, 
specifically, all recorded ratios are divided by Rmax (R/Rmax) and as a consequence the 
normalized saturated sensor ratio is given a value of 1 (as Rmax/Rmax = 1). Between 
experiments, the reservoir vessel for the ACSF solution was flushed twice in order to 
remove residual glycine from previous experiments. Unless otherwise stated, all 
experiments using two-photon microscopy follows this described basic methodology. 
 
Figure 34: The observed FRET ratio in a hippocampal slice in with initially no 
exogenous glycine and then with saturating (5 mM glycine). The saturated glycine ratio 
is used as the 100% ratio (Rmax) and acts as a constant reference point between slices. 
 
Glycine transport inhibition recordings. The sensor was puffed into the brain slice at 
the border between the stratum radiatum and stratum lacunosum moleculare and 
recordings of the puffed region were taken at 15 and 20 minutes (lasting approximately 
20-30 seconds, 509x509 µm region) at both the slice surface (10 µm) and deeper within 
the slice (50-60 µm). Immediately after the 20 minute recording, a glycine transport 
inhibitor N-[3-(4′-fluorophenyl)-3-(4′-phenylphenoxy)propyl])sarcosine, (NFPS,  5 µM) 
or N-[[1-(Dimethylamino)cyclopentyl]methyl]-3,5-dimethoxy-4-
(phenylmethoxy)benzamide, (ORG25543, 1 µM) would be added to the ACSF 
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reservoir. 5 minutes after the addition of the inhibitor, another recording would be taken 
(25 minutes), after which saturating glycine (5 mM) would be added to the reservoir and 
allowed to equilibrate with the slice for 15 minutes before another recording was taken 
(40 minutes). The control followed the same procedure, with the exception that no 
inhibitors were added after the second recording (20 minutes). 
Resting glycine estimation recordings. Different regions of the hippocampal slice 
were puffed/labelled with the sensor (radiatum, lacunosum moleculare, oriens and 
pyramidal cells). Recordings were taken of these regions after the 15 minute 
equilibration period (20-30 Seconds, 509x509 µm region, 50 µm deep). The reservoir 
would then have 5 µM NFPS, 1 µM ORG25543 and 5 mM glycine added, allowed to 
equilibrate for 15 minutes, at which point a final recording would then be taken. 
Concentrations were determined through the following equation (derived from the hill 
equation, simplified with n = 1):  
𝟖) 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 = 𝐾𝑑 ×
𝑅 − 𝑅0
𝑅𝑚𝑎𝑥 − 𝑅
 
Where R is the observed ratio, Kd is the affinity of the sensor, R0 is the ratio of the apo 
sensor (derived from the meniscus titrations, Figure 35) and Rmax is the ratio of the holo 
(saturated) sensor.  
 
Neuron substructure recordings. A single neuron was identified and penetrated at the 
soma of the neuron with a patch pipette (2.5-4 MΩ resistance) filled with Alexa Fluor 
594 (AF594, 200 µM). The dye was injected and allowed to diffuse throughout the 
intracellular matrix of the neuron for 5-10 minutes, at which point the GRIP sensor was 
puffed onto an area encompassing the highest density of neuron substructures 
(dendrites, axon, etc). The slice was allowed to equilibrate for 15 minutes following the 
sensor puff, after which a stack of recordings were taken of a region within the labelled 
area (34x34 µm) at 0.5 µm depth intervals from a depth range of 20 to 30 µm, with each 
depth interval imaged 5 times. After this set of recordings, 1 µM ORG25543, 5 µM 
NFPS and 5 mM glycine was added, allowed to equilibrate for 15 minutes, and then a 
stack of images were recorded the same manner as previously. 
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Long term potentiation recordings. For these experiments D-APV and strychnine was 
not added to the circulating ACSF. A concentric bipolar electrode (FHC) was inserted 
into the Cornu Ammonis-3 (CA3) of the hippocampal slice and a region of the radiatum 
in the Cornu Ammonis-1 (CA1) was puffed with the GRIP sensor. The sensor was 
allowed to equilibrate for 15 minutes, at which point the tissue sample (CA3 schaffer 
collaterals) underwent high frequency stimulation (HFS, total time 1 s, 100Hz, 70 µA 
intensity, individual pulse 1 ms). The HFS was initiated 10 seconds into the start of the 
optical recording and the continued for 90 seconds after the stimulus. Field potentials 
were recorded with a patch pipette at the CA1. 
 
Study of age dependent changes in glycine concentrations. The age of rats used for 
this study ranged between 8 to 35 days old and were also categorized into two age 
groups, young rats (< 3 weeks old) and old rats (> 3 weeks old). The stratum radiatum 
of the hippocampal slice was labelled with the sensor and allowed to equilibrate for 15 
minutes. Recordings were taken of these regions after the 15 minute equilibration period 
(20-30 Seconds, 509x509 µm region, 50 µm deep). The reservoir would then have 5 µM 
NFPS, 1 µM ORG25543 and 5 mM glycine added, allowed to equilibrate for 15 
minutes, at which point a final recording would then be taken. 
 
Data analysis and processing. Data was analyzed in Matlab using a custom script 
(Appendix AC4.1, written by Dr. Michel Herde and Professor Christian Henneberger). 
In brief, regions of interest are selected and converted into an average ratio 
(ECFP/Venus) by the script, where the selected image area over the time length (or 
frames) of the recording is averaged and baseline corrected as a part of script function. 
The ratio taken from the image average was treated as a single data value measurement 
for a given recording and the overall error for all replicates for an experiment set was 
determined only from the variability between replicates. 
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4 E. RESULTS AND DISCUSSION 
4 E I. CONSIDERATIONS FOR THE APPLICATION OF THE SENSOR UNDER THE TWO 
PHOTON MICROSCOPY SYSTEM AND IN SITU 
The GRIP sensor was first examined through meniscus titrations under the two-photon 
microscopy system in order to develop a standard dose response curve to glycine 
(Figure 35). The sensor was found to possess a dynamic range of 20% and was 
consistent with previously determined binding affinities (Kd 20 µM, Chapter 2). 
 
Figure 35: Dose-response curve for the GRIP sensor under two photon microscopy. 
The full dynamic range is 20% ECFP/Venus. Values shown are the mean ± S.E.M. 
Figure was prepared by Professor Christian Henneberger. 
 
Under the two photon system, the dynamic range was determined using ECFP/Venus 
ratios. Previously, the ratios were determined using Venus/ECFP, yielding a 
maximal -25% dynamic range, where increasing glycine concentrations corresponded to 
a decrease in the FRET ratio. The change in ratio determination from Venus/ECFP to 
ECFP/Venus is to help clarify changes in glycine, as by using the ECFP/Venus ratio, it 
now means that an increased ratio corresponds to an increase in glycine concentrations. 
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Another consideration is that there is sometimes a decrease in the maximum dynamic 
range of a sensor batch due to the lyophilization process, where prior to lyophilization 
the sensor shows a ratio change of 20%, but after reconstitution the dynamic range is 
sometimes found to have decreased (on average to 16%). This indicates that 
lyophilization can result in denaturation of a portion of the available sensor, meaning 
that if there is a need to maximize the available dynamic range, lyophilization should be 
avoided when possible. The method of sensor reconstitution can also impact the 
dynamic range significantly. Specifically; one batch of sensor used in the experiments 
presented in this Chapter was reconstituted at 37 °C for 1 hour, rather than for 15 
minutes at R.T, decreasing the dynamic range to 13% instead of 20%. Instances where 
the dynamic range of the sensor used for a given study or experiment is not 20% will be 
stated in the respective figure. 
Labeling of the hippocampal slice with the GRIP sensor was done by tethering 
the biotin-tagged GRIP sensor onto the cell with streptavidin (Figure 36).
262
 Although 
the sensor is “genetically encodable” and it should be possible to express the sensor 
through viral transfection, the sensor should first be validated for functionality in situ 
before in vivo work is undertaken, due to the additional time and resources required to 
implement and troubleshoot such a system. Initially GRIP sensor concentration was 
approximately 60 µM in PBS. It was found that increasing this concentration to 90 µM 
(with a corresponding increase to the streptavidin concentration) improved labeling 
efficiency as indicated by overall higher intensities of labeled areas. While it is true that 
the optical sensor is not intensity dependent in the quantitative sense because FRET 
ratios are independent of fluorescent intensity, in practice, higher intensities will 
improve the signal noise ratio, resulting in greater accuracy in recordings. As such, 
improvements to total sensor intensity are desirable and should be adopted whenever 
possible. The sensor was found to be stable at 34 °C for at least 50 minutes in situ 
(Figure 37) and although a significant portion (approximately 50%) of the sensor was 
shown to be washed out in the initial 15 minutes of incubation, this decrease in sensor 
intensity plateaued quickly and did not appear to influence the observed FRET ratio, 
reinforcing the notion that the ratiometric sensor signal is independent of the total 
sensor concentration (unlike intensity based or single fluorophore based sensors). As a 
note, although this experiment demonstrated that the change in sensor concentration 
does not influence the ratiometric signal, it may be possible in other physiological 
context or experiments that it may become an issue. As such, quantifying sensor 
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availability or controlling the amount of available sensor in situ or in vivo may be 
desirable, which in principle can be accomplished through quantifying fluorescence 
with post-experimental flow cytometry or through controlled expression of the sensor in 
a genetically encoded system.
44,263,264
  
 
Figure 36: Representation of the labeling of brain slices with the sensor using biotin 
and streptavidin. First the brain slice is labeled with biotin, after which point the sensor, 
pre-incubated with streptavidin, is added to the slice, resulting the adhesion of the 
sensor to the slice surface. 
 
Figure 37: Sensor washout and signal (ratio) stability over time in vivo at 34 °C. The 
sensor washed out/diffused quickly within the first 15 minutes (determined from total 
fluorescent intensity), after which it slowly decreased. This washout was not found to 
influence the signal stability, demonstrating that the signal output is independent of 
sensor concentration. Values shown for the intensity represent the mean ± S.E.M.  
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Another consideration is the need to thoroughly remove any residual glycine from the 
ACSF circulation system, as this residual glycine was found to significantly affect the 
reproducibility of the initial baseline ratio between measurements. A high initial glycine 
concentration will in turn impact the sensitivity of the sensor to changes in glycine (as 
the sensor response is logarithmic) reducing the sensor output. Purging the circulation 
system more conscientiously resulted in a large improvement in the reproducibility of in 
situ measurements, as well as an improvement in the response of the sensor towards 
small changes in glycine concentrations. 
Finally, although physiological leucine concentrations should not affect the 
function of the GRIP sensor as discussed in Chapter 2, it should be possible to confirm 
this with the previously described “high affinity” mutant WAW. This mutant was 
converted into an optical sensor in the same manner as the GRIP (AYW) sensor, with 
the same dynamic range. This high affinity sensor, which had an affinity for glycine and 
leucine at approximately 6 µM and 700 nM respectively, would reach 100% sensor 
saturation at concentrations above 9 µM of leucine (Figure 38). The sensor was puffed 
into a hippocampal slice under the two photon imaging system, allowed to equilibrate 
and then the slice was exposed to saturating glycine. As the sensor had further ratio 
changes from the addition of saturating glycine (Figure 39), that the basal concentration 
of leucine must not be saturating and thus is lower than 9 µM. As the GRIP sensor has 
no appreciable response to leucine below 9 µM, this means that all ratio changes 
observed by the sensor in vivo should be a product of glycine concentrations, including 
estimations of basal glycine concentrations. 
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Figure 38: Dose response curve of the optical sensor made using the high affinity 
binding core (mutant WAW). Approximate affinity for leucine and glycine is 0.7 and 6 
µM respectively. 
 
Figure 39: FRET ratio of the high-affinity sensor puffed onto a hippocampal slice. As 
the sensor was not saturated, evidenced by further ratio changes at 5 mM glycine, this 
necessitates that the ambient resting levels of analytes are below saturating 
concentrations. Only one replicate was done for this experiment. 
0 .0 0 1 0 .0 1 0 .1 1 1 0 1 0 0
7 0
8 0
9 0
1 0 0
1 1 0
L ig a n d  (m ic ro m o la r)
R
a
ti
o
 (
%
 a
p
o
)
L e u c in e G lyc ine
ra
d
ia
tu
m
la
c
 m
o
l
0 .9 0
0 .9 5
1 .0 0
1 .0 5
1 .1 0
N
o
r
m
a
li
z
e
d
 r
a
ti
o
 c
h
a
n
g
e
(%
s
a
tu
r
a
te
d
)
B a s e lin e B lo c k e rs 5  uM  g lyc ine 5  m M  g lyc ine
Chapter 4 
101 
 
4 E II. EFFECTS OF GLYCINE TRANSPORT INHIBITORS 
While studying glycine in the context of its role in neuronal synaptic plasticity was one 
of the primary goals, it was first important to show that the sensor was capable of 
functioning in vivo. As such we sought to demonstrate that the sensor was able to detect 
changes in glycine concentrations in situ under physiologically exaggerated conditions 
induced through exposure of the hippocampal slice to glycine transport inhibitors 
(NFPS or ORG25543), which should result in the accumulation of glycine in a 
predictable and controlled manner.
23,265
 This was also motivated by the possibility that 
normal physiological changes of glycine may not be large enough to be unambiguously 
observed by the sensor, as if it is not possible to observe pharmacologically mediated 
changes in glycine, it would then be very unlikely that the sensor would be able to 
observe the (usually smaller) changes in glycine under normal physiological regulation. 
Conversely, should it be possible to observe glycine accumulation, it would demonstrate 
that the sensor is responsive to glycine changes in situ. Furthermore, even if it were 
shown later to be unable to observe changes or differences under normal physiological 
conditions, it could still have some value as a tool for the analysis of glycine in response 
to various pharmacological agents. The sensor was applied to the border region between 
the stratum radiatum and the stratum lacunosum moleculare, as this would allow for the 
analysis of both subregions simultaneously (Figure 40). In doing this, it is possible to 
observe if the different subregions would respond differently under the same conditions. 
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Figure 40: Image of the hippocampal slice puffed/labeled with the GRIP sensor. The 
area averaging of the ECFP/Venus ratio (panel 2, white box) encompasses an area 
within the area of the puff (panel 1, black lines). Averaging is done for both subregions 
(panel 1, divided by red dotted line, radiatum right, lacunosum moleculare left). 
 
The sampling of each region encompassed the largest area possible while not including 
any areas not labeled by the sensor, and aimed to be as close in area and location as 
possible between different time point recordings for a given hippocampal slice. 
In the radiatum, the results matched expectations, where it was found that 
addition of either the GlyT1 inhibitor NFPS or the GlyT2 inhibitor ORG25543 resulted 
in the accumulation of glycine, and where in the control recordings where no inhibitors 
were present, glycine concentrations did not change over the time course of the 
experiment. However, the lacunosum moleculare behaved differently, where although 
there appeared to be a qualitative increase in glycine concentrations, this was not found 
to be statistically significant from the control recording. Furthermore the control 
1 
2 
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appeared to increase over time despite the lack of glycine transporter inhibitors (Figure 
41). 
 
Figure 41: Bar graph showing the changes in the normalized glycine ratio from the 
baseline recording with and without the addition of inhibitors (glycine blockers NFPS 
and ORG 25543). Unlike the lacunosum radiatum (radiatum), the control for the 
lacunosum moleculare (Lac mol) was found to increase despite no addition of 
inhibitors. The addition of inhibitors to the radiatum resulted in the accumulation of 
glycine relative to the control. While there was a trend towards increased glycine in the 
lacunosum moleculare after the addition of inhibitors, it was not found to be significant 
(paired t-test, p>0.05). Values shown are the mean ± S.E.M. n = 8, 7 and 6 for NFPS, 
ORG25543 and control measurements respectively for both radiatum and lacunosum 
moleculare. 
 
It is unclear why the lacunosum moleculare behaves differently from the radiatum in 
terms of glycine regulation (or retention) and the relative effect of glycine inhibitors. 
This may be a consequence of one or more of the structural and functional differences 
between two brain regions, or it may be an artifact arising from using hippocampal 
brain slices, where the lacunosum moleculare may be more sensitive to the physical 
manipulation required in the brain preparation or labeling resulting in poorer glycine 
regulation. This gradual increase in ambient glycine may be the reason behind the 
smaller observable relative effect of the inhibitors, as it would be more difficult to 
resolve the true effect of these inhibitors to statistical significance in comparison to the 
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control. While investigating the origin of this difference may be of interest, this is 
tangential to the original goal of characterizing the in situ capacity of the sensor. The 
results demonstrate that the sensor is able to observe changes in glycine concentration, 
and that it is able to distinguish between differences in glycine concentration (and by 
implication, utilization or regulation) between different sub regions of the hippocampus. 
This outcome supported further use of the sensor to study other points of interest. 
 
4 E III. STUDY OF RESTING GLYCINE CONCENTRATIONS 
There is some interest in whether different subregions of the CA1 of the hippocampus 
displayed variations in resting/basal glycine concentrations. As such the glycine 
concentrations in the Stratum oriens, pyramidal cells, radiatum and lacunosum 
moleculare were examined using the GRIP sensor (Figure 42). 
 
Figure 42: Resting glycine concentrations of the Stratum oriens (SO), pyramidal cells 
(SP), radiatum (SR) and lacunosum moleculare (SLM). No significant difference was 
found between the studied regions (one-way ANOVA, p>0.05). The maximum dynamic 
range for the sensor batch used in this study was 16% (dotted line). Values shown are 
the mean ± S.E.M. Figure was prepared by Professor Christian Henneberger. 
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Two different batches of sensor with different maximum dynamic ranges (20% and 
16%) were used and no significant difference was found between the different regions 
for either sensor batch (p>0.05 for one-way ANOVA as well as for systematic paired t-
tests). For the first sensor batch (20% dynamic range) the estimated concentrations were 
found to be 4.6 ± 0.4, 5.0 ± 0.4, 3.7 ± 0.7 and 8.1 ± 2.1 µM (mean ± S.E.M) for the 
radiatum (n = 20), lacunosum moleculare (n = 20), oriens (n = 6) and pyramidal cells (n 
= 7) respectively. The estimated concentrations determined by the second batch (16% 
dynamic range) showed higher resting concentrations of 19.4 ± 2.1, 18.8 ± 1.5, 19.4 ± 
1.2 and 26.6 ± 5.1 µM respectively (radiatum n = 36, lacunosum molculare n 19, oriens 
n = 17 and pyramidal cells n = 17). While the values estimated by the experiments using 
the more sensitive batch lie within the range of some proposed values for resting 
glycine concentrations in the hippocampus (estimations range from 2-11 µM),
23,202
 the 
discrepancy between the values obtained with the two different sensor batches 
introduces some doubt to the accuracy of this method of determining resting 
concentrations. One possible explanation for this variability is that a portion of the less 
sensitive batch of sensor (16%) may have partially unfolded, and only after being 
introduced to the slice did this subpopulation completely denature. This would affect the 
observed baseline as this denatured fraction of the labeled sensor would report incorrect 
or false ratios (i.e. glycine independent FRET ratios), explaining the differences in 
observed glycine concentrations between the sensor batches. 
An alternative explanation is that the tethering of the sensor to the slice may 
influence sensor behavior and thereby effect the dynamic range (and therefore observed 
baseline), which could convolute basal glycine concentration estimations as there would 
be ratio changes arising from sources other than ambient glycine concentrations 
(including ratios obtained from the more sensitive 20% sensor). A solution would be to 
deplete available glycine using glycine oxidases and inhibitors to confirm if the 
maximum dynamic range in situ is consistent within the range observed in a glycine 
free in vivo environment, which would necessitate that any observed changes in the 
dynamic range under normal conditions is from resting glycine levels or glycine release 
and not an artifact from labeling the sensor within in vivo environments. These types of 
neurotransmitter depletion experiments have in the past proven to be technically 
difficult (Dr. Michel Herde, personal communication), and as such were not pursued at 
this time for the GRIP sensor, as other experiments took priority. Although the ability to 
quantitatively estimate resting glycine concentrations requires some more 
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troubleshooting, the ratiometric output of the sensor has been shown to be unaffected by 
variability to total intensity such as that caused by sensor washout, which indicates that 
the sensor design used here is comparatively more robust than alternative designs of 
qualitative (intensity based and single fluorophore) sensors. 
Another point for consideration is that there was an observable difference in 
“resting” glycine concentration previously observed in the study using glycine uptake 
inhibitors between the lacunosum moleculare and radiatum (Section 4 E II), but not in 
these set of experiments measuring resting concentrations (Figure 42). As this increase 
in glycine concentrations in the lacunosum moleculare occurred slowly over time, the 
shorter experimental time for studying resting concentrations in these experiments 
meant that the total increase in glycine was lower in comparison to the inhibitor 
experiments, resulting in no statistical difference between the radiatum and the 
lacunosum moleculare. 
Finally, it hypothetically is possible that an extremely sensitive optical sensor 
and a large sample size may clarify differences in resting glycine concentrations 
between these subregions. However, these differences would necessarily be small 
(beyond the ability of the GRIP sensor to resolve), which would also make the 
physiological relevance of such differences questionable. As such, focus of applying the 
sensor shifted towards other possible experiments with the GRIP sensor, particularly 
those more directly related to studying synaptic plasticity. 
 
4 E IV. NEURON SUBSTRUCTURE STUDY 
One aspect of the model proposed by Papouin et al. is that glycine is actively depleted 
from the synapse by astrocytes, which then also transports the glycine to the 
extrasynaptic space. It should be possible to visualize this difference with the optical 
sensor and simultaneously determine the limits or capacity for the sensor to resolve 
small spatial differences. This was done by illuminating an individual neuron with a dye 
that did not interfere with the FRET pair in use (AF594), identifying a region populated 
with neuronal substructures of interest (spines and shafts) and puffing the sensor over 
that region (Figure 43). 
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Figure 43: Example of a single neuron in the hippocampal CA1 illuminated with AF594 
(red) as well as the region labeled with the GRIP sensor (blue, false color). 
 
The dendritic spines are known to embody the postsynaptic component of a 
synapse.
266,267
 As such, examining the immediate surroundings of the spine, which 
would encompass the corresponding synapse, should allow for the study of glycine in 
synapses. Although previous studies suggests that adhesion of the sensor to neuronal 
surfaces using biotin and streptavidin does not allow for the sensor to enter and label 
areas within the synaptic cleft,
40
 it will still label pre- and postsynaptic structures as well 
as the supporting glial structures (astrocytes), which would permit detection of 
differences between synaptic and non-synaptic regions to be resolved. 
Comparison between the shafts and spines of neurons revealed differences in 
local glycine concentrations, where spines had a lower FRET ratio (ECFP/Venus) and 
therefore a lower glycine concentration, and conversely, the shafts had a higher glycine 
concentration (Figure 44). 
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Figure 44: Example of substructures studied. Spines (orange) and shafts (green) were 
sampled and the average of the values combined per neuron. The data point of each 
neuron recorded is presented for clarity and a pairwise comparison between shafts and 
spines shows statistical significance (paired t-test, n = 8, p<0.05, 3-14 spines and 
shafts sampled per experiment). The different subtypes of dendritic spines they have 
been treated as equivalent for the purposes of this experiment. Figure was prepared by 
Professor Christian Henneberger. 
 
This difference in resting glycine concentrations between synaptic and extrasynaptic is 
consistent with the findings of Papouin et al. who had previously described synaptic 
glycine depletion in their model of hippocampal synapses. Furthermore, this also 
demonstrates that the sensor is able to resolve differences on the micron scale, meaning 
that it can be used to not only study differences between spines and shafts, but it can 
potentially be used to study the many different substructures and subregions of neurons 
of a comparable scale. As the purpose for the development of this sensor was to enable 
the direct observation of physiologically relevant differences in glycine with high 
spatial resolution, these results show that the GRIP sensor can perform and behave as 
desired, albeit qualitatively at this point in time. 
Although this study compared spines and shafts, no statistical distinction could 
be made between spine subtypes (mushroom, thin, etc). While a difference in glycine 
concentration between subtypes of spines is not necessarily expected, it may be 
possible, as the different spine subtypes have different receptor, transporter and vesicle 
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populations.
266
 The lack of any observable difference in glycine concentrations between 
the spine subtypes means that there is either no physiological difference in glycine 
regulation between spine subtypes in reality, or that the differences are too slight to be 
observed by the GRIP sensor, meaning that there may still be some value in further 
improving the glycine optical sensor in the future. Regardless, the sensor is sensitive 
enough to distinguish variability between different substructures and regional types, 
which has allowed for the study and differentiation of synaptic and extrasynaptic 
glycine concentrations. 
 
4 E V. STUDY OF GLYCINE RELEASE AS A COMPONENT OF LONG TERM POTENTIATION 
As glycine mediates LTD through interaction with extrasynaptic NMDARs, it has been 
postulated that it is not a component of LTP related processes, such as being released as 
a result of LTP inducing stimulus. However as it has been previously shown that 
neuronal glycine release and regulation may have some links to neuronal D-serine 
release through the Asc-1 transporters, which means that it is possible that stimulation 
may result in time-resolvable changes to glycine, which would be indicative of both 
glycine neurotransmission and clearance as a result of LTP inducing stimulus. 
The CA1 stratum radiatum was labeled with the sensor in order to observe the 
effects of LTP inducing stimulus on glycine concentrations (Figure 45) 
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Figure 45: Image showing the experimental setup for studying LTP. The GRIP sensor 
was labeled onto the CA1 stratum radiatum and the slice was stimulated (stim.) at the 
CA3 schaffer collaterals. The region of interest (ROI, red box) was used to determine 
changes in ratio in response to stimulation. SR is the stratum radiatum and SP is the 
stratum pyramidale. 
 
Stimulation of the CA3 Schaffer collaterals was found to result in an increase in glycine 
concentrations, and the increase was correlated with the time length of the HFS. The 
initiation of the HFS resulted in a spike in glycine concentrations, which began to 
decrease over the duration of the HFS and returned to baseline levels over time (Figure 
46). The control experiments of no stimulation and stimulation under saturating glycine 
did not indicate any difference between stimulation and baseline levels of glycine, 
eliminating the possibility that there are optical artifacts arising from stimulation. One 
possible stimulation artifact of particular concern is the possibility that the stimulation is 
inducing a transient change in ambient pH, which could affect the fluorescent output of 
the fluorophores and therefore give a false signal in observed FRET ratios. We believe 
this is not the case seen here, as firstly such a change in pH should also result in an 
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observable signal in the saturated glycine control experiment and secondly, stimulation 
experiments with an arginine sensor using the same type of FRET pair (discussed in 
chapter 5) did not result in any observable signal. This leaves us to conclude that the 
signal observed to correlate with the HFS is a result of changing glycine concentrations. 
 
Figure 46: Data showing the change in ratio in response to HFS. HFS causes an 
increase in glycine that coincides with the timeframe of the stimulation. The glycine 
returns to baseline levels over time.  The ratio change is significant during stimulation 
compared to pre and post stimulation measurements (paired Student’s t-test, p<0.05, n 
= 9), while no significant change can be seen without stimulation (paired Student’s t-
test, p>0.05, n = 7), or when there is stimulation in the presence of 5 mM glycine 
(paired Student’s t-test, p>0.05, n = 5). Values shown are the mean ± S.E.M as well as 
the individual data points for replicates (grey).  
 
The spike in the FRET ratio correlating to the duration of the HFS establishes the 
release of glycine in response under LTP inducing conditions, which is something 
unexpected in the context of the previously proposed LTP model. While any 
conclusions made regarding the source of this glycine based on these results are mostly 
speculative in nature, it is reasonable to assume that it would be unlikely that the 
glycine was released via vesicles from astrocytes due to the lack of glycine vesicles 
within glial cells. The remaining possible sources of glycine are from the GlyT1 
transporters of astrocytes and/or from neurons, via vesicles or transporters. Glycine 
release from astrocytes may be possible through reversal of glycine transporters, as the 
direction of glycine transport by GlyT1 transporter is dependent on the sodium 
gradient,
268
 changes to available sodium ions due to the depolarization induced by the 
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HFS could result in the release of glycine from astrocytes. For neuronal release of 
glycine, a link between D-serine and glycine release has been previously demonstrated 
for the Asc-1 neuronal transport system.
255
 Although the Asc-1 transporters themselves 
are not sensitive to depolarization,
269
 they are regulated by the presence of other amino 
acids,
270
 which themselves can be directly regulated through depolarizing conditions (L-
serine).
271
 Hence, LTP inducing stimulus may result in the increase of non-
neurotransmitter amino acids, which can then be exchanged through the Asc-1 
transporter for glycine (and D-serine). Finally, vesicular release of glycine from neurons 
is also possible, as functional GlyRs have been shown recently by Muller et al. to exist 
in the hippocampus. where glycine vesicles have been shown to depopulate due to 
stimulation (implying release).
254
 However Muller at al. were unable to detect vesicular 
glycine release from the neurons directly using a sniffer-patch technique under 
physiological conditions.  
It must be stated, however, that although an increase in glycine concentrations 
was observed, this was across multiple neurons and glia and comprising all extracellular 
structural elements of these cells, and not specifically synapses. This means that there 
may not automatically be an increased presence of glycine within synapses, as it is 
entirely possible that the increase glycine is within the extrasynaptic space, while the 
synaptic space remained tightly regulated. As such, this result does not necessarily 
contradict the model proposed by Papouin et al. or the current understanding of glycine 
utilization within the hippocampus, but exactly how this new information fits within the 
current model of synaptic plasticity and synapse neurotransmitter regulation is currently 
unclear and will require further investigation. 
Finally, in terms of sensor functionality, as both the rise and fall of glycine over 
time could be observed, this shows that the GRIP sensor is capable of giving not only 
spatially relevant information, but also temporally relevant information. Furthermore, 
although this was expected, the sensor could be used in tandem with 
electrophysiological techniques, further reinforcing the notion that the use of optical 
sensors should be viewed as complementary to electrophysiological techniques, and 
vice versa. 
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4 E VI. AGE DEPENDENT CHANGES IN GLYCINE UTILIZATION 
The populations of various receptor subtypes have been shown to change with age and 
recent work by Le Bail et al. shows that this process occurs within the CA1 of the 
hippocampus.
261
 Specifically, the work showed changes in the composition of CA1 
Schaffer collateral NMDARs from the glycine binding GluN2B subunit to the D-serine 
binding GluN2A subunit. Such changes are expected to be accompanied by changes in 
the availability of the respective co-agonists for these subunits, and while an increase in 
D-serine concentrations could be discerned through HPLC analysis, a change in glycine 
concentrations (decrease) was unable to be resolved to statistical significance. 
Application of the GRIP sensor aimed to clarify whether age was a contributing factor 
towards the regulation and usage of glycine by examining resting/basal glycine 
concentrations in respect to developmental age (Figure 47, Figure 48). 
 
Figure 47: Trend showing the changes in resting glycine concentration in respect to 
age. Found to be significant (Pearson R = -0.69, n = 11, 2-4 brain slices per animal) 
Dynamic range of the sensor batch used was 13% (dotted line). 
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Figure 48: Observed ratio of the stratum radiatum of rats in respect to a defined age 
bracket. The difference between young and old rats is significant (two population t-test, 
p<0.005, young n = 19, old n = 13) and is consistent with the trend observed by Le Bail 
et al. that was previously unable to be resolved to significance. Dynamic range of the 
sensor batch used was 16% (dotted line). Values shown are the mean ± S.E.M.  
 
The correlated decrease of glycine concentrations in respect to the age of the studied 
rats directly confirms that the regulation and availability of glycine changes during the 
maturation of the CNS, or in the very least, in the CA1 stratum radiatum, with glycine 
concentrations showing a decrease between young (< 3 weeks) and older (> 3 weeks) 
rats. This finding is consistent with the observed decrease in glycine sensitive NMDAR 
populations, as it would be expected that the presence of a given neurotransmitter would 
correlate with the presence (or lack thereof) of endogenous receptors and transporters. 
These results also encourage further investigation of broader questions such as why this 
change occurs, or what the full effect and extent of such changes are. 
Another important outcome is that it also shows that the detection or study of 
glycine concentrations using the GRIP sensor may be more precise than analysis 
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through some other methods. In particular, although Le Bail et al. observed a trend 
towards decreased glycine concentrations, it was unable to be shown to be significant. 
Use of GRIP the sensor allowed for this small difference to be resolved in vivo, 
indicating that in the very least, it can be more precise than HPLC, which is a method 
that has frequently been used in the past for these kinds of analyses. 
 
4 F. CONCLUSIONS 
Application of the sensor hippocampal CA1 rat brain slices allowed the observation and 
measurement of glycine accumulation within the radiatum and lacunosum moleculare in 
response to exposure to glycine uptake inhibitors. Study of resting glycine 
concentrations in different subregions of the hippocampus found no significant 
difference between the examined areas, but did clarify that without additional 
calibration experiments, the sensor cannot conclusively be shown to behave 
quantitatively in situ and as such, the information gained from the sensor can only be 
viewed as qualitative at this point in time. Studies relating to synaptic plasticity 
identified differences in glycine concentrations between synaptic and extrasynaptic (or 
non-synaptic) space, which is consistent with the model proposed by Papouin et al. LTP 
inducing stimulus of the hippocampal slice unexpectedly revealed the time-correlated 
release of glycine, the implications of which are currently unclear. Studies relating 
glycine usage to age (or development) of the hippocampus showed differences in resting 
glycine concentrations, which is in agreement with the work performed by Le Bail et al. 
These experiments demonstrated that the sensor functions in situ and is able to 
respond to changes in glycine with micron scale resolution. It is also able to provide 
time-dependent information such as glycine release and clearance from stimulation. The 
properties of the GRIP sensor match the originally specified criteria for a desirable 
optical sensor, specifically, that it is able to produce meaningful information in both 
spatial and temporal dimensions and can be used complementarily with other techniques 
such as electrophysiology. A caveat remains in that the sensor still requires some further 
study to establish its ability to give quantitative information. 
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ARTICLE INTRODUCTION 
 
It is important for optical sensors to be able to report information unambiguously, 
independent of environmental variables such as ambient temperature. This means that 
signal stability of a given optical sensor must be demonstrated at physiological 
temperatures, as the target environment of optical biosensors is in situ or in vivo. This 
work shows that temperature can significantly and irreversibly impact the signal output 
for optical biosensors, where sensors that can give consistent and reproducible signal 
outputs in vitro at ambient temperatures cannot do so under physiological conditions.  
As arginine is the physiological precursor to nitrous oxide, an important 
neuromodulator, an optical sensor for this ligand is desirable. The wild type arginine 
binding protein ArtJ was converted into an optical sensor, however the signal output of 
this sensor was found to have an irreversible dependency on ambient temperatures. 
Using ancestral reconstruction, we have created a thermostable arginine sensor, 
cpFLIPR, able to reliably report changes in arginine concentrations at physiological 
temperatures. 
This demonstrates that the thermostability of optical sensors is an important 
consideration when designing and assessing optical sensors for in vivo use and the 
method of ancestral reconstruction can facilitate the development of stable optical 
biosensors. 
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APPENDIX 
CHAPTER 2 APPENDIX 
 
AC2.1. PETMCS3 sequence 
TTAATTCTTGAAGACGAAAGGGCCTCGTGATACGCCTATTTTTATAGGTTAA
TGTCATGATAATAATGGTTTCTTAGACGTCAGGTGGCACTTTTCGGGGAAAT
GTGCGCGGAACCCCTATTTGTTTATTTTTCTAAATACATTCAAATATGTATCC
GCTCATGAGACAATAACCCTGATAAATGCTTCAATAATATTGAAAAAGGAA
GAGTATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCAT
TTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCTGGTGAAAGTAAAAGATGC
TGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACAG
CGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGC
ACTTTTAAAGTTCTGCTATGTGGCGCGGTATTATCCCGTGTTGACGCCGGGC
AAGAGCAACTCGGTCGCCGCATACACTATTCTCAGAATGACTTGGTTGAGT
ACTCACCAGTCACAGAAAAGCATCTTACGGATGGCATGACAGTAAGAGAAT
TATGCAGTGCTGCCATAACCATGAGTGATAACACTGCGGCCAACTTACTTCT
GACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAACATGGG
GGATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAGCCAT
ACCAAACGACGAGCGTGACACCACGATGCCTGCAGCAATGGCAACAACGTT
GCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTA
ATAGACTGGATGGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGCC
CTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGGTGAGCGTGGGT
CTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGT
AGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGACA
GATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAACTGTCAGACCA
AGTTTACTCATATATACTTTAGATTGATTTAAAACTTCATTTTTAATTTAAAA
GGATCTAGGTGAAGATCCTTTTTGATAATCTCATGACCAAAATCCCTTAACG
TGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATC
TTCTTGAGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAA
CCACCGCTACCAGCGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACTCTTT
TTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTTCT
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AGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTAC
ATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAG
TCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAG
CGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACG
ACCTACACCGAACTGAGATACCTACAGCGTGAGCATTGAGAAAGCGCCACG
CTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGG
AACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTA
TAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCT
CGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTAC
GGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCC
CCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGCTGATACCGCTC
GCCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAA
GAGCGCCTGATGCGGTATTTTCTCCTTACGCATCTGTGCGGTATTTCACACC
GCATATATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAGC
CAGTATACACTCCGCTATCGCTACGTGACTGGGTCATGGCTGCGCCCCGACA
CCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCC
GCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTT
CACCGTCATCACCGAAACGCGCGAGGCAGCTGCGGTAAAGCTCATCAGCGT
GGTCGTGAAGCGATTCACAGATGTCTGCCTGTTCATCCGCGTCCAGCTCGTT
GAGTTTCTCCAGAAGCGTTAATGTCTGGCTTCTGATAAAGCGGGCCATGTTA
AGGGCGGTTTTTTCCTGTTTGGTCACTTGATGCCTCCGTGTAAGGGGGAATT
TCTGTTCATGGGGGTAATGATACCGATGAAACGAGAGAGGATGCTCACGAT
ACGGGTTACTGATGATGAACATGCCCGGTTACTGGAACGTTGTGAGGGTAA
ACAACTGGCGGTATGGATGCGGCGGGACCAGAGAAAAATCACTCAGGGTC
AATGCCAGCGCTTCGTTAATACAGATGTAGGTGTTCCACAGGGTAGCCAGC
AGCATCCTGCGATGCAGATCCGGAACATAATGGTGCAGGGCGCTGACTTCC
GCGTTTCCAGACTTTACGAAACACGGAAACCGAAGACCATTCATGTTGTTGC
TCAGGTCGCAGACGTTTTGCAGCAGCAGTCGCTTCACGTTCGCTCGCGTATC
GGTGATTCATTCTGCTAACCAGTAAGGCAACCCCGCCAGCCTAGCCGGGTC
CTCAACGACAGGAGCACGATCATGCGCACCCGTGGCCAGGACCCAACGCTG
CCCGAGATGCGCCGCGTGCGGCTGCTGGAGATGGCGGACGCGATGGATATG
TTCTGCCAAGGGTTGGTTTGCGCATTCACAGTTCTCCGCAAGAATTGATTGG
CTCCAATTCTTGGAGTGGTGAATCCGTTAGCGAGGTGCCGCCGGCTTCCATT
CAGGTCGAGGTGGCCCGGCTCCATGCACCGCGACGCAACGCGGGGAGGCA
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GACAAGGTATAGGGCGGCGCCTACAATCCATGCCAACCCGTTCCATGTGCT
CGCCGAGGCGGCATAAATCGCCGTGACGATCAGCGGTCCAGTGATCGAAGT
TAGGCTGGTAAGAGCCGCGAGCGATCCTTGAAGCTGTCCCTGATGGTCGTC
ATCTACCTGCCTGGACAGCATGGCCTGCAACGCGGGCATCCCGATGCCGCC
GGAAGCGAGAAGAATCATAATGGGGAAGGCCATCCAGCCTCGCGTCGCGA
ACGCCAGCAAGACGTAGCCCAGCGCGTCGGCCGCCATGCCGGCGATAATGG
CCTGCTTCTCGCCGAAACGTTTGGTGGCGGGACCAGTGACGAAGGCTTGAG
CGAGGGCGTGCAAGATTCCGAATACCGCAAGCGACAGGCCGATCATCGTCG
CGCTCCAGCGAAAGCGGTCCTCGCCGAAAATGACCCAGAGCGCTGCCGGCA
CCTGTCCTACGAGTTGCATGATAAAGAAGACAGTCATAAGTGCGGCGACGA
TAGTCATGCCCCGCGCCCACCGGAAGGAGCTGACTGGGTTGAAGGCTCTCA
AGGGCATCGGTCGACGCTCTCCCTTATGCGACTCCTGCATTAGGAAGCAGCC
CAGTAGTAGGTTGAGGCCGTTGAGCACCGCCGCCGCAAGGAATGGTGCATG
CAAGGAGATGGCGCCCAACAGTCCCCCGGCCACGGGGCCTGCCACCATACC
CACGCCGAAACAAGCGCTCATGAGCCCGAAGTGGCGAGCCCGATCTTCCCC
ATCGGTGATGTCGGCGATATAGGCGCCAGCAACCGCACCTGTGGCGCCGGT
GATGCCGGCCACGATGCGTCCGGCGTAGAGGATCGAGATCTCGATCCCGCG
AAATTAATACGACTCACTATAGGGAGACCACAACGGTTTCCCTCTAGTAAT
AATTTTGTTTAATCGGATCCTAAGGAGGTTAATATTATGCACCATCACCATC
ACCATATGACGTCGACGCGTCTGCAGAAGCTTCTAGAATTCGAGCTCCCGG
GTACCATGGCATGCATCGATAGATCCGGCTGCTAACAAAGCCCGAAAGGAA
GCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGG
GCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGAACTATATCCG
GATATCCACAGGACGGGTGTGGTCGCCATGATCGCGTAGTCGATAGTGGCT
CCAAGTAGCGAAGCGAGCAGGACTGGGCGGCGGCCAAAGCGGTCGGACAG
TGCTCCGAGAACGGGTGCGCATAGAAATTGCATCAACGCATATAGCGCTAG
CAGCACGCCATAGTGACTGGCGATGCTGTCGGAATGGACGATATCCCGCAA
GAGGCCCGGCAGTACCGGCATAACCAAGCCTATGCCTACAGCATCCAGGGT
GACGGTGCCGAGGATGACGATGAGCGCATTGTTAGATTTCATACACGGTGC
CTGACTGCGTTAGCAATTTAACTGTGATAAACTACCGCATTAAAGCTTATCG
ATGATAAGCTGTCAAACATGAGAA 
 
Gibson segment used for generating PCR fragments 
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Gibson termination used for PCR (no TAA) 
T7 start 
T7 end 
 
AC2.2 pDOTS10 sequence 
ATTGCAGCACTGGGGCCAGATGGTAAGCGCTCCCGTATCGTAGTTATCTACA
CGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGACAGATCGCTGAG
ATAGGTGCCTCACTGATTAAGCATTGGTAACTGTCAGACCAAGTTTACTCAT
ATATACTTTAGATTGATTTAAAACTTCATTTTTAATTTAAAAGGATCTAGGT
GAAGATCCTTTTTGATAATCTCATGACCAAAATCCCTTAACGTGAGTTTTCG
TTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGAT
CCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTAC
CAGCGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGT
AACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTTCTAGTGTAGCC
GTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCT
CTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTA
CCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCT
GAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCG
AACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAG
GGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAG
CGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTC
GGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGG
GGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGG
GCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCT
GTGGATAACCGTATTACCGCCTTTGAGTGAGCTGATACCGCTCGCCGCAGCC
GAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCCCA
ATACGCAAACCGCCTCTCCCCGCGCGTTGGCCGATTCATTAATGCAGATCTC
GATCCCGCGAAATTAATACGACTCACTATAGGGAGACCACAACGGTTTCCC
TCTAGATAATTTTGTTTAACTTTAAGAAGGAGATATACATATGCGGGGTTCT
CATCATCATCATCATCATGGTATGGCTAGCATGACTGGTGGACAGCAAATG
GGTCGGGATCTGTACGACGATGACGATAAGGATCCgAAACTGAAGGTAACA
GTCAACGGCACTGCGTATGACGTTGACGTTGACGTCGACAAGTCACACGAA
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AACCCGATGGGCACCATCCTGTTCGGCGGCGGCACCGGCGGCGCGCCGGCA
CCGGCAGCAGGTGGCGCAGGCGCCGGTAAGGCCGGAGAGGGCGAGATTCC
CGCTCCGCTGGCCGGCACCGTCTCCAAGATCCTCGTGAAGGAGGGTGACAC
GGTCAAGGCTGGTCAGACCGTGCTCGTTCTCGAGGCCATGAAGATGGAGAC
CGAGATCAACGCTCCCACCGACGGCAAGGTCGAGAAGGTCCTGGTCAAGGA
GCGTGACGCGGTGCAGGGCGGTCAGGGTCTCATCAAGATCGGGGATCTCGA
GCTCATCGAAGGCTCGAGCGGTtcGGATCCgggccgcATGGTGAGCAAGGGCGA
GGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGT
AAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTA
CGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCC
CTGGCCCACCCTCGTGACCACCCTGACCTGGGGCGTGCAGTGCTTCAGCCGC
TACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAA
GGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAG
ACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAG
CTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTG
GAGTACAACTACATCAGCCACAACGTCTATATCACCGCCGACAAGCAGAAG
AACGGCATCAAGGCCAACTTCAAGATCCGCCACAACATCGAGGACGGCAGC
GTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCC
GTGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAA
GACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCC
GCCGGGATCACTCTCGGCATGGACGAGCTGTACAAGggtggtaccggaATCAgaaga
gcactgcatggtGCGGCCGCcaccactctcgctcttcCCTCgccggtaccggtggaATGGTGAGCAAG
GGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGC
GACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCC
ACCTACGGCAAGCTGACCCTGAAGCTGATCTGCACCACCGGCAAGCTGCCC
GTGCCCTGGCCCACCCTCGTGACCACCCTGGGCTACGGCCTGCAGTGCTTCG
CCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCC
CGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTA
CAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCAT
CGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACA
AGCTGGAGTACAACTACAACAGCCACAACGTCTATATCACCGCCGACAAGC
AGAAGAACGGCATCAAGGCCAACTTCAAGATCCGCCACAACATCGAGGAC
GGCGGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGAC
GGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCTACCAGTCCGCCCTGA
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GCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGA
CCGCCGCCGGGATCACTCTCGGCATGGACGAGCTGTACAAGTAAaagcttGATC
CGGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTG
AGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTT
TTTTGCTGAAAGGAGGAACTATATCCGGATCTGGCGTAATAGCGAAGAGGC
CCGCACCGATCGCCCTTCCCAACAGTTGCGCAGCCTGAATGGCGAATGGGA
CGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAG
CGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCC
CTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGG
GCTCCCTTTAGGGTTCCGATTTAGAGCTTTACGGCACCTCGACCGCAAAAAA
CTTGATTTGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTT
TTCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAA
ACTGGAACAACACTCAACCCTATCGCGGTCTATTCTTTTGATTTATAAGGGA
TTTTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAATATT
TAACGCGAATTTTAACAAAATATTAACGTTTACAATTTCGCCTGATGCGGTA
TTTTCTCCTTACGCATCTGTGCGGTATTTCACACCGCATACAGGTGGCACTTT
TCGGGGAAATGTGCGCGGAACCCCTATTTGTTTATTTTTCTAAATACATTCA
AATATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTCAATAATATT
GAAAAAGGAAGAGTATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCCTT
TTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCTGGTGAAA
GTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTG
GATCTCAACAGCGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTC
CAATGATGAGCACTTTTAAAGTTCTGCTATGTGATACACTATTATCCCGTAT
TGACGCCGGGCAAGAGCAACTCGGTCGCCGCATACACTATTCTCAGAATGA
CTTGGTTGAGTACTCACCAGTCACAGAAAAGCATCTTACGGATGGCATGAC
AGTAAGAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGCGGC
CAACTTACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTG
CACAACATGGGGGATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTG
AATGAAGCCATACCAAACGACGAGAGTGACACCACGATGCCTGTAGCAATG
CCAACAACGTTGCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCC
GGCAACAATTAATAGACTGAATGGAGGCGGATAAAGTTGCAGGACCACTTC
TGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGG
TGAGCGTGGGTCTCGCGGTATC 
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T7 forward + Terminator 
Biotin 
ECFP 
Venus 
 
AC2.3. Autoinducing TB composition 
Yeast extract 5 g, Tryptone 20 g, NaCl 5 g, KH2PO4 3 g, Na2HPO4 6 g, 1 L of water. 
After autoclaving the media add (under sterile conditions): Autoclaved 60% glycerol 10 
ml, autoclaved 10% glucose 5 ml, autoclaved 10% lactose 25 ml. 
 
AC2.4 Truncations based on the publication by Deuschle et al. 
R1, -4% range: 
ECFPACTCTCGGCATGGACGAGCTGTACAAG-GGTGGTACCGGAATCATGAYW
CCGGATGGCAAATTCACCTATATTCAGCAGGGTGGA-
GTGAGCAAGGGCGAGVenus 
R2, -5.5% range: 
ECFPACTCTCGGCATGGACGAGCTGTACAAG-GGTGGTACCGGAATCATGAYW
CCGGATGGCAAATTCACCTATATTCAGCAGGGTGGA-Venus 
R3, -7% range:  
ECFP-GGTGGTACCGGAATCATGAYWCCGGATGGCAAATTCACCTATATTCAG
CAGGGTGGA-Venus 
R4, -7% range:  
ECFP-AYWCCGGATGGCAAATTCACCTATATTCAGCAGGGTGGA-Venus 
R5, 0% range:  
ECFP-AYWCCGGATGGCAAATTCACCTATATTCAGCAG-Venus 
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R6, Did not express:  
ECFP-AYW-Venus 
 
Residues that do not originate from a protein (from the vector) are marked in red. 
 
AC2.5. Pertz kit array dynamic ranges 
Sensor construct number Dynamic range 
(Venus/mTFP or 
Venus/ECFP, % of apo) 
Sensor design structure 
A1 1.8 mTFP-WT Venus-WT 
A2 <1 mTFP-WT Venus-157 
A3 <1 mTFP-WT Venus-173 
A4 <1 mTFP-WT Venus-195 
A5 <1 mTFP-WT Venus-229 
A6 -2.7 mTFP-105 Venus-WT 
A7 -2.1 mTFP-105 Venus-157 
A8 <1 mTFP-105 Venus-173 
A9 -1.1 mTFP-105 Venus-195 
A10 -2.3 mTFP-105 Venus-229 
A11 -4.2 mTFP-159 Venus-WT 
A12 -3.1 mTFP-159 Venus-157 
B1 <1 mTFP-159 Venus-173 
B2 <1 mTFP-159 Venus-195 
B3 <1 mTFP-159 Venus-229 
B4 -2.1 mTFP-175 Venus-WT 
B5 -1.3 mTFP-175 Venus-157 
B6 <1 mTFP-175 Venus-173 
B7 <1 mTFP-175 Venus-195 
B8 <1 mTFP-175 Venus-229 
B9 <1 mTFP-227 Venus-WT 
B10 2.3 mTFP-227 Venus-157 
B11 <1 mTFP-227 Venus-173 
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B12 1.4 mTFP-227 Venus-195 
C1 2.4 mTFP-227 Venus-229 
A1-ECFP -4% ECFP-WT Venus-WT 
A2-ECFP -7% ECFP-WT Venus-157 
A3-ECFP <1% ECFP-WT Venus-173 
A4-ECFP -8% ECFP-WT Venus-195 
A5-ECFP -7% ECFP-WT Venus-229 
The table above shows the fluorescence ratio (Venus/mTFP or Venus/ECFP) in the 
presence of 1 mM glycine normalized to control (0 mM glycine) for each sensor 
construct. The sensor design structure refers to the circular permutation residue location 
of the fluorescent proteins used. For example A3 corresponds to a wild type mTFP and 
a Venus fluorescent protein that has been circularly permuted at residue 173. The 
highest response of the original Pertz kit was -4% and thus the biggest dynamic range 
was measured for A-11. When mTFP was replaced with ECFP, a dynamic range of -8% 
could be obtained (A4-ECFP) 
 
AC2.6 SnFR insertion sites 
 
The promiscuous SBP Atu2422 from Agrobacterium tumefaciens with SnFR insertion 
residues identified. Positions 12, 166, 180, 326 and 327 (spheres). These insertions did 
not create sensors with observable changes in fluorescent spectra upon saturation with 
glycine. ITC analysis indicated that the protein could be deactivated by such insertions 
(not shown). 
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AC2.7 Spectra of the rigid linker variants after SEC (best fraction) 
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GS(EAAAK)3GS 
 
AC2.8 DNA and protein sequence of the GRIP sensor 
ATGCGGGGTTCTCATCATCATCATCATCATGGTATGGCTAGCATGACTGGTG
GACAGCAAATGGGTCGGGATCTGTACGACGATGACGATAAGGATCCGAAAC
TGAAGGTAACAGTCAACGGCACTGCGTATGACGTTGACGTTGACGTCGACA
AGTCACACGAAAACCCGATGGGCACCATCCTGTTCGGCGGAGGCACCGGCG
GCGCGCCGGCACCGGCAGCAGGTGGCGCAGGCGCCGGTAAGGCCGGAGAG
GGCGAGATTCCCGCTCCGCTGGCCGGCACCGTCTCCAAGATCCTCGTGAAG
GAGGGTGACACGGTCAAGGCTGGTCAGACCGTGCTCGTTCTCGAGGCCATG
AAGATGGAGACCGAGATCAACGCTCCCACCGACGGCAAGGTCGAGAAGGT
CCTGGTCAAGGAGCGTGACGCGGTGCAGGGCGGTCAGGGTCTCATCAAGAT
CGGGGATCTCGAGCTCATCGAAGGCTCGAGCGGTTCGGATCCGGGCCGCAT
GGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGA
GCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGA
GGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGG
CAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTGGGGCGTG
CAGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGT
CCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACG
ACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGG
TGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCC
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TGGGGCACAAGCTGGAGTACAACTACATCAGCCACAACGTCTATATCACCG
CCGACAAGCAGAAGAACGGCATCAAGGCCAACTTCAAGATCCGCCACAAC
ATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCC
ATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCAG
TCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTG
GAGTTCGTGACCGCCGCCGGGATCGATGTTGTTATTGCAGTTGGTGCACCGC
TGACCGGTCCGAATGCAGCATTTGGTGCACAGATTCAGAAAGGTGCAGAAC
AGGCAGCAAAAGATATTAATGCAGCCGGTGGTATTAATGGCGAGCAGATTA
AAATCGTTCTGGGTGATGATGTTAGCGATCCGAAACAGGGTATTAGCGTTG
CCAATAAATTCGTTGCAGATGGCGTTAAATTTGTGGTGGGTCATGCGAACA
GCGGTGTTAGCATTCCGGCAAGCGAAGTTTATGCAGAAAATGGTATTCTCG
AGATTACACCGTATGCAACCAATCCGGTTTTTACCGAACGTGGTCTGTGGAA
TACCTTTCGTACCTGCGGCCGCGACGATCAGCAGGGTGGTATTGCAGGTAA
ATATCTGGCAGATCATTTCAAAGATGCCAAAGTGGCCATCATCCATGATAA
AACCCCGTATGGTCAGGGTCTGGCCGATGAAACCAAAAAAGCAGCAAATGC
AGCGGGTGTTACCGAAGTTATGTATGAAGGTGTTAATGTGGGCGATAAAGA
TTTTAGCGCACTGATCAGCAAAATGAAAGAAGCAGGCGTTAGCATTATCTA
TTGGGGTGGTTGGCATACCGAAGCAGGTCTGATTATTCGTCAGGCAGCAGA
TCAGGGCCTGAAAGCAAAACTGGTTAGCGGTGATGGTATTGTTAGCAATGA
ACTGGCAAGCATTGCCGGTGATGCAGTTGAAGGCACCCTGAATACATTTGG
TCCTGATCCGACCCTGCGTCCGGAAAATAAAGAACTGGTTGAAAAATTCAA
AGCCGCAGGCTTTAATCCGGAAGCATATACCCTGTATAGCTATGCAGCAAT
GCAGGCAATTGCGGGTGCAGCCAAAGCAGCAGGTAGCGTTGAACCGGAAA
AAGTTGCAGAAGCACTGAAAAAAGGTAGCTTTCCGACCGCACTGGGTGAAA
TCAGCTTTGATGAAAAAGGTGATCCTAAACTGCCTGGCTATGTGATGTATGA
ATGGAAAAAAGGACCGGATGGCAAATTCACCTATATTCAGCAGGAAGCAGC
AGCAAAAGAAGCCGCTGCCAAAGAAGCGGCAGCGAAAGTGAGCAAGGGCG
AGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACG
TAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCT
ACGGCAAGCTGACCCTGAAGCTGATCTGCACCACCGGCAAGCTGCCCGTGC
CCTGGCCCACCCTCGTGACCACCCTGGGCTACGGCCTGCAGTGCTTCGCCCG
CTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGA
AGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAA
GACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGA
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GCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCT
GGAGTACAACTACAACAGCCACAACGTCTATATCACCGCCGACAAGCAGAA
GAACGGCATCAAGGCCAACTTCAAGATCCGCCACAACATCGAGGACGGCGG
CGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCC
CGTGCTGCTGCCCGACAACCACTACCTGAGCTACCAGTCCGCCCTGAGCAA
AGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGC
CGCCGGGATCACTCTCGGCATGGACGAGCTGTACAAGTAA 
 
MRGSHHHHHHGMASMTGGQQMGRDLYDDDDKDPKLKVTVNGTAYDVDVD
VDKSHENPMGTILFGGGTGGAPAPAAGGAGAGKAGEGEIPAPLAGTVSKILVK
EGDTVKAGQTVLVLEAMKMETEINAPTDGKVEKVLVKERDAVQGGQGLIKIG
DLELIEGSSGSDPGRMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDAT
YGKLTLKFICTTGKLPVPWPTLVTTLTWGVQCFSRYPDHMKQHDFFKSAMPEG
YVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNY
ISHNVYITADKQKNGIKANFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNH
YLSTQSALSKDPNEKRDHMVLLEFVTAAGIDVVIAVGAPLTGPNAAFGAQIQK
GAEQAAKDINAAGGINGEQIKIVLGDDVSDPKQGISVANKFVADGVKFVVGHA
NSGVSIPASEVYAENGILEITPYATNPVFTERGLWNTFRTCGRDDQQGGIAGKY
LADHFKDAKVAIIHDKTPYGQGLADETKKAANAAGVTEVMYEGVNVGDKDFS
ALISKMKEAGVSIIYWGGWHTEAGLIIRQAADQGLKAKLVSGDGIVSNELASIA
GDAVEGTLNTFGPDPTLRPENKELVEKFKAAGFNPEAYTLYSYAAMQAIAGAA
KAAGSVEPEKVAEALKKGSFPTALGEISFDEKGDPKLPGYVMYEWKKGPDGKF
TYIQQEAAAKEAAAKEAAAKVSKGEELFTGVVPILVELDGDVNGHKFSVSGEG
EGDATYGKLTLKLICTTGKLPVPWPTLVTTLGYGLQCFARYPDHMKQHDFFKS
AMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHK
LEYNYNSHNVYITADKQKNGIKANFKIRHNIEDGGVQLADHYQQNTPIGDGPV
LLPDNHYLSYQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK* 
 
White = Biotin domain 
ECFP 
Binding core AYW 
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Rigid linker EAAAK x 3 
Venus 
Note: the binding core of the GRIP sensor has had the methionine removed, so in this 
construct the mutant residues are F76A, A99Y and L201W instead of F77A, A100Y 
and L202W. 
 
AC 2.9 Vector map of the unmodified PETMCS3 vector as well as an insert 
showing the arrangement of the GRIP construct when cloned in.  
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CHAPTER 3 APPENDIX 
 
AC3.1 Sequence of the GRIPPED sensor (svCFP-AYW G178C) 
ATGCGGGGTTCTCATCATCATCATCATCATGGTATGGCTAGCATGACTGGTG
GACAGCAAATGGGTCGGGATCTGTACGACGATGACGATAAGGATCCGAAAC
TGAAGGTAACAGTCAACGGCACTGCGTATGACGTTGACGTTGACGTCGACA
AGTCACACGAAAACCCGATGGGCACCATCCTGTTCGGCGGAGGCACCGGCG
GCGCGCCGGCACCGGCAGCAGGTGGCGCAGGCGCCGGTAAGGCCGGAGAG
GGCGAGATTCCCGCTCCGCTGGCCGGCACCGTCTCCAAGATCCTCGTGAAG
GAGGGTGACACGGTCAAGGCTGGTCAGACCGTGCTCGTTCTCGAGGCCATG
AAGATGGAGACCGAGATCAACGCTCCCACCGACGGCAAGGTCGAGAAGGT
CCTGGTCAAGGAGCGTGACGCGGTGCAGGGCGGTCAGGGTCTCATCAAGAT
CGGGGATCTCGAGCTCATCGAAGGCTCGAGCGGTTCGGATCCGGGCCGCAT
GGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGA
GCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGA
GGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTCTACCACCGG
CAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTGGGGCGTG
CAGGTGTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAG
TCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGAC
GACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTG
GTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATC
CTGGGGCACAAGCTGGAGTACAACTACATCAGCCACAACGTCTATATCACC
GCCGACAAGCAGAAGAACGGCATCAAGGCCAACTTCAAGATCCGCCACAA
CATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCC
CATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCA
GTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCT
GGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGACGAGCTGTACAA
GGGTGGTACCGGAATCATGGATGTTGTTATTGCAGTTGGTGCACCGCTGACC
GGTCCGAATGCAGCATTTGGTGCACAGATTCAGAAAGGTGCAGAACAGGCA
GCAAAAGATATTAATGCAGCCGGTGGTATTAATGGCGAGCAGATTAAAATC
GTTCTGGGTGATGATGTTAGCGATCCGAAACAGGGTATTAGCGTTGCCAAT
AAATTCGTTGCAGATGGCGTTAAATTTGTGGTGGGTCATGCGAACAGCGGT
GTTAGCATTCCGGCAAGCGAAGTTTATGCAGAAAATGGTATTCTCGAGATT
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ACACCGTATGCAACCAATCCGGTTTTTACCGAACGTGGTCTGTGGAATACCT
TTCGTACCTGCGGCCGCGACGATCAGCAGGGTGGTATTGCAGGTAAATATC
TGGCAGATCATTTCAAAGATGCCAAAGTGGCCATCATCCATGATAAAACCC
CGTATGGTCAGGGTCTGGCCGATGAAACCAAAAAAGCAGCAAATGCAGCG
GGTGTTACCGAAGTTATGTATGAAGGTGTTAATGTGTGCGATAAAGATTTTA
GCGCACTGATCAGCAAAATGAAAGAAGCAGGCGTTAGCATTATCTATTGGG
GTGGTTGGCATACCGAAGCAGGTCTGATTATTCGTCAGGCAGCAGATCAGG
GCCTGAAAGCAAAACTGGTTAGCGGTGATGGTATTGTTAGCAATGAACTGG
CAAGCATTGCCGGTGATGCAGTTGAAGGCACCCTGAATACATTTGGTCCTG
ATCCGACCCTGCGTCCGGAAAATAAAGAACTGGTTGAAAAATTCAAAGCCG
CAGGCTTTAATCCGGAAGCATATACCCTGTATAGCTATGCAGCAATGCAGG
CAATTGCGGGTGCAGCCAAAGCAGCAGGTAGCGTTGAACCGGAAAAAGTTG
CAGAAGCACTGAAAAAAGGTAGCTTTCCGACCGCACTGGGTGAAATCAGCT
TTGATGAAAAAGGTGATCCTAAACTGCCTGGCTATGTGATGTATGAATGGA
AAAAAGGACCGGATGGCAAATTCACCTATATTCAGCAGTAA 
 
MRGSHHHHHHGMASMTGGQQMGRDLYDDDDKDPKLKVTVNGTAYDVDVD
VDKSHENPMGTILFGGGTGGAPAPAAGGAGAGKAGEGEIPAPLAGTVSKILVK
EGDTVKAGQTVLVLEAMKMETEINAPTDGKVEKVLVKERDAVQGGQGLIKIG
DLELIEGSSGSDPGRMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDAT
YGKLTLKFISTTGKLPVPWPTLVTTLTWGVQVFSRYPDHMKQHDFFKSAMPEG
YVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNY
ISHNVYITADKQKNGIKANFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNH
YLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYKGGTGIMDVVIAVGA
PLTGPNAAFGAQIQKGAEQAAKDINAAGGINGEQIKIVLGDDVSDPKQGISVAN
KFVADGVKFVVGHANSGVSIPASEVYAENGILEITPYATNPVFTERGLWNTFRT
CGRDDQQGGIAGKYLADHFKDAKVAIIHDKTPYGQGLADETKKAANAAGVTE
VMYEGVNVCDKDFSALISKMKEAGVSIIYWGGWHTEAGLIIRQAADQGLKAK
LVSGDGIVSNELASIAGDAVEGTLNTFGPDPTLRPENKELVEKFKAAGFNPEAY
TLYSYAAMQAIAGAAKAAGSVEPEKVAEALKKGSFPTALGEISFDEKGDPKLP
GYVMYEWKKGPDGKFTYIQQ* 
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White = biotin 
ECFP 
Linker 
AYW binding core 
 
AC3.2 Sequence of GASP (GABA sensor, ATU-svcpECFP S174C) 
AACGATCTGGTTTTTAGCAGCTGGGGTGGCACCACCCAGGATGCACAGAAA
GCAGCATGGGCAGAAAAATTCATGGTTGAAACCGGTATTAATGTGCTGCAG
GATGGTCCGACCGATTATGGTAAACTGAAAGCAATGGTTGAAGCCGGGGGA
TATATCTCTCACAACGTGTATATTACGGCAGATAAACAGAAAAATGGCATT
AAGGCGAACTTTAAAATTCGCCACAACATCGAAGATGGATCAGTGCAGCTG
GCGGACCATTATCAGCAAAATACTCCTATTGGCGACGGTCCCGTGCTGTTAC
CGGATAATCATTATCTGTCCACACAGAGCGCGCTGTCCAAAGACCCAAACG
AGAAGCGTGACCACATGGTGCTGTTGGAATTTGTGACGGCCGCCGGCATTA
CTCTGGGTATGGATGAACTTTATAAAGGGGGGTCCGGGGGCATGGTTTCAA
AAGGCGAAGAGCTTTTCACCGGTGTGGTTCCCATTCTGGTAGAATTAGATGG
AGACGTGAATGGCCACAAATTTAGCGTGAGTGGGGAAGGCGAGGGTGATG
CGACGTACGGTAAATTGACCCTTAAGTTTATTTCAACCACCGGAAAATTGCC
GGTGCCCTGGCCTACCCTGGTAACTACCCTCACGTGGGGAGTGCAGGTGTTC
AGTCGCTATCCAGATCATATGAAACAACATGATTTCTTTAAAAGCGCTATGC
CCGAGGGCTATGTGCAAGAACGCACAATTTTCTTCAAAGATGATGGTAATT
ACAAAACCCGTGCTGAGGTGAAGTTCGAGGGAGATACCCTGGTGAATCGGA
TCGAACTGAAAGGCATTGATTTTAAAGAGGACGGCAATATCCTGGGTCATA
AACTGGAATATAATAACCCTAATGGTGTTACCTGGGATGTTGTTGATGTTGA
AGGTGATTATGCAGCACAGGCAGGTCCGAAAGGTCTGCTGGAAAAACTGGA
TTTTAGCGTGATCGATAAAACCAAACTGGACCCTCGTTTTGTTACCGATTAT
AGCGTTGGTAGCTTCTATTACAGCTTTGTGATTGGTTGCAATGTTGATAGCG
TTAGCGCATGTCCGAAAAGCTGGGCAGACCTGTTTGATACCGCAAAATTTCC
GGGTAAACGCACCTTCTATAAATGGTCAGCACCGGGTGTTATTGAAGCAGC
ACTGCTGGCAGATGGTGTGACCGCAGATAAACTGTATCCGCTGGATCTGGA
TCGTGCATTCAAAAAACTGGACACCATTAAATGCGATATCATTTGGTGGTCA
Appendix 
157 
 
GGTGGTGCACAGAGCCAGCAGCTGATTGCAAGCGCAGAAGCACCGTTTGGT
AGCGTTTGGAATGGTCGTATGACCGCACTGGAACAGAGCGGTGTTAAAGTT
GAAACCAGCTGGGCACAGAATATTACCGCAGCAGATAGCCTGGTTGTTCCG
AAAGGCACCAAAAACAAAGATGCAGCCATGAAATTTATCGCACTGGCAACC
AGCGCACAGGCACAGGCCGATATGGCAACCGCAACCGGTTATGCACCGGTT
AATATTGAAAGCGCAAAACTGATGGACCCGAAAATTGCAAAAAGCCTGCCG
GATCAGCAGACCGAAAGCCAGGTTAATGCAGATATGAATTATTGGGCACAG
CACCGTGATGAAATTGGTGAACGTTGGTATGCATGGCAGGCAAAATAA 
 
NDLVFSSWGGTTQDAQKAAWAEKFMVETGINVLQDGPTDYGKLKAMVEAGG
YISHNVYITADKQKNGIKANFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDN
HYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYKGGSGGMVSKGEE
LFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFISTTGKLPVPWPTL
VTTLTWGVQVFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEV
KFEGDTLVNRIELKGIDFKEDGNILGHKLEYNNPNGVTWDVVDVEGDYAAQA
GPKGLLEKLDFSVIDKTKLDPRFVTDYSVGSFYYSFVIGCNVDSVSACPKSWAD
LFDTAKFPGKRTFYKWSAPGVIEAALLADGVTADKLYPLDLDRAFKKLDTIKC
DIIWWSGGAQSQQLIASAEAPFGSVWNGRMTALEQSGVKVETSWAQNITAADS
LVVPKGTKNKDAAMKFIALATSAQAQADMATATGYAPVNIESAKLMDPKIAK
SLPDQQTESQVNADMNYWAQHRDEIGERWYAWQAK 
 
cpECFP 
 
AC3.3 Derivatization of the equation predicting the dynamic range from a set of 
FRET efficiencies (Derived by Joshua Mitchell) 
Given the average FRET efficiencies of two sensor conformations, it is desirable to 
calculate the dynamic range of a sensor with those two major conformations. Ratios of 
intensities of the characteristic fluorescence peaks of both fluorophores are measured in 
two states, apo and bound. Let 𝐼𝐴be the intensity of the peak associated with the 
acceptor fluorophore in the given state, and let 𝐼𝐷 be the intensity of the peak associated 
with donor. The ratio of signals is then: 
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𝑟𝑎𝑡𝑖𝑜 =  
𝐼𝐴
𝐼𝐷
 
Intensity is the rate of change of radiant energy with respect to time, here from 𝑛𝜆 
fluorescence events with average emitted wavelength 𝜆. 
𝐼 =
𝜕
𝜕𝑡
(𝑛𝜆ℎ𝜆) 
𝑟𝑎𝑡𝑖𝑜 =  
𝜕
𝜕𝑡 (𝑛𝜆𝐴ℎ𝜆𝐴)
𝜕
𝜕𝑡 (𝑛𝜆𝐷ℎ𝜆𝐷)
 
𝑟𝑎𝑡𝑖𝑜 =  
𝑛𝜆𝐴𝜆𝐴
𝑛𝜆𝐷𝜆𝐷
 
The wavelengths 𝜆𝐴 and 𝜆𝐷 is chosen, making the number of fluorescent events the only 
unknowns. By definition of the quantum yield, the number of fluorescence events for a 
fluorophore in the absence of FRET is the number of excitation events 𝑛𝑒𝑥 multiplied 
by the fluorescence quantum yield 𝑄: 
𝑛 =  𝑛𝑒𝑥𝑄 
The proportion of these fluorescence events occurring at a particular wavelength is the 
intensity of the emission spectrum of that fluorophore in isolation at that wavelength 
after the emission spectrum has been normalized to unity: 
𝑛𝜆 = 𝑛𝑒𝑥𝑄𝐹𝜆 
𝐹𝜆 =
𝑓𝜆
∫ 𝑓 𝑑𝜆
∞
0
 
The presence of FRET changes the number of fluorescence events. For the donor, the 
fluorescence quantum yield is altered by competition with FRET. In general, a quantum 
yield is the ratio of rates of the interesting relaxation pathway to that of all relaxation 
pathways. Under the assumption that FRET is the only relaxation pathway with a rate 
that is variable over the course of a single experiment, this definition can be rearranged 
to give the fluorescence rate constant: 
𝑄𝐷 =
𝑘𝑓𝑙𝑢𝑜𝑟
𝑘𝑎𝑙𝑙,𝑛𝑜𝐹𝑅𝐸𝑇
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𝑘𝑓𝑙𝑢𝑜𝑟 = 𝑄𝐷𝑘𝑎𝑙𝑙,𝑛𝑜𝐹𝑅𝐸𝑇 
FRET efficiency is defined as the quantum yield of FRET, so can be calculated 
analogously from the relevant rate constants: 
𝐸 =
𝑘𝐹𝑅𝐸𝑇
𝑘𝑎𝑙𝑙,𝑛𝑜𝐹𝑅𝐸𝑇 + 𝑘𝐹𝑅𝐸𝑇 
 
1 − 𝐸 = 1 −
𝑘𝐹𝑅𝐸𝑇
𝑘𝑎𝑙𝑙,𝑛𝑜𝐹𝑅𝐸𝑇 + 𝑘𝐹𝑅𝐸𝑇 
 
1 − 𝐸 =
𝑘𝑎𝑙𝑙,𝑛𝑜𝐹𝑅𝐸𝑇 + 𝑘𝐹𝑅𝐸𝑇
𝑘𝑎𝑙𝑙,𝑛𝑜𝐹𝑅𝐸𝑇 + 𝑘𝐹𝑅𝐸𝑇 
−
𝑘𝐹𝑅𝐸𝑇
𝑘𝑎𝑙𝑙,𝑛𝑜𝐹𝑅𝐸𝑇 + 𝑘𝐹𝑅𝐸𝑇 
 
1 − 𝐸 =
𝑘𝑎𝑙𝑙,𝑛𝑜𝐹𝑅𝐸𝑇
𝑘𝑎𝑙𝑙,𝑛𝑜𝐹𝑅𝐸𝑇 + 𝑘𝐹𝑅𝐸𝑇 
 
Considering the fluorescence quantum yield in the presence of the acceptor (and 
therefore in the presence of FRET) then yields its dependence on the FRET efficiency: 
𝑄𝐷𝐴 =
𝑘𝑓𝑙𝑢𝑜𝑟
𝑘𝑎𝑙𝑙,𝑛𝑜𝐹𝑅𝐸𝑇 + 𝑘𝐹𝑅𝐸𝑇
 
𝑄𝐷𝐴 =
𝑄𝐷,𝑓𝑙𝑢𝑜𝑟𝑘𝑎𝑙𝑙,𝑛𝑜𝐹𝑅𝐸𝑇
𝑘𝑎𝑙𝑙,𝑛𝑜𝐹𝑅𝐸𝑇 + 𝑘𝐹𝑅𝐸𝑇
 
𝑄𝐷𝐴 = 𝑄𝐷(1 − 𝐸) 
The number of donor excitation events is independent of FRET, so the number of donor 
fluorescence events in the presence of FRET is: 
𝑛𝐷 = 𝑛𝐷,𝑒𝑥𝑄𝐷(1 − 𝐸) 
For the acceptor, the number of excitation events is the simply the number of FRET 
events: 
𝑛𝐴 = 𝑛𝐹𝑅𝐸𝑇 𝑄𝐴 
By definition of the FRET efficiency, the number of FRET events is the number of 
donor excitation events multiplied by the efficiency 𝐸: 
𝑛𝐹𝑅𝐸𝑇 =  𝑛𝐷,𝑒𝑥𝐸 
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Thus, the number of fluorescence events for the donor and acceptor at a given 
wavelength can be calculated: 
𝑛𝜆𝐴𝐷 = 𝑛𝐷,𝑒𝑥𝐸 𝑄𝐴𝐹𝜆𝐴 
𝑛𝜆𝐷𝐴 = 𝑛𝐷,𝑒𝑥𝑄𝐷(1 − 𝐸)𝐹𝜆𝐷 
FRET fluorophore design is complicated by the possibility of “cross-talk” between 
fluorophores. The acceptor may be directly excited by the incident light and donor 
emission may overlap the acceptor peak. In principle, it is also possible for the acceptor 
to donate FRET to the donor and for acceptor emission to overlap the donor peak, but 
this does not occur for the donor-acceptor pairs under study here owing to the width of 
the donor spectra and narrowness of the acceptor spectra. The total number of 
fluorescence events at the acceptor peak wavelength is therefore the sum of those 
caused by FRET, calculated above, those caused by direct excitation, and those from the 
donor: 
𝑛𝜆𝐴 = 𝑛𝜆𝐴𝐴𝐷 + 𝑛𝜆𝐴𝐴 + 𝑛𝜆𝐴𝐷𝐴 
𝑛𝜆𝐴 = 𝑛𝐷,𝑒𝑥𝐸 𝑄𝐴𝐹𝜆𝐴𝐴 + 𝑛𝐴,𝑒𝑥𝑄𝐴𝐹𝜆𝐴𝐴 + 𝑛𝐷,𝑒𝑥𝑄𝐷(1 − 𝐸)𝐹𝜆𝐴𝐷 
𝑛𝜆𝐷 = 𝑛𝜆𝐷𝐴 = 𝑛𝐷,𝑒𝑥𝑄𝐷(1 − 𝐸)𝐹𝜆𝐷𝐷 
The peak ratio for a given efficiency is thus: 
𝑟𝑎𝑡𝑖𝑜 =  
𝑛𝜆𝐴
𝑛𝜆𝐷
=
𝑛𝐷,𝑒𝑥𝐸 𝑄𝐴𝐹𝜆𝐴𝐴 + 𝑛𝐴,𝑒𝑥𝑄𝐴𝐹𝜆𝐴𝐴 + 𝑛𝐷,𝑒𝑥𝑄𝐷(1 − 𝐸)𝐹𝜆𝐴𝐷
𝑛𝐷,𝑒𝑥𝑄𝐷(1 − 𝐸)𝐹𝜆𝐷𝐷
 
To simplify this expression, the number of direct acceptor excitation events 𝑛𝐴,𝑒𝑥can be 
expressed in terms of those of the donor with the newly-defined conversion factor 𝑋𝐴: 
𝑛𝐴,𝑒𝑥 = 𝑋𝐴𝑛𝐷,𝑒𝑥 
Substituting this into the ratio expression: 
𝑟𝑎𝑡𝑖𝑜 =  
𝑛𝐷,𝑒𝑥𝐸 𝑄𝐴𝐹𝜆𝐴𝐴 + 𝑋𝐴𝑛𝐷,𝑒𝑥𝑄𝐴𝐹𝜆𝐴𝐴 + 𝑛𝐷,𝑒𝑥𝑄𝐷(1 − 𝐸)𝐹𝜆𝐴𝐷
𝑛𝐷,𝑒𝑥𝑄𝐷(1 − 𝐸)𝑆𝜆𝐷𝐷
 
𝑟𝑎𝑡𝑖𝑜 =  
𝐸 𝑄𝐴𝐹𝜆𝐴𝐴
𝑄𝐷(1 − 𝐸)𝐹𝜆𝐷𝐷
+
𝑋𝐴𝑄𝐴𝐹𝜆𝐴𝐴
𝑄𝐷(1 − 𝐸)𝐹𝜆𝐷𝐷
+
𝐹𝜆𝐴𝐷
𝐹𝜆𝐷𝐷
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Define 𝐴 and 𝐵 to simplify calculation. These are composed only of variables kept 
constant over the course of an experiment, all of which can eventually be consolidated 
into a single “fudge factor” 𝑆: 
𝐴 =
𝑄𝐷𝐹𝜆𝐴𝐷
𝑄𝐴𝐹𝜆𝐴𝐴
 
𝐵 =
𝑄𝐴𝐹𝜆𝐴𝐴
𝑄𝐷𝐹𝜆𝐷𝐷
 
∴ 𝐴𝐵 =
𝐹𝜆𝐴𝐷
𝐹𝜆𝐷𝐷
 
𝑆 =
1 − 𝐴
𝑋𝐴 + 1
=
𝑄𝐴𝐹𝜆𝐴𝐴 − 𝑄𝐷𝐹𝜆𝐴𝐷
𝑄𝐴𝐹𝜆𝐴𝐴(𝑋𝐴 + 1)
=
1 −
𝑄𝐷𝐹𝜆𝐴𝐷
𝑄𝐴𝐹𝜆𝐴𝐴
𝜀𝐴,𝑒𝑥
𝜀𝐷,𝑒𝑥
+ 1
 
𝑟𝑎𝑡𝑖𝑜 =  
𝐸 𝑄𝐴𝐹𝜆𝐴𝐴
𝑄𝐷(1 − 𝐸)𝐹𝜆𝐷𝐷
+
𝑋𝐴𝑄𝐴𝐹𝜆𝐴𝐴
𝑄𝐷(1 − 𝐸)𝐹𝜆𝐷𝐷
+
𝐹𝜆𝐴𝐷
𝐹𝜆𝐷𝐷
 
𝑟𝑎𝑡𝑖𝑜 =  
𝐸𝐵
(1 − 𝐸)
+
𝑋𝐴𝐵
(1 − 𝐸)
+ 𝐴𝐵 
𝑟𝑎𝑡𝑖𝑜 =  𝐵 (
𝐸 + 𝑋𝐴
1 − 𝐸
+ 𝐴) 
The maximum theoretical dynamic range is simply the ratio of ratios in the two extreme 
states, with the subtracted unit. Substituting and expanding: 
𝑑𝑟 =
𝐵 (
𝐸1 + 𝑋𝐴
1 − 𝐸1
+ 𝐴)
𝐵 (
𝐸0 + 𝑋𝐴
1 − 𝐸0
+ 𝐴)
− 1 
𝑑𝑟 =
𝐸1 + 𝑋𝐴
1 − 𝐸1
+ 𝐴
𝐸0 + 𝑋𝐴
1 − 𝐸0
+ 𝐴
− 1 
𝑑𝑟 =
(1 − 𝐸0)(𝐸1 + 𝑋𝐴) + 𝐴(1 − 𝐸0)(1 − 𝐸1)
(1 − 𝐸1)(𝐸0 + 𝑋𝐴) + 𝐴(1 − 𝐸0)(1 − 𝐸1)
− 1 
𝑑𝑟 =
𝐸1 + 𝑋𝐴 − 𝐸0𝐸1 − 𝐸0𝑋𝐴 + 𝐴 − 𝐴𝐸1 − 𝐴𝐸0 + 𝐴𝐸0𝐸1
𝐸0 + 𝑋𝐴 − 𝐸0𝐸1 − 𝐸1𝑋𝐴 + 𝐴 − 𝐴𝐸1 − 𝐴𝐸0 + 𝐴𝐸0𝐸1
− 1 
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𝑑𝑟
=
𝐸1 + 𝑋𝐴 − 𝐸0𝐸1 − 𝐸0𝑋𝐴 + 𝐴 − 𝐴𝐸1 − 𝐴𝐸0 + 𝐴𝐸0𝐸1 − 𝐸0 − 𝑋𝐴 + 𝐸0𝐸1 + 𝐸1𝑋𝐴 − 𝐴 + 𝐴𝐸1 + 𝐴𝐸0 − 𝐴𝐸0𝐸1
𝐸0 + 𝑋𝐴 − 𝐸0𝐸1 − 𝐸1𝑋𝐴 + 𝐴 − 𝐴𝐸1 − 𝐴𝐸0 + 𝐴𝐸0𝐸1
 
𝑑𝑟 =
𝐸1 − 𝐸0𝑋𝐴 − 𝐸0 + 𝐸1𝑋𝐴
𝐸0 + 𝑋𝐴 − 𝐸0𝐸1 − 𝐸1𝑋𝐴 + 𝐴 − 𝐴𝐸1 − 𝐴𝐸0 + 𝐴𝐸0𝐸1 + 1 − 1 + 𝐸1 − 𝐸1
 
Factorizing and simplifying: 
𝑑𝑟 =
(𝐸1 − 𝐸0)(𝑋𝐴 + 1)
𝐸0(1 − 𝐴) + (𝑋𝐴 + 1) − (1 − 𝐴) − 𝐸0𝐸1(1 − 𝐴) − 𝐸1(𝑋𝐴 + 1) + 𝐸1(1 − 𝐴)
 
𝑑𝑟 =
𝐸1 − 𝐸0
𝐸0
1 − 𝐴
𝑋𝐴 + 1
+
𝑋𝐴 + 1
𝑋𝐴 + 1
−
1 − 𝐴
𝑋𝐴 + 1
− 𝐸0𝐸1
1 − 𝐴
𝑋𝐴 + 1
− 𝐸1
𝑋𝐴 + 1
𝑋𝐴 + 1
+ 𝐸1
1 − 𝐴
𝑋𝐴 + 1
 
𝑑𝑟 =
𝐸1 − 𝐸0
𝐸0𝑆 + 1 − 𝑆 − 𝐸0𝐸1𝑆 − 𝐸1 + 𝐸1𝑆
 
𝑑𝑟 =
𝐸1 − 𝐸0
𝑆(𝐸0(1 − 𝐸1) − (1 − 𝐸1)) + 1 − 𝐸1
 
𝑑𝑟 =
𝐸1 − 𝐸0
(1 − 𝐸1)(1 + 𝑆(𝐸0 − 1))
 
To determine 𝑋𝐴, the Beer-Lambert law is used. Here 𝐼𝑖 is the intensity of incident light, 𝐼𝑡 
is the intensity of transmitted light, 𝜀 is the molar attenuation coefficient at the excitation 
wavelength (with the assumption that the excitation light is monochromatic), 𝑙 is the path 
length, and 𝑐 is the concentration: 
log10
𝐼𝑖
𝐼𝑡
= 𝜀𝑙𝑐 
𝐼𝑖 = 𝐼𝑡10
𝜀𝑙𝑐 
Substituting in the definition of intensity, remembering that there are 𝑛 photons with 
average wavelength 𝜆: 
𝜕
𝜕𝑡
(𝑛𝑖ℎ𝜆)  =
𝜕
𝜕𝑡
(𝑛𝑡ℎ𝜆) 10
𝜀𝑙𝑐 
𝑛𝑖  = 𝑛𝑡10
𝜀𝑙𝑐 
𝑛𝑡 =  
𝑛𝑖
10𝜀𝑙𝑐
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The number of absorbed photons, and hence excitation events, is the difference between 
the numbers of incident and transmitted photons: 
𝑛𝑒𝑥 = 𝑛𝑖 − 𝑛𝑡 
𝑛𝑒𝑥 = 𝑛𝑖 −
𝑛𝑖
10𝜀𝑙𝑐
 
The number of direct excitation events of the acceptor can be expressed in terms of 
those of the donor by definition of 𝑋𝐴. Solving for 𝑋𝐴: 
𝑛𝐴,𝑒𝑥 = 𝑛𝑖 −
𝑛𝑖
10𝜀𝐴𝑙𝑐
= 𝑋𝐴𝑛𝐷,𝑒𝑥 
𝑛𝐴,𝑒𝑥 = 𝑛𝑖 −
𝑛𝑖
10𝜀𝐴𝑙𝑐
= 𝑋𝐴(𝑛𝑖 −
𝑛𝑖
10𝜀𝐷𝑙𝑐
) 
1 −
1
10𝜀𝐴𝑙𝑐
= 𝑋𝐴(1 −
1
10𝜀𝐷𝑙𝑐
) 
𝑋𝐴 =
1 −
1
10𝜀𝐴𝑙𝑐
1 −
1
10𝜀𝐷𝑙𝑐
 
𝑋𝐴 =
10𝜀𝐷𝑙𝑐 −
10𝜀𝐷𝑙𝑐
10𝜀𝐴𝑙𝑐
10𝜀𝐷𝑙𝑐 − 1
 
𝑋𝐴 =
10𝜀𝐴𝑙𝑐10𝜀𝐷𝑙𝑐 − 10𝜀𝐷𝑙𝑐
10𝜀𝐴𝑙𝑐(10𝜀𝐷𝑙𝑐 − 1)
 
𝑋𝐴 =
10𝜀𝐷𝑙𝑐(10𝜀𝐴𝑙𝑐 − 1)
10𝜀𝐴𝑙𝑐(10𝜀𝐷𝑙𝑐 − 1)
 
For small 𝑙𝑐, this is approximately equal to the limit: 
𝑋𝐴 ≈ lim
𝑙𝑐→0
𝑋𝐴 =
𝜀𝐴
𝜀𝐷
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AC3.4 Scripts used for predicting dynamic ranges (written and provided by 
Joshua Mitchell, superfluous text removed) 
 
Martini_setup_multirun-rewrite.sh 
#!/bin/bash 
# martini_setup_multirun.sh, Josh Mitchell, 2015 
# Takes an input .pdb file and runs a number of simulations on 
it with different starting velocities in the Martini coarse 
grained force field 
 
# Usage: Edit the options under #config, then run in the same 
folder as $input_file 
 
#title comments from 
http://patorjk.com/software/taag/#p=display&h=0&v=0&c=bash&f=ANS
I%20Shadow&t=6-equilibration 
 
set -o errexit 
set -o nounset 
 
##################################################### 
 
input_file=atu_open_4eq7_met.pdb 
system_name="ATU-CFP-open" 
num_runs=30 
 
# I'll remove rubber bands involving these residues. Comma 
seperated list 
linker_residues="328,329,330,331,332,333,334,335,336,337,338,339
,340,341,342,343,344,345,346" 
 
desired_conc=0.2 #Desired NaCl concentration in mol/L 
 
box_type=dodecahedron # triclinic, cubic, dodecahedron, 
octahedron 
box_distance=0.5 # Distance between the solute and the box 
 
# Set prompt timeouts. -1 means wait forever: 
setup_timeout=10 # Timeout for prompt after each step during 
setup 
ind_timeout=3 # Timeout for prompt after each step during 
individual runs 
 
# Set this to true to skip grompping and mdrunning the 
production step, so you can do them seperately. 
dry_run=false 
 
md_timestep=0.02 
production_nsteps=10000000 
enermin_nsteps=1000 
equil_nsteps=50000 
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# Names for other programs 
dssp_name=mkdssp 
gromacs_name=gmx 
 
# Store a basic mdp file in the $mdp_base variable, which can be 
modified later: 
 
read -d '' -r mdp_base <<EOF || true 
; 
; STANDARD MD INPUT OPTIONS FOR MARTINI 2.x 
; Updated 02 feb 2013 by DdJ 
; 
; for use with GROMACS 4.5/4.6 
; 
 
title                    = Martini 
 
; TIMESTEP IN MARTINI 
; Most simulations are numerically stable 
; with dt=40 fs, some (especially rings and polarizable water) 
require 20-30 fs. 
; Note that time steps of 40 fs and larger may create local 
heating or 
; cooling in your system. Although the use of a heat bath will 
globally 
; remove this effect, it is advised to check consistency of 
; your results for somewhat smaller time steps in the range 20-
30 fs. 
; Time steps exceeding 40 fs should not be used; time steps 
smaller 
; than 20 fs are also not required unless specifically stated in 
the itp file. 
 
 
integrator               = md 
dt                       = $md_timestep 
nsteps                   = $production_nsteps 
nstcomm                  = 10 
comm-grps                = 
 
nstxout                  = 0 
nstvout                  = 0 
nstfout                  = 0 
nstlog                   = 1000 
nstenergy                = 100 
nstxtcout                = 1000 
xtc_precision            = 100 
xtc-grps                 = 
energygrps               = Protein non-Protein 
 
; NEIGHBOURLIST and MARTINI 
; Due to the use of shifted potentials, the noise generated 
; from particles leaving/entering the neighbour list is not so 
large, 
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; even when large time steps are being used. In practice, once 
every 
; ten steps works fine with a neighborlist cutoff that is equal 
to the 
; non-bonded cutoff (1.2 nm). However, to improve energy 
conservation 
; or to avoid local heating/cooling, you may increase the update 
frequency 
; and/or enlarge the neighbourlist cut-off (to 1.4 nm). The 
latter option 
; is computationally less expensive and leads to improved energy 
conservation 
 
nstlist                  = 10 
ns_type                  = grid 
pbc                      = xyz 
rlist                    = 1.4 
 
; MARTINI and NONBONDED 
; Standard cut-off schemes are used for the non-bonded 
interactions 
; in the Martini model: LJ interactions are shifted to zero in 
the 
; range 0.9-1.2 nm, and electrostatic interactions in the range 
0.0-1.2 nm. 
; The treatment of the non-bonded cut-offs is considered to be 
part of 
; the force field parameterization, so we recommend not to touch 
these 
; values as they will alter the overall balance of the force 
field. 
; In principle you can include long range electrostatics through 
the use 
; of PME, which could be more realistic in certain applications 
; Please realize that electrostatic interactions in the Martini 
model are 
; not considered to be very accurate to begin with, especially 
as the 
; screening in the system is set to be uniform across the system 
with 
; a screening constant of 15. When using PME, please make sure 
your 
; system properties are still reasonable. 
; 
; With the polarizable water model, the relative electrostatic 
screening 
; (epsilon_r) should have a value of 2.5, representative of a 
low-dielectric 
; apolar solvent. The polarizable water itself will perform the 
explicit screening 
; in aqueous environment. In this case, the use of PME is more 
realistic. 
; 
; For use in combination with the Verlet-pairlist algorithm 
implemented 
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; in Gromacs 4.6 a straight cutoff in combination with the 
potential 
; modifiers can be used. Although this will change the potential 
shape, 
; preliminary results indicate that forcefield properties do not 
change a lot 
; when the LJ cutoff is reduced to 1.1 nm. Be sure to test the 
effects for 
; your particular system. The advantage is a gain of speed of 
50-100%. 
 
coulombtype              = Reaction_field      ;(for use with 
Verlet-pairlist) ;PME (especially with polarizable water) ;Shift 
rcoulomb_switch          = 0.0 
rcoulomb                 = 1.1                 ;(for use with 
Verlet-pairlist) ;1.2 
epsilon_r                = 15                  ; 2.5 (with 
polarizable water) 
vdw_type                 = cutoff              ;(for use with 
Verlet-pairlist)   ;Shift 
rvdw_switch              = 0.9 
rvdw                     = 1.1                 ;(for use with 
Verlet-pairlist) ;1.2 
 
cutoff-scheme            = verlet 
coulomb-modifier         = Potential-shift 
vdw-modifier             = Potential-shift 
epsilon_rf               = 0                   ; epsilon_rf = 0 
really means epsilon_rf = infinity 
verlet-buffer-drift      = 0.005 
 
; MARTINI and TEMPERATURE/PRESSURE 
; normal temperature and pressure coupling schemes can be used. 
; It is recommended to couple individual groups in your system 
separately. 
; Good temperature control can be achieved with the velocity 
rescale (V-rescale) 
; thermostat using a coupling constant of the order of 1 ps. 
Even better 
; temperature control can be achieved by reducing the 
temperature coupling 
; constant to 0.1 ps, although with such tight coupling 
(approaching 
; the time step) one can no longer speak of a weak-coupling 
scheme. 
; We therefore recommend a coupling time constant of at least 
0.5 ps. 
; The Berendsen thermostat is less suited since it does not give 
; a well described thermodynamic ensemble. 
; 
; Pressure can be controlled with the Parrinello-Rahman 
barostat, 
; with a coupling constant in the range 4-8 ps and typical 
compressibility 
; in the order of 10-4 - 10-5 bar-1. Note that, for 
equilibration purposes, 
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; the Berendsen thermostat probably gives better results, as the 
Parrinello- 
; Rahman is prone to oscillating behaviour. For bilayer systems 
the pressure 
; coupling should be done semiisotropic. 
 
tcoupl                   = v-rescale 
tc-grps                  = Protein non-Protein 
tau_t                    = 1.0  1.0 
ref_t                    = 320 320 
Pcoupl                   = parrinello-rahman   ; Set to 
'berendsen' for equilibration 
Pcoupltype               = semiisotropic 
refcoord-scaling         = no                  ; Set to 'all' or 
'com' for equilibration 
tau_p                    = 12.0 12.0           ;parrinello-
rahman is more stable with larger tau-p, DdJ, 20130422 
compressibility          = 3e-4  3e-4 
ref_p                    = 1.0  1.0 
 
gen_vel                  = no 
gen_temp                 = 320 
gen_seed                 = 473529 
 
; MARTINI and CONSTRAINTS 
; for ring systems and stiff bonds constraints are defined 
; which are best handled using Lincs. 
 
constraints              = none 
constraint_algorithm     = Lincs 
unconstrained_start      = no 
lincs_order              = 4 
lincs_warnangle          = 30 
EOF 
 
#Preliminary processing of config: 
 
starting_structure=${input_file%.pdb} 
 
if ((setup_timeout==-1)); then 
setup_timeout_options="" 
else 
setup_timeout_options="-t ${setup_timeout}" 
fi 
 
if ((ind_timeout==-1)); then 
ind_timeout_options="" 
else 
ind_timeout_options="-t ${ind_timeout}" 
fi 
 
vac_name=system-vacuum 
sol_name=system-solvated 
 
# OK, let's go 
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echo "This script will prepare a martini coarse-grained MD 
simulation on $input_file. \ 
It will then perform this simulation $num_runs times, each with 
a new, randomly generated set of initial velocities. \ 
It will download all the files it needs, all you need to do is 
configure it and provide the input .PDB 
 
It can also be used to continue a previous run built by this 
script. It uses the directory structure of \ 
the working directory to determine where to begin. It does this 
by assuming the last step performed was \ 
incomplete, but that all previous steps were completed 
successfully. For instance, if it detects that run \ 
2 has been started but run 3 has not, it will redo run 2 in its 
entirety. If run 1 has started, it will \ 
start from scratch. 
 
Bare this in mind when stopping it part way through. 
 
Timeout for setup steps is $setup_timeout, and timeout for other 
steps is $ind_timeout. A timeout of -1 \ 
means 'wait forever', so this script cannot necessarily be left 
unattended. Otherwise, the timeout is in \ 
seconds. 
" 
 
if $dry_run; then 
echo "dry_run is set, so fully equilibrated systems will be 
placed in each run folder, but no production runs will be 
performed" 
fi 
 
# Define all our functions so we can jump around 
 
################################################ 
 
function prep_visual { 
topology=$1 
trajectory=$2 
filename_out="${trajectory%.*}-vis.${trajectory##*.}" 
echo 0 | $gromacs_name trjconv -ur compact -s $topology -f 
$trajectory -o $filename_out -pbc atom  2>&1 | tee 
$filename_out.out 
} 
 
function do_setup_and_runs { 
mkdir setup 
cd setup 
 
# Keep the base .mdp for reference 
echo "$mdp_base" > base.mdp 
 
compile_topology 
read -p "Base topology constructed, press enter to Martinize" 
$setup_timeout_options || true 
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do_martinize 
read -p "Martinized, press enter to generate box" 
$setup_timeout_options || true 
do_editconf 
read -p "Box generated, press enter to run a short energy 
minimisation in vacuo" $setup_timeout_options || true 
do_vac_enermin 
read -p "Vacuum minimisation complete, press enter to continue 
with salting and solvation." $setup_timeout_options || true 
do_solvation 
read -p "Salted and solvated, check topology and 
out_af_nacl.gro. Future steps do not require internet access. 
Press enter to continue with solvent minimisation" 
$setup_timeout_options || true 
do_sol_enermin 
read -p "Solvent minimisation complete. Press enter to continue 
with equilibration" $setup_timeout_options || true 
do_equilibrate 
cd .. 
read -p "Equilibration complete. Press enter to begin individual 
runs." $setup_timeout_options || true 
do_ind_runs_loop 1 $num_runs 
} 
 
 
function compile_topology { 
## Download and configure the martini forcefield parameters 
mkdir topology 
cd topology 
wget 
http://md.chem.rug.nl/cgmartini/images/parameters/ITP/martini_v2
.1.itp 
 
cat >martini.itp <<EOF 
; First include the file containing all particle definitions, 
; the interaction matrix, plus the topology for water. 
 
#include "martini_v2.1.itp" 
 
; Then include the file(s) containing the topologies of other 
; molecules present in your system. 
 
EOF 
 
# Comment out what you don't need 
 
# Amino acids 
wget 
http://md.chem.rug.nl/cgmartini/images/parameters/ITP/martini_v2
.1_aminoacids.itp 
echo '#include "martini_v2.1_aminoacids.itp"' >> martini.itp 
 
# ions 
wget 
http://md.chem.rug.nl/cgmartini/images/parameters/ITP/martini_v2
.0_ions.itp 
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echo '#include "martini_v2.0_ions.itp"' >> martini.itp 
 
 
# Finish it off 
echo " 
 
; Define a name for your system 
 
[ system ] 
$system_name" >> martini.itp 
 
cd .. 
 
} 
 
################################################################ 
 
# Generate structure and topology with Martinize 
function do_martinize { 
mkdir 1-martinize 
cd 1-martinize 
wget http://www.cgmartini.nl/images/tools/martinize/martinize-
2.5/martinize.py 
python martinize.py -f ../../$starting_structure.pdb -o 
$vac_name.top -x $starting_structure-cg.pdb -dssp $dssp_name -p 
backbone -ff martini21 -nt -elastic -ef 500 -el 0.5 -eu 0.9 -ea 
0 -ep 0 2>&1 | tee martinize.out 
# Remove unwanted elastic bands 
for itp in *.itp; do 
gawk -v pdb_filename="$starting_structure-cg.pdb" -v 
resis_to_unband="$linker_residues" ' 
FILENAME == pdb_filename && match($0, /ATOM +([0-9]+) +[A-Z0-9]+ 
+[A-Z]{3} . *([0-9]+) +([\-.0-9]+ +){3}/, ary) && 
match(resis_to_unband,"(^|,) *"ary[2]" *(,|$)") 
{atoms_to_unband[ary[1]]=1} 
FILENAME != pdb_filename && match($0, / +([0-9]+) +([0-9]+) +[0-
9]+ +[\-.0-9]+ RUBBER_FC\*1\.000000/, ary) && (ary[1] in 
atoms_to_unband || ary[2] in atoms_to_unband) {next} 
FILENAME != pdb_filename {print $0} 
' $starting_structure-cg.pdb $itp > ../topology/$itp 
done 
cp *.top ../topology/ 
cd .. 
} 
################################################################ 
 
# Generate a box 
function do_editconf { 
mkdir 2-editconf 
cd 2-editconf 
$gromacs_name editconf -f ../1-martinize/$starting_structure-
cg.pdb -o $starting_structure-cg-box.gro -bt $box_type -d 
$box_distance 2>&1 | tee editconf.out 
cd .. 
} 
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################################################################ 
 
# Run a short in vacuo energy minimisation 
function do_vac_enermin { 
mkdir 3-vacuum_ener_min 
cd 3-vacuum_ener_min 
 
# Write out an mdp for in vacuo energy minimisation 
 
echo "$mdp_base" | gawk -v numsteps=$enermin_nsteps ' 
BEGIN {FS="= "} 
$1 ~ /integrator +/ {print $1 "= steep"; next} 
$1 ~ /nsteps +/ {print $1 "= " numsteps; next} 
$1 ~ /tc-grps +/ {print $1 "= Protein"; next} 
$1 ~ /energygrps +/ {print $1 "= Protein"; next} 
$1 ~ /tau_t +/ {print $1 "= 1.0"; next} 
$1 ~ /ref_t +/ {print $1 "= 320"; next} 
{print} 
' > 3-vacuum_ener_min.mdp 
$gromacs_name make_ndx -f ../2-editconf/$starting_structure-cg-
box.gro -o vac.ndx <<EOF 
q 
EOF 
$gromacs_name grompp -f 3-vacuum_ener_min.mdp -p 
../topology/$vac_name.top -c ../2-editconf/$starting_structure-
cg-box.gro -n vac.ndx 2>&1 | tee grompp.out 
$gromacs_name mdrun -v 2>&1 | tee mdrun.out 
 
#for visualisation 
prep_visual topol.tpr ../2-editconf/$starting_structure-cg-
box.gro 
 
cd .. 
} 
################################################################ 
 
# Solvate the box 
function do_solvation { 
mkdir 4-solvate 
cp topology/$vac_name.top topology/$sol_name.top 
cd 4-solvate 
 
wget 
http://md.chem.rug.nl/cgmartini/images/applications/water/water.
gro 
 
$gromacs_name solvate -cs water.gro -cp ../3-
vacuum_ener_min/confout.gro -radius 0.21 2>&1 | tee solvate.out 
 
# generate a freezing water only topology 
# genion apparently only works on molecule types and doesn't 
read indexes, so this is necessary 
cp ../topology/$sol_name.top ../topology/water-$sol_name.top 
echo " 
W            $(grep "\d*W *W" out.gro -c)" >> ../topology/water-
$sol_name.top 
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# Calculate the number of NaCl formula units to add to the box 
 
# Concentration (mol/L) of water in pure water 
water_molarity=55.5 
 
# Get the number of waters from the structure file 
number_waters=$(grep "\d*W *W" out.gro -c) 
 
# 4 is because CG waters represent 4 real waters 
# bash truncates; using python for correct maths 
nacl_to_add=$(python -c "print int((4 * $desired_conc * 
$number_waters) / $water_molarity)") 
 
 
#convert the calculated number of waters to ions 
#first generate a .tpr because genion is cool like that 
cat >ions.mdp <<EOF 
; ions.mdp - used as input into grompp to generate ions.tpr 
integrator  = steep     ; Algorithm (steep = steepest descent 
minimization) 
emtol       = 1000.0    ; Stop minimization when the maximum 
force < 1000.0 kJ/mol/nm 
emstep      = 0.01      ; Energy step size 
nsteps      = 50000     ; Maximum number of (minimization) steps 
to perform 
nstlist     = 1         ; Frequency to update the neighbor list 
and long range forces 
ns_type     = grid      ; Method to determine neighbor list 
(simple, grid) 
rlist       = 1.0       ; Cut-off for making neighbor list 
(short range forces) 
coulombtype = PME       ; Treatment of long range electrostatic 
interactions 
rcoulomb    = 1.0       ; Short-range electrostatic cut-off 
rvdw        = 1.0       ; Short-range Van der Waals cut-off 
pbc         = xyz       ; Periodic Boundary Conditions (yes/no) 
EOF 
$gromacs_name grompp -f ions.mdp -c out.gro -p 
../topology/water-$sol_name.top -o ions.tpr 2>&1 | tee 
grompp.out 
 
# Run genion to salt and neutralise the solution 
# Genion isn't happy with '+'s in ion names, so we'll leave it 
with the default NA and CL and change it later 
echo 13 | $gromacs_name genion -s ions.tpr -o out_nacl.gro -p 
../topology/water-$sol_name.top -np $nacl_to_add -nn 
$nacl_to_add -neutral 2>&1 | tee genion.out 
 
#can delete that water-* topology now, along with the backup 
genion made 
rm ../topology/water-$sol_name.top 
rm ../topology/#water-$sol_name.top.1# 
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# Convert every tenth water to antifreeze water in the structure 
file, then move those records to the bottom of the file because 
the order is sensitive for the topology 
# Meanwhile, change NA to NA+ and CL to CL-, because genion 
won't and martini is wierd, but leave them in place 
gawk 'BEGIN {n=0; OFS = ""; Footer[0]=""} 
/ *\d*W *W.*/ {n=n+1;} 
match($0, /( *[0-9]*)(W )( *)( W)(.*)/, ary) && n==10 
{Footer[length(Footer) + 1] = ary[1]"WF"ary[3]"WF"ary[5]; n=0; 
next} 
match($0, /( *[0-9]*)(NA )( *)( NA)(.*)/, ary) {print 
ary[1]"NA+"ary[3]"NA+"ary[5]; next} 
match($0, /( *[0-9]*)(CL )( *)( CL)(.*)/, ary) {print ary[1]"CL-
"ary[3]"CL-"ary[5]; next} 
/^ *([0-9.]+ +){2,8}[0-9.]+$/ {Footer[length(Footer) + 1]=$0; 
next} 
$0 != "" {print $0} 
END {for (i=2;i<=length(Footer);i++) 
print Footer[i] 
}' out_nacl.gro > out_af_nacl.gro 
 
 
# Update the topology with solvent and ions 
# Order is sensitive 
echo " 
W            $(grep "\d*W *W" out_af_nacl.gro -c)" >> 
../topology/$sol_name.top 
echo "NA+          $(grep "\d*NA+ *NA" out_af_nacl.gro -c)" >> 
../topology/$sol_name.top 
echo "CL-          $(grep "\d*CL- *CL" out_af_nacl.gro -c)" >> 
../topology/$sol_name.top 
echo "WF           $(grep "\d*WF *WF" out_af_nacl.gro -c)" >> 
../topology/$sol_name.top 
 
# Build a new index that actually makes sense for course-grained 
simulation 
$gromacs_name make_ndx -f out_af_nacl.gro <<EOF 
del 10 
del 9 
del 8 
del 7 
del 6 
del 5 
del 4 
del 3 
del 2 
q 
EOF 
 
cd .. 
} 
 
################################################################ 
 
# Solvent energy minimisation 
function do_sol_enermin { 
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mkdir 5-solvent_ener_min 
cd 5-solvent_ener_min 
 
# Write out an mdp for solvated energy minimisation 
 
echo "$mdp_base" | gawk -v numsteps=$enermin_nsteps ' 
BEGIN {FS="= "} 
$1 ~ /integrator +/ {print $1 "= steep"; next} 
$1 ~ /nsteps +/ {print $1 "= " numsteps; next} 
{print} 
' > 5-solvent_ener_min.mdp 
 
$gromacs_name grompp -f 5-solvent_ener_min.mdp -p 
../topology/$sol_name.top -c ../4-solvate/out_af_nacl.gro -n 
../4-solvate/index.ndx 2>&1 | tee grompp.out 
$gromacs_name mdrun -v 2>&1 | tee mdrun.out 
 
#for visualisation 
prep_visual topol.tpr confout.gro 
 
cd .. 
} 
 
################################################################ 
 
function do_equilibrate { 
mkdir 6-equilibration 
cd 6-equilibration 
cp ../4-solvate/index.ndx index.ndx 
 
# Generating velocities and running 5-10 steps MD unrestrained 
before continuing. 
 
echo "$mdp_base" | gawk -v randvar=$RANDOM ' 
BEGIN {FS="= "} 
$1 ~ /nsteps +/ {print $1 "= 10"; next} 
$1 ~ /Pcoupl +/ {print $1 "= berendsen"; next} 
$1 ~ /refcoord-scaling +/ {print $1 "= all"; next} 
$1 ~ /gen_vel +/ {print $1 "= yes"; next} 
{print} 
' > 6-quickmd.mdp 
 
# Write out an mdp for restrained protein equilibration 
 
prev_force_constant="" 
$gromacs_name grompp -f 6-quickmd.mdp -p ../topology/system-
solvated.top -c ../5-solvent_ener_min/confout.gro -n index.ndx -
o out_$prev_force_constant 2>&1 | tee grompp.out 
$gromacs_name mdrun -v -deffnm out_$prev_force_constant 2>&1 | 
tee mdrun.out 
for force_constant in 1000.0 500.0 100.0 50.0 10.0; do 
# Generate an MDP for this equilibration: 
echo "$mdp_base" | gawk -v numsteps=$equil_nsteps ' 
BEGIN {FS="= "} 
$1 ~ /nsteps +/ {print $1 "= " numsteps; next} 
$1 ~ /Pcoupl +/ {print $1 "= berendsen"; next} 
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$1 ~ /refcoord-scaling +/ {print $1 "= all"; next} 
{print} 
' > 6-equilibration_${force_constant}.mdp 
echo "define                   = -DPOSRES -
DPOSRES_FC=${force_constant}" >> 6-
equilibration_${force_constant}.mdp 
 
# Run the equilibration/relaxation 
$gromacs_name grompp -f 6-equilibration_${force_constant}.mdp -p 
../topology/system-solvated.top -c out_$prev_force_constant.gro 
-n index.ndx -o out_$force_constant 2>&1 | tee 
grompp$force_constant.out 
$gromacs_name mdrun -v -deffnm out_$force_constant 2>&1 | tee 
mdrun$force_constant.out 
 
prev_force_constant=$force_constant 
done 
 
cp out_${prev_force_constant}.gro production_ready.gro 
cd .. 
} 
 
# Setup is now complete, start iterating through runs 
 
function do_ind_run { 
n=$1 
echo "" 
echo "Beginning run $n" 
echo "" 
 
mkdir run${n} 
cd run${n} 
cp -r ../setup/topology topology 
rm topology/$vac_name.top 
mv topology/$sol_name.top topology/system.top 
cp ../setup/4-solvate/index.ndx index.ndx 
cp ../setup/6-equilibration/production_ready.gro 
run${n}_genvel_start.gro 
 
# Equilibration has been moved to setup 
#do_equilibrate 
read -p "Press enter to begin velocity generation for run $n"  
$ind_timeout_options || true 
 
 
################################################################ 
 
# Generate an MDP for a individual velocity generation, and 
final relaxation without posres: 
echo "$mdp_base" | gawk -v numsteps=$equil_nsteps -v 
randvar=$RANDOM$RANDOM ' 
BEGIN {FS="= "} 
$1 ~ /nsteps +/ {print $1 "= " numsteps; next} 
$1 ~ /Pcoupl +/ {print $1 "= berendsen"; next} 
$1 ~ /refcoord-scaling +/ {print $1 "= all"; next} 
$1 ~ /gen_vel +/ {print $1 "= yes"; next} 
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$1 ~ /gen_seed +/ {print $1 "= " randvar; next} 
{print} 
' > 6-equilibration_noposres.mdp 
 
$gromacs_name grompp -f 6-equilibration_noposres.mdp -p 
topology/system.top -c run${n}_genvel_start.gro -n index.ndx -o 
run${n}_production_start.tpr 2>&1 | tee grompp_noposres.out 
$gromacs_name mdrun -v -deffnm run${n}_production_start 2>&1 | 
tee mdrun_equil.out 
# Write out an mdp for the production run - $mdp_base has 
gen_vel on! 
echo "$mdp_base" > run${n}_production.mdp 
 
if ! $dry_run; then 
read -p "Press enter to begin production run $n"  
$ind_timeout_options || true 
$gromacs_name grompp -f run${n}_production.mdp -c 
run${n}_production_start.gro -p topology/system.top -o 
run${n}_production.tpr 2>&1 | tee grompp${n}.out 
$gromacs_name mdrun -v -s -deffnm run${n}_production 2>&1 | tee 
mdrun${n}.out 
 
prep_visual run${n}_production.tpr run${n}_production.gro 
prep_visual run${n}_production.tpr run${n}_production.xtc 
prep_visual run${n}_production.tpr run${n}_production_start.gro 
fi 
 
cd .. 
 
} 
 
######################################### 
 
function do_ind_runs_loop { 
for i in $(seq $1 $2); do 
do_ind_run $i 
# Make the next directory to mark completion so that progress 
isn't lost if user quits at prompt 
mkdir run$[i+1] 
read -p "Run $i complete! Press enter to begin next run."  
$ind_timeout_options || true 
# Remove the directory because the next run will make it for you 
rmdir run$[i+1] 
done 
} 
 
if [ ! -d "setup" ]; then # If setup hasn't been completed, 
start with it 
# Count the number of directories whose names start in run 
# Just need this so we don't have problems later with pre-
existing folders 
count=`ls -1 run* 2>/dev/null | wc -l` 
if [ $count != 0 ]; then 
read -p "Press enter to delete all directories named 'run*' and 
begin setup." $setup_timeout_options || true 
rm -r run* 
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else 
read -p "Press enter to begin setup." $setup_timeout_options || 
true 
fi 
do_setup_and_runs 
elif [ ! -d "run1" ]; then # If setup is done, but run1 isn't, 
redo setup 
read -p "Press enter to restart setup." $setup_timeout_options 
|| true 
rm -r setup 
do_setup_and_runs 
else # If setup and at least 1 run has started, restart the last 
run and go from there 
for j in $(seq 2 $num_runs); do # Iterate over existing runs 
if [ ! -d "run$j" ]; then # until you find a directory that's 
missing, then restart the previous run 
read -p "Press enter to restart run $[j-1]. This will delete any 
folders named run$[j-1] through to run$num_runs in the working 
directory." $setup_timeout_options || true 
# Delete runs from the last one onward 
rm -r run$[j-1] 
for k in $(seq $[j+1] $num_runs); do 
if [ -d "run$k" ]; then 
rm -r run$k 
fi 
done 
do_ind_runs_loop $[j-1] $num_runs 
break 
fi 
done 
fi 
 
echo "$num_runs runs complete!" 
 
pickleize-all.bash 
 
#! /bin/bash 
 
set -o errexit 
set -o nounset 
 
for run in ../run*; do 
num=${run##*"run"} 
input_trajectory=${run}/run${num}_production-vis.xtc 
input_runfile=${run}/run${num}_production.tpr 
 
input_start=run${num}_production_start-vis 
input_end=run${num}_production-vis 
 
index_file=index.ndx 
temp_xtc=pbcnojump_temp_${num}.xtc 
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output_xtc=run${num}_protein_fitted.xtc 
 
rms_file=run${num}_rms.xvg 
 
cg_pdb_out=cg_traj${num}.pdb 
 
pdb_dt=1000 
equilibrated_time=150000 
end_time=200000 
 
echo 1 | gmx51 trjconv -f $input_trajectory -o $temp_xtc -s 
$input_runfile -n $index_file -pbc nojump -dt $pdb_dt  -b 
$equilibrated_time -e $end_time 
echo "1 1" | gmx51 trjconv -f $temp_xtc -o $cg_pdb_out -s 
$input_runfile -n $index_file -fit rot+trans -conect 
 
rm $temp_xtc 
done 
 
Pickleprocessall.py (Pickleize-all.py + import_data.py + process_pickle.py, in 
order) 
 
import numpy 
import math 
import glob 
import time 
import re 
import cPickle as pickle 
 
#Configuration 
 
# Define names of each set of structures to compare 
structures_to_load=glob.glob('./*.pdb') 
 
# Define the residues you want to test 
# Finds by line-by-line regex searching 
residues_to_check = range(24,334) 
 
# Set the name for the output file 
pickle_filename="sim.pickle" 
 
calc_data = dict() 
 
total_coords = 0 
total_time = 0 
 
def subtract_vector(first, second): 
output=[] 
for i in range(len(first)): 
output.append(first[i] - second[i]) 
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return output 
 
def vector_magnitude(vector): 
sum_squares=0 
for n in vector: 
sum_squares += n**2 
return math.sqrt(sum_squares) 
 
 
def angle_between_vectors(first, second): 
dot_product = float(numpy.dot(first,second)) 
magnitude_first = float(vector_magnitude(first)) 
magnitude_second = float(vector_magnitude(second)) 
# round the result to avoid floating point errors 
return math.acos(round(dot_product/(magnitude_first * 
magnitude_second),14)) 
 
def calculate_geom(donor_end, donor_start, acceptor_end, 
acceptor_start): 
donor_dipole = subtract_vector(donor_end, donor_start) 
acceptor_dipole = subtract_vector(acceptor_end, acceptor_start) 
donor_acceptor_path = subtract_vector(acceptor_start, 
donor_start) 
 
theta = dict() 
theta['t'] = angle_between_vectors(donor_dipole, 
acceptor_dipole) 
theta['a'] = angle_between_vectors(acceptor_dipole, 
donor_acceptor_path) 
theta['d'] = angle_between_vectors(donor_dipole, 
donor_acceptor_path) 
 
#Convert all angles to acute positive angles 
theta_deg = dict() 
for index in theta: 
theta[index] = abs(theta[index]) 
if theta[index] > math.pi: 
theta[index] = math.pi - theta[index] 
theta_deg[index] = theta[index]*(360/(2*math.pi)) 
 
kappa_squared = (math.cos(theta['t']) - (3.0 * 
math.cos(theta['a']) * math.cos(theta['d'])))**2 
#kappa_squared = float(2)/3 
r = vector_magnitude(donor_acceptor_path) 
 
return ((donor_end, donor_start, acceptor_end, acceptor_start), 
(donor_dipole, acceptor_dipole, donor_acceptor_path), 
theta, theta_deg, kappa_squared, r) 
 
 
def get_coords_from_line(line): 
x = float(line[30:38]) 
y = float(line[38:46]) 
z = float(line[46:54]) 
return (x,y,z) 
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def load_structure(structure, dipoles, regex): 
this_coords = 0 
coords_count=dict() 
coords = dict() 
for quartet in dipoles: 
coords[quartet] = dict() 
for pattern in quartet: 
coords[quartet][pattern] = [] 
coords_count[pattern] = 0 
 
print("Loading " + str(structure) + "...") 
start = time.clock() 
open_file = open(structure) 
#THIS STEP IS SLOOOOOW 
for line in open_file: 
for pattern in regex: 
if regex_patterns[pattern].search(line): 
this_coords += 1 
coords_count[pattern] += 1 
for quartet in coords: 
if pattern in quartet: 
coords[quartet][pattern].append(get_coords_from_line(line)) 
 
open_file.close() 
end = time.clock() 
 
#print dipoles 
#print coords 
 
model_coordinates = dict() 
model_efficiencies = dict() 
mean_model_efficiencies = dict() 
for quartet in dipoles: 
model_coordinates[quartet] = zip(coords[quartet][quartet[0]], 
coords[quartet][quartet[1]], coords[quartet][quartet[2]], 
coords[quartet][quartet[3]]) 
# print "quartet[0]" 
# print coords[quartet][quartet[0]] 
# print "quartet[1]" 
# print coords[quartet][quartet[1]] 
# print "quartet[2]" 
# print coords[quartet][quartet[2]] 
# print "quartet[3]" 
# print coords[quartet][quartet[3]] 
# print len(model_coordinates[quartet]) 
model_efficiencies[quartet] = [] 
for coordinates in model_coordinates[quartet]: 
calc_data[(quartet,len(model_efficiencies[quartet]),structure)] 
= calculate_geom(*coordinates) 
 
global total_coords 
global total_time 
 
this_time = end - start 
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total_coords += this_coords 
total_time  += this_time 
 
print("Loaded " + str(this_coords) + " co-ordinates in " + 
str(this_time) + " seconds.\n") 
 
def load_all_structures(structures, dipoles, regex): 
structure_efficiencies = dict() 
 
for structure in structures: 
load_structure(structure, dipoles, regex) 
 
all_dipoles = [] 
dipole_definitions = dict() 
regex_patterns = dict() 
#for quartet in dipole_definitions: 
for resi in residues_to_check: 
quartet = (r"BB  TRP . 404 ", r"BB  GLY . 405 ", r"BB  ... . +" 
+ str(resi) + " +", r"BB  ... . +" + str(resi+1) + " +") 
dipole_definitions[quartet] = resi 
all_dipoles.append(quartet) 
for pattern in quartet: 
if pattern not in regex_patterns: 
regex_patterns[pattern] = re.compile(pattern) 
print pattern, regex_patterns[pattern], resi 
 
for structure in structures_to_load: 
load_structure(structure, all_dipoles, regex_patterns) 
 
pickle_file = open(pickle_filename, "w") 
pickle.dump((dipole_definitions,calc_data), pickle_file) 
pickle_file.close() 
print "Finished in " + str(total_time) + " seconds." 
print "Read " + str(total_coords) + " co-ordinates." 
print "Data saved to file: " + pickle_filename 
 
 
import cPickle as pickle 
 
(dipole_definitions,calc_data) = pickle.load(open("sim.pickle", 
"r")) 
# print (dipole_definitions,calc_data) 
 
 
coordinates = dict() 
vectors = dict() 
theta = dict() 
theta_deg = dict() 
kappa_squared = dict() 
r = dict() 
for index in calc_data: 
a,b,c = index 
newmeta = (dipole_definitions[a],b,c) 
(coordinates[newmeta], vectors[newmeta], 
theta[newmeta], theta_deg[newmeta], 
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kappa_squared[newmeta], r[newmeta])                = 
calc_data[index] 
 
from numpy import mean, sqrt, square, log, pi 
 
def is_key_open(key): 
return key[2][2:6] == "open" 
 
def is_key_closed(key): 
return key[2][2:8] == "closed" 
 
def average_by_sensor(variable,mutation,returnnum): 
varlist=dict() 
varlist[1] = [] 
varlist[2] = [] 
for key in variable: 
if key[0] == mutation: 
if is_key_open(key): 
varlist[1].append(variable[key]) 
if is_key_closed(key): 
varlist[2].append(variable[key]) 
return (mean(varlist[returnnum])) 
 
def calculate_FRET_efficiency_geom(donor_end, donor_start, 
acceptor_end, acceptor_start): 
donor_dipole = subtract_vector(donor_end, donor_start) 
acceptor_dipole = subtract_vector(acceptor_end, acceptor_start) 
donor_acceptor_path = subtract_vector(acceptor_start, 
donor_start) 
 
theta = dict() 
theta['t'] = angle_between_vectors(donor_dipole, 
acceptor_dipole) 
theta['a'] = angle_between_vectors(acceptor_dipole, 
donor_acceptor_path) 
theta['d'] = angle_between_vectors(donor_dipole, 
donor_acceptor_path) 
 
#Convert all angles to acute positive angles 
for index in theta: 
theta[index] = abs(theta[index]) 
if theta[index] > math.pi: 
theta[index] = math.pi - theta[index] 
 
kappa = math.cos(theta['t']) - (3.0 * math.cos(theta['a']) * 
math.cos(theta['d'])) 
 
r = vector_magnitude(donor_acceptor_path) 
r_nought = fret_constant * ((kappa ** 2)**(1/float(6))) 
efficiency = 1/(1+(r/r_nought)**6) 
 
return efficiency 
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def calculate_FRET_efficiency(r, kappa2, j, Qd): 
RefractiveIndex = 1.4; 
AvogadrosNumber = 6.0221413*(10**23); 
r_nm = r/10 
r_nought = 
(10**7)*((9000*Qd*log(10)*kappa2*j)/(128*pi**5*RefractiveIndex**
4*AvogadrosNumber))**(1/float(6)) 
efficiency = 1/(1+(r_nm/r_nought)**6) 
 
return efficiency 
 
 
def dynamic_range(efficiency_bound, efficiency_apo, fudge): 
dynamic_range = (efficiency_bound - efficiency_apo)/((1 - 
efficiency_bound)*(1 + (fudge * (efficiency_apo - 1)))) 
#fudge ~ 0.7 for CFP-Venus or CFP-OG488 
#fudge ~ 0.816191 for CFP-AF532 
return dynamic_range 
 
def recalculate_efficiencies_all(r, mutation, kappa, j, Qd): 
varlist=dict() 
varlist[1] = [] 
varlist[2] = [] 
for key in r: 
if key[0] == mutation: 
if isinstance(kappa,dict): 
if is_key_open(key): 
varlist[1].append(calculate_FRET_efficiency(r[key], kappa[key], 
j, Qd)) 
if is_key_closed(key): 
varlist[2].append(calculate_FRET_efficiency(r[key], kappa[key], 
j, Qd)) 
else: 
if is_key_open(key): 
varlist[1].append(calculate_FRET_efficiency(r[key], kappa**2, j, 
Qd)) 
if is_key_closed(key): 
varlist[2].append(calculate_FRET_efficiency(r[key], kappa**2, j, 
Qd)) 
 
return (mean(varlist[1]), mean(varlist[2])) 
 
def recalculate_dr_all(r, mutation, kappa, j, Qd, fudge): 
(efficiency_apo, efficiency_bound) = 
recalculate_efficiencies_all(r, mutation, kappa, j, Qd) 
out = dynamic_range(efficiency_bound, efficiency_apo, fudge) 
return out 
 
def get_all_dr(r,kappa,j,Qd,fudge): 
drs=dict() 
for key in r: 
mutation = key[0] 
if mutation not in drs: 
drs[mutation] = recalculate_dr_all(r, mutation, kappa, j, Qd, 
fudge) 
return drs 
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def subtract_vector(first, second): 
output=[] 
for i in range(len(first)): 
output.append(first[i] - second[i]) 
return output 
 
def vector_magnitude(vector): 
sum_squares=0 
for n in vector: 
sum_squares += n**2 
return sqrt(sum_squares) 
 
def get_data(r,kappa,j,Qd,fudge): 
#for AF532-CFP, run: 
#import process_pickle as pp 
#pp.get_data(r,kappa_squared, 2*10**(-13),0.4,0.816191) 
dr_fixedkappa = get_all_dr(r,sqrt(2/float(3)),j,Qd,fudge) 
dr_varkappa = get_all_dr(r,kappa,j,Qd,fudge) 
print("residue,kappa^2=2/3,estimated kappa,r_open,r_closed") 
r_open = dict() 
r_closed = dict() 
mutations = [] 
for key in r: 
mutation = key[0] 
if mutation not in mutations: 
mutations.append(mutation) 
r_open[mutation] = [] 
r_closed[mutation] = [] 
if is_key_open(key): 
r_open[mutation].append(r[key]) 
if is_key_closed(key): 
r_closed[mutation].append(r[key]) 
mutations = sorted(mutations) 
for mutation in mutations: 
if mutation in r_open and mutation in r_closed: 
r_open[mutation] = mean(r_open[mutation]) 
r_closed[mutation] = mean(r_closed[mutation]) 
print(str(mutation)+","+str(dr_fixedkappa[mutation])+","+str(dr_
varkappa[mutation])+","+str(r_open[mutation])+","+str(r_closed[m
utation])) 
elif mutation in r_open: 
del r_closed[mutation] 
else: 
del r_open[mutation] 
 
def get_single_traj_residuedistances(coordinates,traj): 
matching_coords_closed = dict() 
matching_coords_open = dict() 
for key in coordinates: 
i=0 
matches=False 
for num in str(traj): 
if key[2][13+i] != num: 
break 
i+=1 
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if i==len(str(traj)): 
matches=True 
if matches: 
if is_key_open(key): 
matching_coords_open[key[0]]=key 
if is_key_closed(key): 
matching_coords_closed[key[0]]=key 
 
muta_distances = dict() 
for mutation in matching_coords_closed: 
if mutation not in matching_coords_open: 
continue 
closed_key = matching_coords_closed[mutation] 
open_key = matching_coords_open[mutation] 
muta_distances[mutation] = 
vector_magnitude(subtract_vector(coordinates[closed_key][2],coor
dinates[open_key][2])) 
return muta_distances 
 
CHAPTER 4 APPENDIX 
 
AC4.1 Matlab script used to obtain ECFP/Venus ratios 
% 20/08/15 included subtraction of dark count 
% July 15: MH adds ratio being copied to clipboard 
 
%% run to load file, frame scanned FLIM data, analyses photon 
counts in both channels (1 and 2) and calculates the ratio 
d = ptu_read('ptu_lastfile', false); 
p = config('sweep_or_frame', true,'frame_binning', true); 
d = ptu_decode_xyf(d, p.sweep_or_frame); 
 
%% select pixel from binned data, 1st ROI for actual data (cyan), 
2nd ROI for background 
figure(); 
while true 
subplot(3, 3, 1); 
im_overview = ptu_image(d, 1, 1); 
imagesc(im_overview); 
 
subplot(3, 3, 2); 
im_overview = ptu_image(d, 1, 2); 
imagesc(im_overview); 
 
 
h = imrect(); 
setColor(h, 'c') 
wait(h); 
roi = getPosition(h); 
 
%    h = imrect(); 
%    setColor(h, 'r') 
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%    wait(h); 
%    bkg = getPosition(h); 
 
p.binning = 1; 
 
pselect = find(d.channel == 1); % get photons for channel 1 
pselect = pselect(find(d.px(pselect) > p.binning * roi(1) & 
d.px(pselect) < p.binning * (roi(1) + roi(3)))); % select photons 
within x range 
pselect = pselect(find(d.py(pselect) > p.binning * roi(2) & 
d.py(pselect) < p.binning * (roi(2) + roi(4)))); % select photons 
within y range 
%    pselect = pselect(find(d.pdt(pselect) > 0.8e-9 & 
d.pdt(pselect) < 10.0e-9)); 
pchannel1 = pselect; 
pchannel1dark = pselect(find(d.pdt(pselect) > 11.5e-9 & 
d.pdt(pselect) < 12.5e-9));   %determine dark count within ROI 
within 1 ns 
 
 
 
%    pselect = find(d.channel == 1); % get photons for channel 1, 
background 
%    pselect = pselect(find(d.px(pselect) > p.binning * bkg(1) & 
d.px(pselect) < p.binning * (bkg(1) + bkg(3)))); % select photons 
within x range 
%    pselect = pselect(find(d.py(pselect) > p.binning * bkg(2) & 
d.py(pselect) < p.binning * (bkg(2) + bkg(4)))); % select photons 
within y range 
%    pchannel1b = pselect; 
 
pselect = find(d.channel == 2); % get photons for channel 2 
pselect = pselect(find(d.px(pselect) > p.binning * roi(1) & 
d.px(pselect) < p.binning * (roi(1) + roi(3)))); % select photons 
within x range 
pselect = pselect(find(d.py(pselect) > p.binning * roi(2) & 
d.py(pselect) < p.binning * (roi(2) + roi(4)))); % select photons 
within y range 
%    pselect = pselect(find(d.pdt(pselect) > 0.8e-9 & 
d.pdt(pselect) < 10.0e-9)); 
pchannel2 = pselect; 
pchannel2dark = pselect(find(d.pdt(pselect) > 11.5e-9 & 
d.pdt(pselect) < 12.5e-9));   %determine dark count within ROI 
within 1 ns 
 
 
%    pselect = find(d.channel == 2); % get photons for channel 2, 
background 
%    pselect = pselect(find(d.px(pselect) > p.binning * bkg(1) & 
d.px(pselect) < p.binning * (bkg(1) + bkg(3)))); % select photons 
within x range 
%    pselect = pselect(find(d.py(pselect) > p.binning * bkg(2) & 
d.py(pselect) < p.binning * (bkg(2) + bkg(4)))); % select photons 
within y range 
%    pchannel2b = pselect; 
 
counts = zeros(max(d.frame), 7) - 1; 
% get counts per channel (in frame only) 
for i = 1:p.frame_binning:max(d.frame) 
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photons1 = 0; 
photons1dark = 0; 
photons2 = 0; 
photons2dark = 0; 
 
for j = 1:p.frame_binning 
photons1 = photons1 + numel(find(d.frame(pchannel1) == (j - 1 + 
i))); 
photons1dark = photons1dark + numel(find(d.frame(pchannel1dark) == 
(j - 1 + i))); 
photons2 = photons2 + numel(find(d.frame(pchannel2) == (j - 1 + 
i))); 
photons2dark = photons2dark + numel(find(d.frame(pchannel2dark) == 
(j - 1 + i))); 
end 
 
counts(i, 1) = i; 
counts(i, 2) = photons1; 
counts(i, 3) = photons1dark * 12.5;  % scale up 1 ns dark count to 
whole detected range 
counts(i, 4) = photons2; 
counts(i, 5) = photons2dark * 12.5;   % scale up 1 ns dark count to 
whole detected range 
 
fprintf('Frame %d out of %d, c1 %d c2 %d\n', i, max(d.frame), 
counts(i,2), counts(i,4)); 
end 
 
% get counts per channel (out of frame and during retrace too) 
pchannel1 = find(d.channel == 1); % get photons for channel 1 
pchannel2 = find(d.channel == 2); % get photons for channel 2 
for i = 1:p.frame_binning:max(d.frame) 
ndx1 = find(d.frame(pchannel1) == i, 1, 'first');   % first photon 
of that frame 
ndx2 = find(d.frame(pchannel1) == (i + p.frame_binning), 1, 
'first'); % last photon before the next set of frames 
if isempty(ndx2) 
ndx2 = ndx1; 
end 
photons1 = ndx2 - ndx1; 
 
ndx1 = find(d.frame(pchannel2) == i, 1, 'first');   % first photon 
of that frame 
ndx2 = find(d.frame(pchannel2) == (i + p.frame_binning), 1, 
'first'); % last photon before the next set of frames 
if isempty(ndx2) 
ndx2 = ndx1; 
end 
photons2 = ndx2 - ndx1; 
 
counts(i, 6) = photons1; 
counts(i, 7) = photons2; 
fprintf('Frame %d out of %d, c1 %d c2 %d\n', i, max(d.frame), 
counts(i,6), counts(i,7)); 
end 
counts = counts(counts(:, 1) >= 0, :); 
 
Aroi = 1;    %   Aroi = roi(3) * roi(4); 
Abkg = 1;    %   Abkg = bkg(3) * bkg(4); 
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subplot(3, 3, 3); 
plot(counts(:,1), counts(:,2)); 
hold on 
plot(counts(:,1), counts(:,3)); 
plot(counts(:,1), counts(:,2) - counts(:,3) * Aroi / Abkg, 'r'); 
hold off 
title('Channel 1 ROI count'); 
 
subplot(3, 3, 4); 
plot(counts(:,1), counts(:,4)); 
hold on 
plot(counts(:,1), counts(:,5)); 
plot(counts(:,1), counts(:,4) - counts(:,5) * Aroi / Abkg, 'r'); 
hold off 
title('Channel 2 ROI count'); 
 
subplot(3, 3, 5); 
ratioROI = (counts(:,2) - counts(:,3) * Aroi / Abkg)  ./ 
(counts(:,4) - counts(:,5) * Aroi / Abkg); 
ratioROI(isnan(ratioROI)) = 0; 
plot(counts(:,1), ratioROI); 
title('ROI ratio (ch1 / ch2)'); 
 
subplot(3, 3, 6); 
plot(counts(:,1), counts(:,6)); 
title('Channel 1 full count'); 
 
subplot(3, 3, 7); 
plot(counts(:,1), counts(:,7)); 
title('Channel 2 full count'); 
 
subplot(3, 3, 8); 
ratio = counts(:,6) ./ counts(:,7); 
ratio(isnan(ratio)) = 0; 
plot(counts(:,1), ratio); 
title('Full ratio (ch1 / ch2)'); 
 
mat2clipXLS([counts ratioROI ratio], [], NaN); 
end 
 
Script was written by Dr. Michel Herde and Professor Christian Henneberger from the 
University of Bonn. 
 
 
 
 
 
